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4SUieiARY
This thesis deals with some factors affecting the plasma 
lipids in apparently healthy persons, in patients with athero­
sclerotic arterial disease, and in two groups of subjects 
predisposed to atherosclerosis; namely, habitual cigaratte- 
smokers and obese persons* It is in five main parts
1. A comparison of fasting plasma lipid concentrations in 
healthy and atherosclerotic subjects.
2. A comparison of fat tolerance tests in healthy and athero­
sclerotic subjects.
3. An examination of several aspects of gastric function alleged 
to influence fat tolerance; namely, the basal secretion, 
motility, and lipolytic ability of the stomach.
U* An investigation of the acute effects of cigarette-smoking 
on the plasma lipids and thrombotic tendency of the blood.
5. A study of the plasma lipid and other metabolic changes 
induced by therapeutic starvation in obese subjects.
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Chapter I INTRODUCTION
THE TlASmi LIPIDS
Lipids have been defined by Bloor (194-3) a.s "a group 
of naturally occurring substances consisting of the higher 
fatty acids, their naturally occurring compounds, and substances 
found naturally in chemical association with them*’. As long 
ago as 1774 Hcwson (see Gage and Fish, I924) demonstrated that 
the milky appearance of the plasma after a meal was due to 
fat particles, and later it was realised that fasting plasma, 
although optically clear, also contained lipid present in 
appreciable amounts in an extremely fine dispersion. Subsequently 
the main chemical classes of plasma lipids were identified as 
cholesterol, triglycerides, phospholipids and, most recently, 
the non-esterified fatty acids.
The pliysical state in wMch these lipids circulate in 
the blood is of considerable importance. It is now appreciated 
that lipids in biological systems exist in the form of protein- 
lipid complexes kno^m as lipoproteins, thus circumventing the 
poor solubility of most lipids in aqueous solutions. The plasma 
lipoproteins have been characterised according to their physical 
properties, such as density and electrophoretic mobility. The 
lipoproteins containing cholesterol, phospholipid, and
triglyceride migrate with the globulins on starch granule 
electrophoresis,” and have been classified into three main 
groups, as illustrated in Table I, Although cholesterol is 
transported mainly by the low-density lipoproteins, and 
triglyceride by the very-low-density lipoproteins, each of the 
three lipoproteins contains cholesterol, phospholipid, and 
triglyceride in varying proportions (Eder, 1957)* The 
non-esterified fatty acids, on the other hand, are almost 
entirely bound to albumin (Olson and Tester, I960).
The objective of this thesis is to consider some of the 
factors causing alterations in the plasma lipid levels. A 
description of the chemical structure and metabolism of each 
of the four main chemical classes of plasma lipids is given 
below.
CHOLESTEROL
(a) CHBIgCAL STRÏÏCTÏÏKS OF CHOLESTEROL
Cholesterol was first identified in human blood by Lecanu 
in 1858, and since then it has been estimated in almost every 
disease condition of man. Its chemical formula was established 
finally in 1932 by Rosenheim and King, and is shown in Fig. 1.
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Fig* 1* Structure of Cholestérol (cholest-5-ene-Sp-ol)
Plasma cholesterol exists mainly in the form of fatty- 
acid esters* The proportion of free cholesterol in the total 
plasma cholesterol is remarkably constant within narrow limits 
at 27 per cent, with the exception of certain liver diseases 
and lipidoses (Sperry, 1936).
(b) FUNCTIONS OP FIASMA CHOLESTEROL
Cholesterol is a precursor of other steroids, such as 
the bile acids, adrenocortical hormones, and sex hormones 
(Kritchevsky, 1938a), and some evidence has been produced 
to show that the cholesterol found in the testes, kidneys, 
adrenals, spleen, and lungs may be derived from the circulating
cholesterol (Landon and Greenberg, 1954)• It is generally 
accepted that cholesterol esters are involved in the metabolism 
and transport of fatty acids. Kritchevsky (196O) has suggested 
that the plasma cholesterol may also, in several ways, serve 
a structural purpose. There is a rapid interchange hetv/een 
plasma free cholesterol and red blood cell cholesterol (Hagerman 
and Gould, 1951), indicating that the plasma cholesterol 
may be necessary for the integrity of the red blood cell structure. 
The fact that cholesterol, both esterified and free, is present 
in all the serum lipoprotein fractions suggests that it may be 
implicated in maintenance of the stability of the lipoproteins 
also.
(0) ke:~taboi.ism op choibstbrol
In recent years a number of reviews of human cholesterol 
metabolism have been published (Kritchevsky, 1958; Whitehouse,
1964; Van Belle, 1965; Taylor and Ho, I967), and a brief account 
of the salient points is given here.
Origin of Plasma Cholesterol
The plasma cholesterol is derived from both endogenous 
and exogenous sources. Almost all tissues in the body are 
capable of synthesising cholesterol from two-carbon fragments
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(Srere ^  al., 1930), but plasma cholesterol originates mainly 
from the liver (Kaplan ^  al*, 1963), and probably also from 
cholesterol synthesis in the intestinal mucosa (Wilson and 
Dietschy, 1966). The contribution of dietary cholesterol 
to the plasma cholesterol is usually small, since the 
intestinal capacity for absorption of cholesterol is limited 
(Karvinen ^  al., 1937).
Catabolism of Cholesterol
Plasma cholesterol is in equilibrium with hepatic 
cholesterol, and the main catabolic pathway of cholesterol 
is conversion to bile acids in the liver (Gould and Cook,
1958). Some hepatic cholesterol is also excreted unchanged 
into the bile and thence into the intestine, where it mixes 
with cholesterol of intestinal cell origin resulting from 
desquamation and possibly also from direct excretion (Whitehouse,
1964). Faecal excretion of■ cholesterol and its catabolites 
occurs, therefore, in the form of bile acids, and of neutral 
steroids derived from unabsorbed dietary cholesterol and 
cholesterol of hepatic and intestinal origin.
Regulation of the Plasma Cholesterol Level
Regulation of the plasma cholesterol concentration therefore
XI
depends on a balance between factors tending to increase 
the cholesterol -level (increased cholesterol synthesis in 
hepatic and extrahepatio tissues, and intestinal absorption 
of cholesterol), and factors tending to remove cholesterol 
from the circulation (increased catabolism to bile acids or 
excretion as cholesterol, metabolism to other substances such 
as the steroid hormones, and possibly sequestration in tissue 
compartments such as muscle or connective tissue). Man 
appears to have little capacity for increased faecal bile 
acid or cholesterol output to compensate for increased amounts 
of absorbed dietary cholesterol (Chevallier, I96I). A negative 
feedback system whereby increased intestinal absorption of 
cholesterol reduces hepatic cholesterol synthesis is of 
considerable importance in the control of the plasma cholesterol 
level in animals. In man this mechanism appears to function 
in a less effective manner (Taylor and Ho, I967).
TRICtLYGBRIDE
(a) CHEMICAL STRUCTURE OP TRIGLYCERIRB
Triglycerides are esters formed by glycerol and fatty 
acids, and may be represented by the following structural 
formula:
12
CH^OCOR^
CHOCOR^
GH^OCOR^
where R^ , R^ , and R^  are the long-chain, hydrocarbon units of 
fatty acids, which may or may not be identical. The tendency 
in all natural fats is towards maximum heterogeneity in the 
composition of the constituent triglycerides (Diem, 1962).
Plasma triglyceride consists of two forms;- lipoprotein tri­
glyceride, which is present in fasting as well as in post­
prandial blood; and chylomicron triglyceride - the particulate 
fat which appears during absorption of a fatty meal. Diglycerides 
and monoglycerides are believed to be undetectable or present 
only in trace amounts in plasma under normal circumstances 
(Hirsch and Ahrens, 1958), although Carlson and Wadstrom (1956) 
reported that they might contribute up to 5 to 10 per cent of 
the total plasma glycerides.
(b) FUNCTIONS OF PL/iSM TRIGLYCERIDS
The bulk of dietary fat is transported from the intestine 
to the liver and other organs in the form of chylomicron 
triglyceride. The lipoprotein triglyceride is the mode of 
transport of fat, both exogenous and endogenous in origin, from
the liver to other organs. The plasma triglyceride is utilised 
in the body either directly to provide energy, or as a building 
material of cells, or stored in the fat depots to form a source 
of easily mobilised energy (Bergstrom, I960),
(c) METABOLISM OF PLASM TRIGLYCERIDE
Origin of Plasma Triglyceride
The triglyceride of fasting blood is synthesised in the 
liver. Its fatty acids are of complex origin, and appear to 
be derived from at least three sources:- chylomicron glycerides, 
plasma non-esterified fatty acids, and de novo synthesis in 
the liver from acetate, and thus indirectly from carbohydrate 
(Bergstrom, I960). Similarly, the glycerol moiety may be the 
product either of fat metabolism, when the triglyceride is syn­
thesised from monoglyceride, or of carbohydrate metabolism, 
when the starting-point of hepatic triglyceride synthesis is 
(^glycerophosphate. Although triglyceride is also synthesised 
in adipose tissue by these two routes (Steinberg ^  ^ . , I96I), 
there is no evidence that this triglyceride is released into 
the circulation.
The chylomicron triglyceride is derived mainly from 
dietary triglyceride. This is hydrolysed in the intestinal 
lumen to form monoglyceride, which is absorbed into the
14
intestinal cell where it is resynthesised, to triglyceride 
(Senior, I964). The chyloniicron then formed is composed of 
a triglyceride droplet with a coating of surfactant material 
(phospholipid, cholesterol, and traces of fatty acids) and an 
outer aone of adsorbed protein (Dole and Hamlin, 1962), The 
chylomicrons are transported via the lymph to the blood stream.
Removal of Plasma Triglyceride
Circulating chylomicrons are, for the most part, removed 
by the liver and secreted into the plasma again as very-low- 
density lipoprotein, which is taken up by adipose tissue, A 
variable proportion of the chylomicron triglyceride, depending 
on the nutritional state, is removed by adipose tissue (Shapiro, 
1965). Some of the chylomicron triglyceride may be utilised 
as a source of energy by the myocardium (Crass and Meng, I966) 
and liver (Shapiro, 1967).
The uptake and subsequent metabolism of chylomicron and 
lipoprotein triglyceride by adipose tissue and heart muscle 
requires the activity of an enzyme, lipoprotein lipase (Rodbell, 
i960), which is present in high concentrations in both these 
tissues (Korn and Quigley, 1955). The amount of lipoprotein 
lipase activity in adipose tissue is related to the rate of 
glucose utilisation in the tissue, and is enhanced by insulin
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(Hollenberg, 1959; Kessler, 1962), The role of this enzyme 
has recently been reviewed (Rodbell and Scow, I965). It does 
not appear to cause intravascular hydrolysis of triglyceride 
to any appreciable extent, but is thought to act by converting 
fat particles which have entered capillary endothelial cells 
into a form wliich- can be transported across the basement membrane 
into the adipose tissue cells. In.contrast to adipose tissue 
and heart muscle, the liver is deficient in lipoprotein lipase, 
and appears to possess some mechanism which permits the passage 
of esterified fatty acids, or perhaps even complete lipoprotein 
entities, through the cell wall without breaIcdo;m (Olivecrona, 
1962).
It is generally agreed that during assimilation by tte 
tissues the triglyceride molecule undergoes considerable and 
rapid degradation, and its constituent fatty acids are used 
in the synthesis of new triglycerides and phospholipids and 
also for combustion to carbon dioxide (Shapiro, I967).
In the liver both glycerol and fatty acids are incorporated 
into fat. In adipose tissue and heart muscle, however, the 
glycerol appears to be lost during uptake of the fatty acids, 
which are then esterified with cK-giycerophosphate to form 
triglyceride (Olivecrona, 1962).
_LO
PHOSPHOLIPID
(a) CHEMICAL STRUCTURE OF PHOSPHOLIPIDS
Phospholipids are complex esters which contain, in 
addition to an alcohol and long-chain fatty acid moieties, a 
phosphoric acid residue and a nitrogen-containing hase (Hanahan, 
i960). The plasma phospholipids consist predominantly of three 
giycerophosphatides (phosphatidyl choline, lysophosphatidyl 
choline, and phosphatidyl ethanolamine), and sphingomyelin.
Their chemical.formulae are shown in Fig* 2. Chromatography 
of human plasma lipoproteins has shorn that the phospholipids 
are present in the following proportions (Phillips, 1958):- 
phosphatidyl choline 69.1 per cent
sphingomyelin 19,0 per cent
lysophosphatidyl choline 7.1 per cent
phosphatidyl ethanolamine 4 .6 per cent
(b) FUNCTIONS OF THE PLASMA PHOSPHOLIPIDS
The various functions of phospholipids in the blood and 
tissues have been reviewed by Rossiter and Striclcland (i960).
It is now well-accepted that plasma phospholipids exist mainly 
as components of lipoproteins and chylomicrons. Phospholipids 
are believed to play an important part in fat transport in
Fig. 2. Chemical Formulae of Plasma Phospholipids
(a) Giycerophosphatides
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contributing’ to the structure and stability of these lipid- 
protein complexes. Certain phospholipids also participate 
in thromboplastin generation, and may be required for normal 
blood coagulation. In the tissues, phospholipids are intimately 
concerned with the structure of certain cellular components, 
and with the metabolic processes related to these structures, 
such as ion transport and protein synthesis.
(c) l,rSTABOI.IS?.I OF PIASia PHOSHIOLIPIDS
Origin of Plasma Phospholipid
The plasma phospholipids, although present in chylomicrons 
as well as lipoproteins, are almost entirely of endogenous origin. 
Experiments with tissue slices in vitro have shov/n that in most 
tissues the phospholipids are formed in situ from the appropriate 
isotopically-labelled precursors, such as inorganic phosphorus, 
fatty acids, glycerol, or nitrogen-containing bases (Rossiter 
and Strickland, i960). The primary source of the plasma 
phospholipids appears to be the liver, since in hepatectomised 
dogs the labelling of phospholipids with '2 is negligible in 
plasma, but normal in the kidneys and intestine (Fishier ab , 
1943). The chylomicron phospholipid is not derived from dietary 
phospholipid, which is broken dora almost completely in the lumen 
of the gut during digestion (Wilson, I962), but is formed by
IS
synthesis in the intestinal mucosal cell (Senior, I964).
Removal of Plasma Phosoholicid
The removal of plasma phospholipids appears to be carried 
out mainly by the liver, since the rate of removal of labelled 
phospholipids from the plasma of dogs is markedly reduced by 
evisceration (Entenman et 194-6), or hepatectomy (Harper
et al., 1953).
FUSMA NON-ESTERIFIED FATTY ACIDS (NEEA)
(a) CHEMICAL STRUCTURE OF NEFA
The non-esterified fatty acids are straight-chain saturated 
or unsaturated fatty acids containing an even number of carbon^  
atoms. In addition to the term non-esterified fatty acids or 
NEFA, first proposed by Dole (1956) and now achieving widespread 
acceptance, they have been designated as unesterified fatty 
acids or UFA (Gordon and Cherkes, 1956), and as free fatty 
acids or FFA (Bragdon, 1959)* Since most of the NEFA in plasma 
is tightly bound to albumn the term free fatty acid is somewhat 
misleading, and should probably be reserved for the small fraction 
which exists in free solution and is not measurable by present 
techniques. The term unesterified fatty acid, introduced shortly
19
after the terra NEFA, is less satisfactory, since it maybe 
confused with unsaturated fatty acid, also abbreviated to UFA.
The principal fatty acids in the NEFA fraction have 
been found to be present in the following proportions in venous 
blood (from Nakamura et §2.,, 196?)
kîyristic acid ( GI4 :0 ) 2.1 per cent
Palmitic acid (016:0) 3 2 ,4 per cent
Palmitoleic acid (Gl6:l) 6 .9 per cent
Stearic acid (C18:0) 10 .3 per cent
Oleic acid (018:1) 37.1 per cent
Linoleic acid (018:2) 11.1 per cent
The chemical formulae of these fatty acids are
(b) FUNCTIONS OF PLASMA NEFA
Although small quantities of NEFA had previously been 
found in lipid extracts from plasma, they were thought to be 
laboratory artefacts, until in 1947 Cohn et ol, and Davis 
reported that fresh human plasma contained NEFA. ' Gordon and 
Gherkes (1957) were the first to postulate that NEFA had an 
important function as the transport form of fat from the depots 
to different tissues for oxidation, and this has since been 
confirmed by numerous other workers. NEFA are extracted from 
the blood and utilised for energy by the liver, striated muscle, 
the heart, and other organs (Rothlin et 1962). In the
Fig* 3. Chemical formulae of plasma non-esterified fatty
acids.
(a) saturated fatty acids
CH^  (CH^)^^ COOH Myristic acid (C14;0)
CH^  (CH^)^ GOGH Palmitic acid (Cl6;0)
CH,5 Stearic acid (C18;0)
(b) monounsaturated fatty acids
CH^(CH^)^CH = CH(CH^)^GOOH Palmitoleic acid (Cl6;l)
CH^(GH^)^CH - CH(CH^)^COOH Oleic acid (ClSsl)
(c) polyunsaturated fatty acids
CH^(GH^)^GH = CH CH^  CH = CH(CH^)^C00H Linoleic acid (C18.:2)
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fasting state the human heart uses NEFA as its major source 
of energy (Gordon and Gherkes^  1956)• The very rapid turnover 
rate of plasma NEFA underlines their metabolic significance: 
the half-life for injected NEFA is reported to be approximately 
two minutes^ both in animals (Havel and Fredrickson, 1956; 
Bierman ^  , 1957b) and in humans (Fredrickson and Gordon,
1957 and 1958a; Laurell, 1957). .
(c) METABOLISM OF PIASMA NEFA
Origin of NEFA
The main source of the plasma NEFA has been shown to be 
the adipose tissue (Gordon and Cherkes, 1956; Hothlin et al.. 
1962). The NEFA carried to the circulation in the thoracic 
duct lymph has been found to be not of exogenous origin. It 
is thought to represent fatty acids mobilised from mesenteric 
adipose tissue, and to be quantitatively unimportant, accounting 
for only 1 to 7 per cent of the total lymph fatty acids in 
humans (Blomstrand and Ahrens, 1958). The contribution to 
plasma NEFA of fatty acids liberated by intravascular lipolysis 
of newly-absorbed lipids is believed to be small -(Borgstrom, 
I960).
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Release of NEFA from Fat Depots
The rate of release of I'lEPA from the fat depots is 
dependent on the state of carbohydrate metabolism, being 
increased in fasting, and decreasing' sharply after glucose and 
insulin administration (Dole, 1956; Gordon and Cherkes, 1956). 
Aminoacid administration has been reported to have an effect 
similar to glucose, although less marked (Dorgstrom, i960). 
Bierman £t al. (1957b) have shown that the decreased NEFA 
level seen after insulin injection is due to decreased outflow 
of fatty acids from adipose tissue, rather than to increased 
utilisation of plasma NEFA. The specific activity of plasma 
NEFA, previously labelled by injection of palmitic acid, 
increases after insulin administration. In vitro studies by 
Engel and %ite (1960) have demonstrated that the action of 
insulin in retarding net NEFA release is mediated through a 
primary action on carbohydrate metabolism, and not direct 
inhibition of lipolysis.
Administration of sympathomimetic amines, notably 
epinephrine, norepinephrine, and isoprenaline, results in rapid 
release of NEFA from fat depots. That the release of NEFA 
from fat depots is mediated by the activity of sympathetic 
nerves is shovai by the fact that it can be blocked by adrenergic 
blocking drugs of either the oc or the p type (innes and Nickerson,
22
1965)- Elevations of the plasma IlSPA level ocour in many 
conditions associated with increased sympathetic nervous system 
activity, such as mental stress (Bogdonoff £t , 1960), 
long-term exercise (Basu ^  af., I960), and hypoglycaemia 
(Armstrong e^ al., I96I; Y/erk ejb , I96I; Eroberg et af.,
1964). • '
Removal of Plasma N1]PA
By injection of G^^-labelled NEFA, the rate at which 
NEFA disappear from the plasma has been followed (Fredrickson 
and Gordon, 1958a) and has been found to be dependent on the 
NEFA concentration in the blood up to a concentration of about 
1 meg. per litre. Above this concentration a constant removal 
of about 50 per cent of the NEFA fraction talées place per 
minute. The NEFA have been shown to recycle in the plasma 
several times before oxidation, partly in the free state and 
partly after incorporation into triglyceride (Fredrickson and 
Gbrdon, 1958a). Injected labelled NEFA are distributed 
extensively to different tissues. Ten minutes after injection 
liver, lung, and heart are most heavily labelled, while 200 
minutes after injection the muscles contain the largest 
percentage activity (Bragdon and Gordon, 1958). Adipose tissue 
is also capable of assimilating NEFA (Stern and Shapiro, 1954?
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Laurell, 1959). The largest fraction of the labelled acids 
after injection of labelled NEFA is found in the triglyceride, 
phospholipid, and cholesterol esters of the different tissues 
(Dole, 1958).
The utilisation of plasma NEFA has been shown to be 
increased in starvation, and diminished after carbohydrate- 
feeding (Lossow and Ghaikoff, 1955). Removal of NEFA from 
the circulation is increased also by muscular exercise. During 
short-term vigorous exercise the muscular demand may temporarily ■ 
exceed the supply from adipose tissue, resulting in a fall 
in the plasma NEFA level (Wood ^  al., 1965),
INTERDEPENDENCE OF PUSMA LIPIDS
Although in the preceding four sections the metabolism 
of each of the four main chemical groups of plasma lipids has 
been considered separately, it will be apparent that this 
separation is somewhat artificial. The physical association 
of cholesterol, phospholipid, and triglyceride in each of the 
plasma lipoprotein fractions and in the chylomicrons (Eder,
1957) has already been mentioned, and it might be anticipated 
for this reason alone that alterations in the plasma concentration 
of one lipid might affect other plasma lipid levels. In addition, 
the complex metabolic processes of the individual lipids are
related in several ways. The central position of the fatty 
acids in lipid interrelationships has been discussed by Cook 
(1958). As their coenzyme A compounds, the fatty acids may 
be transferred to cholesterol esters, to phospholipids, and to 
triglycerides, and the synthesis of these lipids must be dependent 
on an adequate.supply of fatty acids. There is a constant 
interchange between circulating plasma NEFA and the fatty acids 
of other plasma lipids, in particular triglyceride, and the 
fatty acids of triglyceride incorporated in adipose tissue 
rapidly reappear as plasma NEFA. Both NEFA and triglyceride 
may be derived from products of carbohydrate metabolism, and 
the rates of production and utilisation of both these lipids 
may be markedly influenced by the state of carbohydrate 
metabolism (Bergstrom, I96O). The synthesis of phospholipid 
may also be connected with that of triglyceride, since the 
substance (X-glycerophosphate is a precursor common to triglyceride 
and the giycerophosphatides (Diem, 1962). In addition, fatty 
acids from dietary triglyceride are rapidly transferred to 
phospholipids in the liver (Olivecrona, 1962).
Inconfirmation of these theoretical considerations, it 
has repeatedly been observed that alteration of one plasma lipid 
may be associated i&th alteration of one or more of the other 
plasma lipids. The evidence that dietary factors, in particular 
the type of fatty acid in the diet, affect several of the plasma
25
lipids has been reviewed by Eilditch and Jasperson (1959)*
In general, the feeding of saturated fatty acids increases the 
plasma levels of cholesterol, triglyceride and phospholipid, 
whereas unsaturated fatty acids have the opposite effect. A 
prolonged increase in plasma NEFA concentration has been shown 
to stimulate increased lipoprotein synthesis in the liver, and 
result in increased plasma levels of both triglyceride and 
cholesterol (Nestel and Steinberg, 19&5). In experimental animals, 
infusions of phospholipid which produce sustained elevation of 
the plasma phospholipids lead to hypercholasterolaemia, but 
infusions of cholesterol fail to cause a secondary rise in 
plasma phospholipid. Similarly infusions of triglyceride 
quicicly induce raised plasma concentrations of both cholesterol 
and phospholipid. Friedman £t (1965) have described various 
clinical conditions, characterised by disorders of more than 
one plasma lipid, which they consider to be analogous to these 
experimental situations,
FACTORS AFFECTING PIASMA LIPID LEY15LS
Plasma lipid levels are influenced by a wide variety of 
factors, both physiological and pathological (Boyd and Oliver,
1958)* They include;- age; sex; race; social class; heredity; 
body weight; dietary constituents such as the type of fat,
26
protein, or carbohydrate, or certain vitamins; exercise; cigarette 
smoking; honmones of the thyroid, pituitary, adrenal, pancreatic, 
and sex glands; various diseases including wasting diseases, 
malabsorption, and the nephroses; environmental factors such as 
the season of the year; and a wide range of drugs. Any 
investigation of the plasma lipids must, therefore, of 
necessity be highly selective.
EVIDENCE LINICINCt ELEVATED PLiSI;IA LIPIDS V/ITH ATHEROSGLBROSIS
The current widespread interest in plasma lipids arose 
mainly from evidence linking blood lipid abnormalities with 
atherosclerosis, and in particular with ischaemic heart disease. 
This evidence was obtained both from animal experiments and 
from human clinical and epidemiological studies. The observation 
that cholesterol was a constituent of the atherosclerotic plaque 
was made more than a century ago (Vogel, I845). A number of 
early investigators were able to induce atherosclerosis in 
rabbits by feeding cholesterol-rich diets (Saltykow, I9O8), 
and the lipid infiltration of the intima was given the name 
atherosclerosis by Marchand (1904). Shortly thereafter it was 
established that cholesterol was the atherogenic stimulus 
contained in these diets (^ Initschl^ ovf and Chalatow, I915). This 
initiated a series of investigations which involved cholesterol-
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feeding in various experimental animals, and which produced 
gross hypercholesterolaemia and lesions resembling atherosclerosis. 
The application of these experiments to the problem of 
atherosclerosis in man, hovæver, has been disputed for several 
reasons: atherosclerosis does not occur spontaneously in these 
animals under normal circumstances; the experiments were of 
short duration; and despite the gross atherosclerotic lesions 
produced by these animal-feeding experiments myocardial infarction 
did not occur.
In man, it has been noted repeatedly that atherosclerosis 
is prominent in clinical states accompanied by hypercholesterolaemia, 
such as diabetes mellitus (liebow and Hellerstein, 1949)? 
nephrosis (Steiner and Doraanski, 1942). and familial 
hypercholesterolaemic xanthomatosis (Adlersberg et al,, 1949)*
In 1937 Davis ^  observed that man;;?* patients with coronary 
artery disease had raised serum cholesterol levels, and later 
workers showed that such patients might in addition have elevated 
levels of low-density lipoproteins (Gofman _et at,, 1950) and 
triglyceride (Albrinic and Man, 1959). More recent studies have 
suggested that peripheral arterial disease also may be associated 
with high serum lipid concentrations (Juergens et , I96O;
McPherson eb , I963? Begg, I965). Numerous epidemiological 
studies have indicated that people of countries or races with 
a high incidence of ischaemic heart disease tend to have higher
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serum cholesterol levels than those belonging to races with 
a low incidence of ischaemic heart disease (Keys, 1956).
More direct evidence linking elevated serum lipids with 
ischaemic heart disease has been supplied by large-scale 
prospective studies such as that in Framingham, Massachusetts, 
in which there is,strong evidence that the risk of developing 
ischaemic disease is related to the serum cholesterol 
concentration (Kannel et al., I964).
PATHOGENESIS OF ATHEROSCLEROSIS AND ITS RELATION TO PLASMA 
LIPIDS
Although there is a considerable weight of evidence 
relating elevation of plasma lipids to increased risk of athero­
sclerotic disease, this does not necessarily imply a causal 
relationship. The various ways in which elevated plasma lipids 
might influence either the development of the atherosclerotic 
process itself, or the severity of the clinical syndrome resulting 
from it, are still the subject of controversy, and have been 
discussed in detail in recent reviews (Bajusz, 1956; Fait on,
1965,' Van Belle, I965). Only three of the main theories of 
atherogenesis will be mentioned here.
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The Filtration Theor:^/'
The filtration theory (Page, 1954) suggests that the lipid 
of the atherosclerotic plaque has resulted from'infiltration 
of plasma lipids from the lumen of the blood vessel through 
the intima. The lipid deposit accumulates over the years, and 
the process may be accelerated by various factors: (a) the 
presence of blood lipid in excess amount, or possibly in abnormal 
form; (b) an increase in the filtration pressure; and (c) abnormal 
permeability of the vascular endothelium resulting from trauma.
The filtration theory affords a plausible explanation of the 
increased risk of atherosclerosis in the presence of elevated 
plasma lipids or hypertension, and also of the localisation 
of plaques at sites of turbulence or velocity change in the 
arterial system. The encroachment of the plaque on the lumen 
of the vessel then favours superadded thrombosis from circulatory 
stasis.
The Thrombogenic Theory
Another theory advanced to explain the relationship between 
elevated plasma lipids and atherogenesis is based on the 
observation that increased plasma lipid levels may be associated - 
with an increased thrombotic tendency, whether measured by clotting 
time (Duncan and Waldron, 1949), platelet survival (Mustard
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and Murphy, 1962), platelet adhesiveness or thromboplastin 
generation (McDonald and Edgill, 1957). This alleged increased 
liability to thrombosis would tend to aggravate, pre-existing 
atherosclerotic lesions, regardless of the mechanism by which 
these are formed. Alternatively, the increased thrombotic 
tendency may lead to formation of mural thrombus or fibrin 
encrustation on the arterial wall. According to the thrombo- 
genic hypothesis revived by Duguid (1954), these mural lesions 
become organised and vascularised. Over a period of time 
lipid accumulates in the lesions as a result of blood destruction 
from small haemorrhages recurring over long periods, and in 
this way atherosclerotic plaques are formed.
The Chylomicron Theory
The chylomicron theory of atherogenesis was proposed 
by Moreton (1947), following Hueper* s (1942) demonstration 
that macromolecular substances injected intravenously in 
animals were deposited in the arterial intima. . This theory 
has recently been restated by Gordon (1963). He has suggested 
that the circulating chylomicron, a carrier of triglyceride, 
phospholipid, and cholesterol, may be pumped into the normally 
clear "rand-zone" of the stream periphery, and enter the intima, 
causing the lesion of atherosclerosis. The process may be
facilitated by lessened blood velocity, and by increased 
chylomicron content of the blood. Plaque formation may thus 
be the result of a forced filtration of the chylomicron lipids.
In one or several of these ways, therefore, atherosclerotic 
disease may be caused, or aggravated, by plasma lipid abnor­
malities. However, since the mechanism of formation of the 
atherosclerotic plaque is still unlmown, in our present state 
of Imowledge the exact role of the plasma lipids must remain 
a matter for speculation.
MTIONALE OF THE PRESENT STUDY
Plasma cholesterol levels have been found to vary con­
siderably from country to country, and have been shovm to 
correlate with the various national mortalities from coronary 
artery disease (Boyd and Oliver, 1958). Other plasma lipids 
have been recorded in only a few of these surveys, mainly 
on account of their greater technical difficulty. An 
association has now been established between the risk of 
ischaemic heart disease and the plasma level of cholesterol 
(Kannel ^  , I964), and possibly of other lipids (Albrink
and Man, 1959; Carlson, 1960b). The male death rate in Scotland 
from arteriosclerotic and degenerative heart disease is the 
third highest in the world, being exceeded only by those of
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the South African European population and Finland (World 
Health Organisation, 1962). Within Scotland itself there are 
marked regional differences in mortality from ischaemic heart 
disease, the highest death rate being recorded in south-west 
Scotland (Bronte-Stewart, I965). It was therefore considered 
of interest to-determine fasting plasma lipid levels in a 
group of subjects with ischaemic heart disease, and to compare 
them with a group of apparently healthy controls in an area 
with a very high incidence of ischaemic heart disease (Glasgow). 
Little information is available on plasma lipid levels in 
subjects with forms of atherosclerosis other than ischaemic 
heart disease. A group of patients with peripheral arterial 
disease has therefore also been studied to determine whether 
or not they showed elevated plasma lipid concentrations.
Abnormalities in the plasma lipid response to a fat load 
have been reported in ischaemic heart disease, particularly in 
patients who had sustained a recent myocardial infarction 
(Schwarts et al., 1952; Barritt, 1956). These abnormalities 
in fat tolerance have been stated by some investigators to give 
better separation of coronary from healthy subjects than fasting 
plasma lipids (Brown ^  al., I96I; Stutman ^  aX., 1961) but 
tills claim has been disputed (Horlick, 1956 and 1957). Much 
of the apparently contradictory evidence may be due to the 
manner of selection of the subjects, and the relatively crude
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methods of plasma lipid measurement used in earlier studies.
In this study fat tolerance tests have been carried out in 
carefully selected groups of ischaemic heart disease patients 
and healthy controls in an attempt to determine whether the 
fat tolerance curve has any advantages over fasting plasma 
lipid measurement -as an indicator of clinical ischaemic heart 
disease. Fat tolerance tests have been performed also in subjects 
with peripheral arterial disease to determine if fat tolerance 
abnormalities are a feature of atherosclerotic disease other 
than ischaemic heart disease.
Fat tolerance is reported to be influenced by a number 
of factors related to the upper gastro-intestinal tract. These 
include gastric acid secretion (l^ rks et al. , 1962; Oliver,
1962), gastric lipolytic activity (Frazer, 194-3; Becker et al., 
1950)3 and gastric motility (Turner et al., I960). A comparison 
of each of these factors has been carried out in atherosclerotic 
patients and controls, to determine whether differences in 
these factors might account for any differences in fat tolerance 
in the two groups.
In recent years numerous reports have confirmed an 
association between cigarette smoking and atherosclerotic disease 
of the coronary and peripheral arteries (Royal College of 
Physicians of London, I962). . The reasons for this association
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are not Imoim, but several possibilities have been raised.
One suggestion is that the harmful effects of cigarette-smoking 
might be mediated by its effects on the plasma lipids, and 
another by its alleged production of an increased thrombotic 
tendency of the blood (Ashby et al., I965). Cigarette-smoking 
has been sho\m.to,be associated with elevated plasma lipids, 
both in long-term (Gofman et al., 1955; Karvonen et al., 1959) 
and in short-term studies (Kershbaum ab al., I96I and 1963).
An investigation has been undertalcen of the short-term effects 
of cigarette-smoking on plasma lipids and the thrombotic 
tendency of the blood, as measured by platelet adhesiveness.
Obesity is yet another factor associated both with 
increased liability to atherosclerotic disease (Keys, 1953;
Dawber et al., 1962), and with elevated plasma lipid levels 
(Waxier and Craig, 1964; Montoye et al., I966). In the last 
few years, total starvation has been used to achieve weight 
reduction, in an effort to alleviate some of the complications 
of obesity. It has been suggested, however, that rapid weight 
loss may cause an increased liability to thrombotic complications 
(Beckett and Lewis, I960). A study has been undertalcen of the 
lipid changes induced in obese patients by total fasting, and 
any simultaneous alterations in thrombotic tendency, as measured 
by platelet adhesiveness, have also been investigated.
The objectives of tliis study, therefore, are four-fold:-
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to compare the plasma lipids before and after fat-loading in 
atherosclerotic and healthy subjects; to examine several gastro­
intestinal factors that may alter the response of these subjects 
to fat-loading; to investigate acute plasma lipid changes in 
cigarette-smokers, a group predisposed to atherosclerotic 
disease; and to follow plasma lipid fluctuations during starvation 
in the obese, another group with an increased liability to 
atherosclerotic disease.
Chapter II. MSTHOPS FOR IHB AMLYSIS OP PTASMA LIPIDS
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Chapter II. IVETHODS FOR THE ANALYSIS OF PIASMA LIPIDS
This chapter describes the procedures and chemical methods 
used throu^out this study for the determination of lipids in 
plasma or serum. Other methods employed only in certain 
sections of the work are dealt with in the appropriate section.
COLLECTION OF BLOOD SAMPLES
All subjects were admitted to a general medical ward, 
and fasting blood samples were taken after an overnight fast 
of approximately twelve hours. Venous blood samples were 
withdrawn from an antecubital vein using a standard no. 1 
needle and a plastic syringe. Care was taken to avoid pro­
longed venous occlusion, which may result in increased con­
centrations of the non-filterable blood constituents (iCoerselman 
et al., 1961) or fist-clenching, which may alter non-esterified 
fatty acid and glucose levels (Rabinowitz and Zierler, 1962). 
Because of the effect of changes in posture on the concentration 
of the non-filterable blood constituents (Stoker and Wynn,
1966), subjects remained in bed until the fasting blood 
sample had been taken, and assumed the recumbent position 
for at least 50 minutes before any further venepunctures.
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PROCESSING OF BLOOD SAlvIPLSS
Plasma for lipid estimations was obtained from 
heparinised blood (50 units heparin per ml*) which immediately 
after collection had been centrifuged for $0 minutes at 
1,500 r.p.m*' Blood samples for serum were placed for one 
hour in a heating block at 37^0 to allow clot retraction before 
centrifugation and separation of the serum. Plasma and serum 
samples for estimation of total or individual non-esterified 
fatty acids (NEFA) were extracted not later than two hours 
after venepuncture, since beyond this time the NEFA level tends 
to rise as a result of triglyceride hydrolysis. The extracts 
mi^t then be stored in a refrigerator for 24 to 48 hours 
without alteration in the NEFA concentration (Forbes and 
Gamlin, 1959). Plasma and serum samples for the other lipid 
estimations were stored at -15 to -20^0 in a deep freeze until 
analysed*
ESTIMATION OF TOTAL CHOLESTEROL
The quantitative determination of total cholesterol 
in plasma or serum was performed by the Technic on autoanalyzer
*
Heparin injection B.P* 5,000 units per ml,
method N-24P, with several minor modifications, ' This method, 
which is based on that described by Zak e t (1954), depends 
on the reaction of ferric chloride in acetic acid and con­
centrated sulphuric acid with steroids having the 5-ene,3p-ol 
grouping.
The modifications of method N-24P are as followss-
(a) A modified aspirator head consisting of a double sampling 
crook was designed so that after aspiration of a plasma sample 
a wash of isopropyl alcohol {90fo) was sucked up and carried 
through the system. This gave a steadier baseline,
(b) .An extra acidflex tube was incorporated into the manifold 
to increase the number of acid-carrying tubes from three to 
four. This allowed a larger volume of acid to react with the 
sample and resulted in faster colour development,
(c) Isopropyl alcohol (9C^) was used in the preparation of 
standards to approximate more closely to the concentration 
of isopropyl alcohol in the extracted plasma sample.
A description of the materials and procedure used is 
given below, 
mTERIALS
Isopropanol* Analar (B,D.H.)
Glacial acetic acids Analar (B,D,H,)
Sulphuric acid (concentrated)s Analar (B.B.H,)
4U
Ferric chloride - hydrated (Fe Ol^.^EgO); Analar (B.D.H.) 
Standard serum; Hyland Labs., Los Angeles, TJ.S.A.
Cholesterol (B.D.H.)
(a) Preparation of Cholesterol Colour Reagent
Ferric chloride (l g.) was dissolved in 100 ml. 
distilled water, and glacial acetic acid added to make the 
solution up to 2 litres. Sulphuric acid (86o ml.) was then 
added and mixed. The reagent was stored in an amber-coloured 
bottle in the dark, and was stable for approximately one 
month.
(b) Determination of Cholesterol
Isopropanol (9*5 ml.) was added to 0.5 ml. of plasma 
or serum, mixed, and centrifuged. The supernatant was then 
analysed for total cholesterol. The standard serum was 
extracted in a similar manner. A flow diagram of the method 
is shown in Fig. 4* The optical density of the colour produced 
by the cholesterol and the ferric chloride colour reagent was 
measured at 5 0^ mjx in a flow.cuvette, and a double wash of 
90^ isopropanol in water was carried out after every sample 
to prevent cross-contamination. A standard serum sample and 
a series of cholesterol standards (100 to 500 mg. per 100 ml.)
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Fig. 4 * Flow diagram of method for cholesterol 
estimation.'.
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in isopropanol were run with each hatch of 12 samples.
(c) Calculation
The optical density of the colour reaction was recorded 
as a tracing on paper calibrated in optical density units. 
When the peak heights of the standards were plotted against 
concentration a linear relationship was observed (Fig. 5)- 
The pealc heists of the test samples were then converted to 
concentrations using this graph. The standard serum was used
as a correction factor A
{ a a known concentration of standard serum \
' m a n  "tT-î rw» a 4:q vi/Î a / *
This fa c to r , w hen .m ultip lied  by the concentrations of the  
te s t  samples, e lim in ated  erro rs  due to  fa c to rs  such as s lig h t  
v a ria tio n s  in  temperature during a day's run.
A comparison of this method with that of Abell ^  al. 
(1952) on ^88 duplicate serum samples showed a correlation 
coefficient of 0.80. The regression equation was 
Y =* O.686IX + 85.53» 
where Y is the cholesterol value in mg. per 100 ml. obtained 
by the autoanalyzer method, and X is the corresponding value 
by the method of Abell et al.
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4^ESTIMATION OF TRIGLYODRIDE
The quantitative determination of plasma or serum 
triglyceride was carried out by the method of Van Handel and 
2ilversmit (1957)* This micromethod is based on the measurement 
of the glycerol component of the glyceride molecule.
The procedure consists essentially of four steps 
(l) the quantitative extraction of plasma lipids and separation 
of triglyceride from other glycerol-containing lipidsj (2) the 
complete saponification of triglyceride; (p) the oxidation of 
glycerol to formic acid and formaldeliyde; and (4) the colorimetric 
estimation of formaldehyde. The extraction procedure used 
differed from that of Van Handel and Zilversmit, and the method 
is described below. 
mTBRIALS
Ethyl alcohol; redistilled.
Bloor's solution: (3 :1 ethanol:diethyl ether)
Sulphuric acid: Analar (B.D.H.)
Silicic acid: Ilîallinckrodt, 72-350 mesh.
Sodium periodate; Analar (B.D.H.)
Sodium arsehite; Analar (B.D.H.)
Chromatropic acid (4,5-&ihydroxy-2,7-napthalene-
\ ^disulphonic acid disodium salt) .
it
Eastman Organic Chemicals, Rochester, 3> Nevf York.
4^
Triolein: (B.D.H.)
METHOD
(a) Preparation of Ghromatropic Acid j^ .agent
Giiromatropic acid (l g. ) was dissolved in 100 ml, water. 
Immediately before use 9 parts of sulphuric acid {66%) were
mixed with 2 parts of chromatropic acid solution to form the
chromatropic acid reagent.
(h) Extraction and Separation of Triglyceride
3 ml. of plasma were extracted with Bloor's solution.
The precipitated protein was removed by filtration and the 
filtrate made up to 50 ml, in a volumetric flask. Duplicate 
2 ml. aliquots were evaporated to dryness in Qulclcfit test 
tubes (20 ml. capacity) and approximately 200 mg. silicic acid 
added. 5 ml. of chloroform was then added to each tube which 
was then shalcen and centrifuged. The chloroform layer was 
carefully drawn off without disturbing the silicic acid.
The chloroform layer contained the triglyceride, while the 
phospholipids were retained on the silicic acid.
(c) Determination of Triglyceride
Duplicate 3 ml. aliquots of the chloroform solution 
were evaporated to dryness in 20 ml. Quickfit test tubes.
Ethyl alcohol (l ml.) and one drop of 5*0% potassium hydroxide
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in ethyl alcohol were added, and the tubes heated at 60 C^ 
for 50 minutes to ensure complete saponification of the 
triglyceride. The solutions were then acidified by addition 
of 4 drops of 6.CÇb acetic acid in methanol before being taken 
to diyness in a boiling water bath. 1 ml. of O .67 Li sulphuric 
acid was then added, and the tubes were gently shaicen.
Sodium periodate 0.02 M (0.3 ml.) was added to each tube 
which was then shaicen and allowed to stand for 10' minutes before 
the addition of 0.5 ml. of 0.2M sodium arsenite. This neutralised 
any excess of periodate present. At this stage a transient 
yellow colour appeared which was due to the liberation of iodine. 
The chromatropic acid reagent was not added until this colour 
had faded.
Addition of 8 .4 ml. of chromatropic acid reagent to each 
tube v/as carried out in a shaded room, since the reagent is 
light-sensitive. The tubes were then stoppered, shaken, and 
placed in a boiling water bath for 30 minutes. The tubes were 
then allowed to cool and the optical densities of the solutions 
were read at 570 mp in a spectrophotometer (Unicam S.P. 600) 
in 1 cm. cuvettes, using the blanlcs as zero. Duplicate 
triolein standards (25 pg to 100 pg) and chloroform blanlcs 
(2 ml.) were treated in the same manner as the plasma extracts.
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(d) Calculation
A straight-line graph v/as obtained by plotting the optical 
density against the concentration of the standards (Pig. 6), 
and plasma triglyceride concentrations were calculated from 
the following formula*
Plasma triglyceride concentration (mg, per 100 ml.) = 
mg. triolein (from graph) x ^  x ^  x
50 vol. of Bloor's extract
v^ liere ^  represents VolV of aliquot taken ' '
represents vol. of plasma extracted
and ^ represents the 3 ml. aliquot taken of the 5 ml. 
chloroform added.
ESTIMATION OF PHOSPHOLIPID
Plasma total phospholipid was estimated by Bartlett's 
(1959) modification of the method of Eiske and Subbarow (I925) 
which measures lipid phosphorus. The following steps are 
involved:- (l) the extraction of the plasma lipids; (2) the 
destruction of organic materials by wet digestion; and (3) 
the colorimetric determination of phosphorus in the residue. 
The colorimetric estimation is based on the observation that 
certain agents reduce the molybdenum of phosphomolybdic acid
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but have only a negligible effect on the molybdenujn of 
uncombined molybdic acid in the same solution, A description 
of the method is given below.
MATERIALS
Potassium dihydrogen phosphate; Analar (B.D.H.)
Ammonium molybdate: Analar (B.D.H.)
Sodium metabisulphite: Analar (B.D.H.)
Sodium sulphite (anhydrous); Analar (B.D.H.) 
l"amino-2-naphthol-4-sulphonic acid; (B.D.H.)
Sulphuric acid; Analar (B.D.H.)
Hydrogen peroxide (100 vols.) (phosphorus-free);. Analar (B.D.H.) 
Bloor's solution (3:1 ethanol;dietliyl ether)
METHOD
(a) Preparation of Fishe-Subbarow Reagent
l-amino-2-naphthol-4-sulphonic acid (0.5 g.) was dissolved 
in 195 ml. of 15% sodium bisulphite, and 5 ml. of 20^ sodium 
sulphite was added. The filtered solution was stored in a dark 
bottle and was stable for two weeks,
(b) Measurement of Phospholipid
Plasma (3 ml.) was extracted into 50 ml. Bloor's solution, 
as described for the triglyceride estimation. Duplicate 2 ml.
aliquots of the extract were evaporated to dryness and 0,5 ml. 
of 10 N sulphuric acid added to each tube. The tubes were then 
placed in a heating-block at 170-180^0 for ij* hours, after which 
time 0,2 ml. of hydrogen peroxide was added while the tubes 
were still hot. The tubes were left in the heating-block 
for a further 1^ hours, in order to ensure complete combustion 
and to decompose any residual hydrogen peroxide. They were 
then removed from the heating block and 4*4 ml, of distilled 
water was added immediately, followed by 0.2 ml, of 5% 
ammonium molybdate. Piske-Subbarow reagent (0,2 ml.) was 
then added, and the contents of the tubes mixed before being 
placed in a boiling water bath for 7 minutes. Each sample 
was then diluted to 50 ml. with distilled water and the optical 
density read in a spectrophotometer (Unicam S,P. 600) at 830 mp 
using a red filter. Phosphorus standards (potassium dihydrogen 
phosphate solution of concentration 5 Pg. phosphorus per ml,; 
standards 5 to 20 pg, phosphorus) and sulphuric acid blanks 
were carried throughout the procedure,
(c) Calculation
By plotting the optical density of the phosphorus standards 
against concentration, a linear relationship was obtained 
(Fig, 7) from which the phosphorus content of the plasma samples 
were derived. The plasma phospholipid concentration was then
O.D.
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calculated as mg, lecithin per 100 ml, from the following 
formula :-
Plasma phospholipid (mg. per 100 ml.) =
where X is the phosphorus content of the samples expressed as 
jug. per ml., and 25 is the factor for conversion of inorganic 
phosphorus to phospholipid,
PLASM M^^ESTERIFIED FATTY ACIDS (NEFA)
Total plasma NLÏ'A concentration was measured by the 
method of Dole and Meinertz (i960). The principles of this 
procedure ajre as follows:- plasma lipids are extracted into 
a one-phase ternary mixture (heptane-isopropyl alcohol-sulphuric 
acid) which, after the addition of water and heptane, separates 
into a two-phase system; the upper non-polar phase contains 
the long-chain fatty acids (NEFA)^  while other more polar acids 
remain in the lower phase; the NEFA in' an aliquot of the upper 
phase are then titrated in a second two-phase system. Details 
of this method are given below*
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MTEKIALS
n-Heptane: redistilled (May and Balder)
Isopropyl alcohol; redistilled (B.D.H.)
Ethyl alcohol: redistilled.
Nile blue: (B.D.H.)
Sodium hydroxide; Analar (B.D.H.)
Sulphuric acid; Analar (B.D.H.)
Palmitic acid; recrystallised (B.D.H.)
Nitrogen gas
Carbon dioxide-free water 
METHOD
(l) Single Extraction Procedure
(a) Preparation of Nile Blue Indicator
Nile blue (0.02 g. ) was dissolved in 100 ml. of ethyl 
alcohol, washed 6 times with hexane, and diluted 1 in 10 
with ethyl alcohol.
(b) Extraction
One tube containing 10 ml. extraction mixture, isopropyl 
alcohol;n-heptane;l N sulphuric acid (4.0:10:1), was set up 
for each sample and also for 3 standards and one blank. Plasma 
(2 ml.) was pipetted into each sample tube, and carbon dioxide-
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free water (2 ml.) into the tubes for standards and blanks.
The contents of the tubes were mixed and allowed to stand for 
5 minutes. Carbon dioxide-free water (4 ml.) in n-heptane 
(6 ml. ) were added to the sample and blank tubes, the contents 
mixed, and allowed to separate into two layers.. To each of the 
tliree standard tubes were added 4 ml. of carbon dioxide-free 
water and 6 ml. of standard palmitic acid solutions in n-heptane, 
of concentrations 2.5 mg., 5.0 mg., and 7.5 mg. per 100 ml, 
respectively.
(c) Titration
An aliquot (3 ml.) from the heptane layer was pipetted 
into a conical centrifuge tube together with 1 ml, of Nile 
blue indicator. Dry, carbon dioxide-free nitrogen (passed 
through dilute alkali and a calcium chloride tower for 30 
minutes before use) was then gently bubbled through the 
mixture while titration of the NEFA was carried out using 0.018 N 
sodium hydroxide in a Conway burette. The end-point was reached 
when the infranatent turned pink. Standards and blanks were 
titrated in the same manner.
(d) Calculation
By plotting the titre against the concentration of.the 
standards a straight line graph was obtained from which the
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NEFA concentration of the plasma samples was calculated (Fig, 8). 
Plasma NEFA (expressed.as mg. of palmitic acid per 100 ml, plasma)
where X is the reading obtained from the graph, 8 .6 is the 
volume in ml, of heptane supernatant obtained, and 3 :1 is the 
ratio of volumes of standard and plasma samples titrated.
Plasma NEFA (peq, per 1. )
= 39.00
(2) Double Extraction Procedure
This method was used in the starvation studies described 
in GhapterVII, in order to eliminate interference by increased 
plasma concentrations of acetoacetic acid and p-hydroxybutyric 
acid.
Plasma (4 ml. ) was extracted with double the quantity 
of reagents used in the single extraction procedure, and a 
3 ml. aliquot of upper phase was taken for titration of single 
extraction acidity. A further aliquot (8 ml.) of upper phase 
was transferred to another extraction tube. After addition of 
14 ml, of blank lower phase (the lower phase talcen from a blanlc 
extraction), the contents of the tube were mixed by inverting 
about 25 times. The two phases were allowed to separate, and
0 -018N. N a O H  
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a 3 ml. aliquot of upper phase was taken for titration.
Palmitic acid standards were treated similarly^ and a straight- 
line graph was obtained for the double extraction procedure 
(Fig, S). The plasma NEFA concentrations given by single 
and double extraction methods were then calculated.
INDIVIDUAL N0N~E8TEEIFIED FATTY ACIDS
The'proportions of the individual non-esterified fatty 
acids present in serum were measured by a combination of thin 
layer chromatography and gas liquid chromatography. Details 
of the procedure are given below.
METHOD
(a) Extraction of Serum Lioids
This was carried out within two hours of venepuncture.
Serum (3 ml. ) was pipetted into a tube containing approximately 
20 ml. of Bloor*s solution and the tube placed in a boiling 
water bath for 2 minutes. The precipitated protein was filtered 
off, and washed twice with fresh Bloor*s solution, and the 
combined extracts evaporated to dryness with a stream of 
nitrogen. The residue was dissolved in the minimum volume 
of diethyl ether and then subjected to thin layer chromatography.
(b) Thin Laver Cliromatography (T.L.Q. )
A glass plate (20 cm. x 20 cm,) was coated with a layer 
(0,25 mm. thick) of Adsorbosil impregnated with Rhodamine B.
The plate, following application of the lipid extract and 
standards, was developed in hexane/diethyl ether/methanol/ 
acetic acid (90:20:3:2 v/v) (Brown and Johnson, 1962) and 
the separated lipids visualised under ultraviolet light 
(3650 A), The band with the same Rf as the fatty acid standard 
(Fig. 9) was accurately outlined and scraped from the plate 
into a test-tube. The fatty acids were eluted from the silica 
gel with petroleum ether (40-60^ ).
(c) Gas Liquid Chromatography (G.L.C.)
The fatty acids obtained from the T.L.C,. plate were 
methylated, using in an early section of the study (Chapter 
VI) the methanol; sulphuric acid method (Morrison and Smith, 
1964). In later phases of the study (Chapter VII) the more 
rapid boron trifluoride: methanol method was employed (Metcalfe 
and Schmitz, I96I),
The fatty acid methyl esters were then separated by gas 
liquid chromatography on a U-shaped glass column (length 3 ft., 
internal diameter 4 mm.), packed with 13^ polyethylene glycol 
adipate (P.E.G, A, ) on acid-washed, siliconised Gas Chrom P
SAMPLE 1 Stds, SAMPLE 2
c ho le s te ro l
ester
t r ig lycer id  e
NEFA
c h o l e s t e r o l
origin
Fig# 9# Dia^ gram of thin layer chromatogram 
showing separation of îTKFA band.
>4
(100-120 mesh). The colvimn temperature was 180^0 and the 
argon flow-rate $0 ml. per minute. Under these conditions 
fatty acids of chain length 012 to 018 were well separated 
from each other (Fig. 10).
Calculation
The areas of the fatty acid peaks obtained were calculated 
by multiplication of the peak height by the width at half the 
height (Homing, I964). The proportions of the individual 
fatty acids were expressed as percentages of the whole.
STATISTICAL ANALYSIS
Differences in mean values betvæen two 'groups were assessed 
by the Student ’t’ test, and the significance of changes from 
a baseline level by the Student 't' test for paired values. 
Correlations were performed by linear regression analysis, 
except in the case of cholesterol, phospholipid, and triglyceride 
values in male controls (Chapter III) where second order 
polynomial equations were used. In the latter case, additional 
lipid values for the eight male subjects described on page I6I 
were included, in order to extend the age range. Triglyceride, 
total plasma NEPA, and skinfold thickness values were found 
to have a skew population distribution, and logarithmic
¥ig* 10# G*L*C* ohart showing: separation of individual 
KEiFA (A-»iîiyfistio aoicl, B-palmitic acid, 
C«palmitolGic acid, B-stearic acid,
E!-oleio acid, ?-linoleio acid)»
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transformation of these values v/as therefore carried out prior 
to statistical analysis*
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Chapter III. FASTING PUS?a LIPIDS 
INTRODUCTION
Reports of plasma lipid levels in normal subjects in 
Great Britain are few in number and, in particular, the 
literature on plasma triglyceride and NEFA concentrations 
is scanty. More information is available on plasma lipids 
in atherosclerotic subjects. In this Chapter the results 
of fasting plasma lipid estimations in healthy controls and 
in atherosclerotic subjects are presented. These were, in 
fact, the basal blood samples taken as a preliminary to the 
fat-loading test described in Chapter IV,
The influence of several factors which might affect 
plasma lipid levels is considered - namely age, sex, v/eight, 
habitual cigarette-smoking, and a family history of ischaemic 
heart disease. A comparison is then made between plasma lipids 
in healthy subjects and patients with atherosclerotic arterial 
disease.
SUBJECTS
The subjects studied were divided into two main groupss-
(a) controls, and (b) arterial disease patients. The clinical
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details of these subjects are presented in Table II.
(a) Control Subjects
There were 72 control subjects, of whom 50 were males, 
with a mean age of 44*5 j; 11,2 years (mean ± standard deviation), 
and 22 were females, y/hose mean age was 44.0 ^ 15,7 years.
The age distribution of these subjects is shown in Fig. 11.
Selection of Control Subjects
The controls were healthy subjects who required minor 
surgical operations for conditions such as varicose veins and 
hernias, and who were invited to volunteer as subjects for 
this study. Those with clinical or electrocardiographic 
evidence of atherosclerosis were eliminated. The controls 
were admitted to a medical ward for the purpose of this 
investigation for 24 to 48 hours prior to operation.
(b) Arterial Disease Subjects
These were 86 subjects with clinical atherosclerotic 
disease. They consisted of 72 males with a mean age of 55-0 ^
7*9 years, and I4 females of mean age 59*4 ± 6.2 years. The 
age distribution of these subjects is shov/n in Fig. 11.
Of the 72 male arterial disease subjects, 27 had sustained
TABLE II; Clinical Details of Subjects (mean ^  S.D*)
Subjects Haight(cm.)
Relative^
Weight
Family 
History 
of I.H.D."
fo
1 Cigarett 
j Smokers
Controls - male 170.7 ± 8 .4 111.9 + 12 .9 11
1
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all ages (n a 34) (n = 34) . (n « 36) 1 (n = 47)
Controls - male 169.9 + 9 .1 116.0 + 14.1 12 i 52
aged 40 and over (n = 21) (n = 21) (n - 26) 1 (a = 51)
Arterial Disease 168.7 ± 6.6 117.9 ± 12.2 ; 50 : 85
male (n “ 61) (n =* 60) i (n = 66) (n - 68)
%ocardial Infarct 169.7 + 5 ,8 116.0 ± 8 .5 ' , 58 84
male (n = 24) (n « 24) (n = 26) 1 m  = 25)
Angina Pectoris 168.1 + 5"6 125.9 + 12.6 57 ! 71
male (n = 16) (n = 16) (n = 19) 1 (a = 17)
Peripheral Art. 168.1 + 8 .1 115.8 i 15.3 , 52
1
1 96
Disease - male (n « 21) (n - 20) (n <= 21) I (n = 26)
Controls - female 161.5 + 4 .3 120.4 + 27 .4 25 56 .
all ages (a = 11) (n « 11) (n = 20) 1 (n = 22)
Controls - female 160.0 + 4 .6 118.0 f 25.4 25 56
aged 50 and over (n =■ 4) (n = 4) (n = 8) 1 (n = 9)
Arterial Disease 156.2 + 4 .8 114.5 ± 12.2 29 ! 71
female (n = 11) (n - 11) (n = 14) (n = 14)
: :_________________ . ---------- -
/Actual weight as percentage of standard weight 
(Kernsley et al., I962)
*
I.H.D. « ischaemic heart disease 
n = no. of observations
CONTROLS (males)
No. of SUBJECTS 
10 -  
5 -  
0
CONTROLS (female)
I Q ­
S '
0 1 T- 1 r i 1— 1
COMBINED ARTERIAL 
DISEASE GROUP 
(male)
20 -1
10 -
MYOCARDIAL INFARCTION
10 ■
5 ■ 
0
10
5
0
10
5
0
(male)
A N G IN A  PECTORIS
(male)
PERIPHERAL ARTERIAL DISEASE 
(male)
a/}in77n
10 
5 
0
COMBINED ARTERIAL DISEASE 
(female)
r n - A - -
20 40
A G E  in Y EA R S
60
11. distribution of subjects.
59
a myocardial infarction, 19 had angina pectoris, and 26 had 
peripheral arterial disease* Further particulars of these 
three groups are given below. In the female group there were 
7 with myocardial infarction, 2 with angina pectoris, and 5 
with peripheral arterial disease. Because of their small 
numbers, the results of the female arterial disease group are 
considered as a whole.
Selection of Patients with Myocardial Infarction
These were selected from patients.attending a medical 
outpatient clinic who had sustained a myocardial infarction, 
confirmed by electrocardiography and/or serum glutamic-oxaloacetic 
transaminase estimations, at least 6 months previously. All 
were taking a normal, unrestricted diet. Twelve patients were 
receiving longterm anticoagulant therapy - ten with phenindione 
and two with warfarin. Only one subject was taking thiazide 
diuretics. The 27 male subjects had a mean age of 51*4 ± 8.1 
years. Of these 27 subjects, 7 also showed evidence of peripheral 
arterial disease, and one had both peripheral and cerebral 
atherosclerotic disease.
Selection of Patients with Angina Pectoris
This group consisted of subjects with a definite history 
of retrosternal pain induced by exertion, but with no history
ou
of prolonged episodes of chest pain (longer than $0 minutes)
01' electrocardiographic signs of myocardial infarction. Of 
the 19 male and 2 female subjects, definite evidence of 
myocardial ischaemia was present in the resting electrocardio­
graphic tracing in 12, and in a post-exercise tracing in 6 
subjects. In two. instances the post-exercise tracing showed 
suggestive, but not diagnostic changes, and one was completely 
normal. The 19 male subjects had a mean age of 53*5 ± 7*2 
years. One had peripheral arterial disease in addition to 
ischaemic heart disease.
Selection of Patients \7ith peripheral Arterial Disease
These were subjects with moderate to severe symptoms 
of peripheral arterial disease who were admitted to hospital 
for arteriography and assessment for surgical treatment. None 
had symptoms or electrocardiographic signs of ischaemic heart 
disease, nor did they have gangrene or infections of the lower 
limbs. There were 26 male subjects with a mean age of 54*8 
+8.1 years.
PHOGEDUEE
The subjects were admitted to the ward on the day prior 
to the test, A standard meal of Icnovm fat content (50 g. fat,
OJL
contained in a meal of two eggs, bread and butter, and tea) 
was given at 5 P#m. and a light supper (a mille drink and 
biscuits) at 9 p.m. Cigarette-smoking was not permitted from 
10 pirn, until completion of the test on the following day.
The subjects remained at rest in bed until the fasting blood 
sample was taken at 9 a.m.
Blood samples were taken for plasma lipid analyses 
(total cholesterol, triglyceride, phospholipid, and total 
NEPA), and processed as described in Chapter II*
RESULTS
It was found useful in analysis of the plasma lipid 
results to divide the subjects into four main groups - male 
controls, female controls, male arterial disease subjects, 
and female arterial disease subjects# In these four groups 
the effects on each of the plasma lipids of the following 
factors were considered*- age, sex, body weight, habitual 
cigarette-smoking, and the presence of a family history of 
ischaemic heart disease. Having tEiken into account the influence 
of these factors, a comparison was then made between the plasma 
lipid levels in healthy controls and arterial disease subjects 
and, in males, between the different clinical types of arterial 
disease# Because of the differing age structures of the control
and arterial disease groups (Fig. 11) the results were analysed 
also in male controls of 40 years and over, and in female 
controls of 50 years and over, for comparison with those 
of the arterial disease subjects.
FASTING PIASm CHOLESTEROL
The mean plasma total cholesterol values for the different 
groups are given in Table Illir
I. EFFECT OF AGE 
Male Controls
The plasma cholesterol was found to be relatively low 
in young male subjects, and to increase with age to a maximum
I
level about the age of 45 years. Thereafter it showed a
tendency to decline progressively up to the age of 65# This
parabolic relationship of age and plasma cholesterol level 
was statistically significant (Fig. 12).
Female Controls
The plasma cholesterol was low in the youngest subjects. 
There was a hi^ily significant progressive increase with age
up to the age of 70 (Fig# IJ)#
TABLE III, Pasting Plasma Cholesterol (mean + 8.D.)
Subjects Ko. of observations
Fasting Plasma Cholesterol 
mg. per 100 ml.
Controls 
male - all ages
50 221.9 + 59.1
Controls 
male - aged 40 and over
34 227.1 + 58.5
Arterial Disease 
male
72 252.4 + 46.2
Myocardial Infarction 
male
27 . 256.0 + 50.8
Angina Pectoris 
male
. 19 255.6 + 40.2
Peripheral Art. Disease 
male
26 246.2 + 46.5
Controls 
female - all ages
22 214.0 + 47.0
Controls 
female - aged 50 and over
9 259.4 + 55.1
Arterial Disease 
female
14 261.8 + 41.9
Fasting Plasma
Cholesterol
mg./lOOmI
300-
250 —
200-
150-
100 - Y = 9*69x-0-1056x^ +10*8
50-
6020 40
AGE in YEARS
Fig. 12. Effect of age on plasma cholesterol
concentration in male controls (t-5.63, 
P< 0.001).
Fasting Plasma 
Cholesterol
mg./lOOmI
300 —1
250 “
200 -
150 -
100 —
50-
6030
AGE in YEARS
50
Pig, 1}, Effect of ago on plasma cholesterol 
oonoontri^tion in female controls 
(r = +0.67, P< 0.001).
Male Arterial Disease Subjects
The plasma cholesterol was highest in the younger subjects, 
and decreased significantly with age (Fig. 14)* This trend 
was more marked in the ischaemic heart disease subjects than 
in those with peripheral arterial disease, in whom it was not 
statistically significant (Table IV).
Female Arterial Disease Subjects
No significant effect of age was seen in these subjects, 
who were all aged 50 years and over (Table IV). .
II. EFFECT OF 8EX
Comparison of Male and Female Controls
Although the mean plasma cholesterol level for the 
whole group of male controls was higher than that of the 
female group (Table III) the difference was not statistically 
significant. On subdivision of the groups according to age, it 
was found that under the age of 40 years, the mean plasma 
cholesterol level of males (210.8 +59*3 mg/ per 100 ml.) 
was significantly higher than that of females (160.4 +28.4 
mg. per 100 ml., P<0.02). Males continued to have a higher 
mean cholesterol level than females up to the age of 54 years.
In the 55 to 64 year age group, however, the mean value for
Fasting Plasma 
Cholesterol 
mg./lOOmI
400 “I
300 - • •
$#
# #
200 -
100 -
y=330*3“l*47x
7040 50 60
AGE In YEARS
Pig* 14, Effeot of age on plasma cholesterol
concentrâtion in male arterial disease 
patients (r «• -0,25, P<0*05),
TABLE IV. Effect of Age on Pasting Plasma Lipids 
(correlation coefficients)
Subjects Choles­terol
Phospho­
lipid
Tri­
glyceride MEPA
Controls - male parabolic 
(n = 57)
parabolic 
(n » 20)
parabolic
(n . 57)
—0* 07 
(n = 50)
Controls - female +0* 67
(n - 22)
+0* 16 
(n = 16)
+0.20
(n = 22)
+0.28 
(n = 22)
Arterial Disease - 
male
*
-0*25
(n - 72)
-0*05 
{n » 50)
**
-0.51
(n . 72)
-0.11 
(n = 72)
Myocardial Infarct 
- male
-0.24  
(n - 27)
0
(n - 19)
_*
—0* 41
(n - 27)
-0.16 
. (n = 27)
Angina Pectoris - 
male
—0* 41
(n = 19)
-0.50
(n - 12)
*
-0*49
(n = 19)
+0.14
(n = 19)
Peripheral Art* 
Disease - male
-0.15
(n - 26)
+0.10 
(n ■= 19)
-0.20 
(n = 26)
-0.30
(n - 26)
Arterial Disease 
female
+0.10 
(n « 14)
+0.14
(n - 5)
+0.03  
(n - 14)
+0.17  
la - 15)
P<0.05,
P<0*01,
P< 0.001
n • no* of observations
t>4
females (2)8,0 + )9.) mg. per 100 ml,) was higher than that 
for males of corresponding age (204,0 +40,0 mg. per 100 ml,), 
although the difference was not statistically significant.
Comparison of Male and Female Arterial Disease Subjects
Comparison of the plasma cholesterol in arterial disease 
females with that in males of corresponding age (50 years and 
over) showed that the mean level in females (261.8 + 41,9 
mg, per 100 ml,) was higher than that of the males (244*7 +
49*9)* The difference was not statistically significant,
III. EFFECT OF BODY WEIGHT
No significant association was observed in any of the 
groups between plasma cholesterol level and body wei^t 
(measured either as actual weight or relative weight). Corre­
lation of actual wei^t with plasma cholesterol gave coefficients 
of +0,^5 in male controls and +0,06 in male arterial disease 
patients,
IV, EFFECT OF HABITUAL CIGARBTTB-SMOKINC 
Male Controls
The mean plasma cholesterol level in the 27 cigarette-
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smokers (223*7 ± 54*5 nig. per 100 ml.) was similar to that 
in the 20 non-smokers (219*9 ±47*6 mg. per 100 ml.). The 
cholesterol level in the 9 heavy cigarette-smokers (20 or 
more cigarettes daily) was 239*8 + 42*8 mg. per 100 ml. (mean 
age of group 41*2 years) which was not significantly higher 
than that of the non-smokers vdiose mean age was 46*3 (t - 1.08).
Male Arterial Disease Subjects
Comparison of cigare11e-smokers with non-smokers was 
carried out only in the subjects with ischaemic heart disease. 
There were no non-smokers in the peripheral arterial disease 
group, the only patient who did not smoke cigarettes being 
a pipe-smoker.
The 35 oigarette-smokers, of mean age 52.4 years, had 
a slightly higher mean cholesterol level (261.0 + 50.1 mg. 
per 100 ml.) than the 8 non-smokers of mean age 47*9 years 
(244*6 + 27.3 mg* per 100 ml.). This slight difference was 
accentuated when the cholesterol concentration in the I9 heavy 
cigarette-smokers (278.8 + 44*5 ®ig. per 100 ml.) was compared 
with that of the non-smokers (P <0.10> O.O5)* The difference, 
however, reached conventional levels of significance only 
in the 50 to 59 year age group, where heavy smokers had a 
mean plasma cholesterol of 298*7 + 55*4 mg* per 100 ml., as
66
compared with 230*7 + 20*3 mg. per 100 ml. (P< 0*05) in the 
non-smokers.
V. EFFECT OF FAMILY HISTORY OF ISCHAEMIC HEART DISEASE
The 4 male controls with a positive family history of 
ischaemic heart disease had higher plasma cholesterol levels 
(262.8 + 42.1 mg. per 100 ml.) than the 23 controls in the 
same age group with a negative family histoiy (225*0 + 51* 1 
mg. per 100 ml., P<0.05)* No significant differences in 
plasma cholesterol concentration were demonstrated between 
the 33 male arterial disease subjects with a positive family 
history (258.5 + 50*1 mg. per 100 ml.) and the 33 with a 
negative family history of ischaemic heart disease (250.6 + 
39*9 mg. per 100 ml.).
71. EFFECT OF ATHEROSCLEROTIC ARTERIAL DISEASE
(a) Comparison of Controls and Arterial Disease Subjects
Male controls of 40 years and over had a significantly 
lower mean cholesterol concentration (227*1 +36*5 mg. per 100 
ml.) than arterial disease subjects of corresponding age 
(251*9 ± 46*0 mg. per 100 ml., P< O.Ol). The difference 
between the two groups was greatest in the 40 to 44 year 
age group where the control level was 229.6 + 30*7 mg. per
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100 ml. as compared with the arterial disease level of
273.9 ± 45.9 mg. per 100 ml. (P<0.02).
Similarly, the mean cholesterol concentration in the 
9 female controls of 50 years and over (239*4 ± 53*1 mg, per
100 ml.) was lower than that in the 14 female arterial disease
subjects (261.8 + 41*9 mg, per 100 ml.), although in this 
case the difference was not statistically significant.
(b) Comparison of Different Types of Arterial Disease
No significant differences were observed in the mean 
plasma cholesterol concentrations in the three clinical groups 
of arterial disease - myocardial infarction, angina pectoris, 
and peripheral arterial disease (Table III).
.SUMMARY OF FACTORS AFFECTING PLASMA CHOLESTEROL
The main factors found to influence the plasma cholesterol 
level were the age and sex of the subjects, and the presence 
of atherosclerotic arterial disease, Male controls with a 
family history of ischaemic heart disease had significantly 
higher plasma cholesterol levels than others in the same age 
group, but in arterial disease patients similar plasma cholesterol 
levels were recorded in those with and without such a family 
histoiy. Only minor differences in plasma cholesterol concentration
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were observed between habitual cigarette-smokers and non-smokers. 
The plasma cholesterol was not related to body weight,
Male control subjects showed a parabolic effect of age, 
with a maximum cholesterol level at about 45 years, whereas in 
females there was a progressive increase with age. The 
cholesterol level was significantly higher in young males 
than in young females, but by the sixth decade cholesterol 
levels in females were slightly greater than those of males.
In male arterial disease subjects the highest levels 
were seen in the younger subjects, and there was a significant 
decrease' in cholesterol with age. This effect was more marked 
in the myocardial infarction and angina pectoris patients than 
in those with peripheral arterial disease. Female arterial 
disease subjects showed no significant age trends, and 
tended to have higher cholesterol levels than male arterial 
disease subjects of corresponding age. Arterial disease 
patients had higher cholesterol levels than controls, but this 
difference was significant only in the males. Cholesterol 
levels were similar in the myocardial infarction, angina 
pectoris, and peripheral arterial disease subjects.
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FASTING- PLASM PHOSPHOLIPID
The mean plasma phospholipid levels for th^ various 
groups are shown in Table V.
I. EFFECT OF AGE 
Male Controls
A parabolic effect of age on plasma phospholipid con­
centration was observed, similar to that recorded for the 
plasma cholesterol (Fig. 15)* The maximum mean phospholipid 
level was attained at about the age of 45 years.
Female Controls
No figures were available in this series for plasma 
phospholipid estimations below the age of 40 years. In the 
16 female subjects aged 40 years and over, only a sli^t, 
insignificant tendency for the phospholipid level to increase 
with age was observed (Tab^e IT).
Male Arterial Disease Subjects
No significant effect of age on fasting plasma phospho­
lipid level was observed (Table IV).
table V. Pasting Plasma Phospholipid (mean + S.D. )
Subjects No. of observations
Pasting Plasma Phospholipid 
mg. per 100 ml.
Controls 
male - all ages 28 203.7 ± 33*1
Controls 
male - aged 40 and over 18 210.8 + 33.9
Arterial Disease 
male 50 219.8 + 32.1
Myocardial Infarction 
male 19 215.9 ± 29.7
Angina Pectoris 
male 12 215.8 + 32.1
Peripheral Art* Disease 
male 19 226.1 + 34.9
Controls 
female - all ages 16 228.2 + 24.9
Controls 
female - aged 50 and over 8 229.6 + 24.2
Arterial Disease 
female 5 259.8 + 28.8'
Fasting Plasma 
Phospholipid 
mg./lOOmI
300 “ I
250 -
200 -
150 -
100 -
y = 9*14x -0*1001 + 7*1
50 -
20 40 60
AGE in YEARS
Fig* 15* Effect of age on plasma phospholipid
concentration in male controls (t ^  2,25# 
P < 0 ,0 5 ) ,
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Female Arterial Disease Sub.jects
No age trend was observed in the very small number of 
estimations (5) made in this group (Table IV),
II. EFFECT OF SEX
Comparison of Male and Femstle Controls
Comparison of the plasma phospholipid levels was possible 
only in subjects over 40 years. The 16 female controls had 
a slightly hi^er fasting level (228.2 + 24.9 mg. per 100 ml) 
than the 18 males (210.8 + 53*9 fflg. per 100 ml.). This difference 
was due almost entirely to the fact that the females in the 
55 to 64 year age group had levels of 223.8 + 26.7 mg* per 
100 ml. as compared with 183*6 + 31*6 mg. per 100 ml* in the 
5 meiles of the same age (P< 0.10 >0.05).
Comparison of Male and Female Arterial Disease Subjects
The 5 female patients had significantly higher fasting 
plasma phospholipid levels (259*8 + 28.8 mg. per 100 ml.) 
than the 32 males of corresponding age (219.5 + 33*6 mg. 
per 100 ml* P<0*02)*
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III, EFFECT OF BODY TOIGHT
No significant association was observed in any of the 
groups between plasma phospholipid level and body weight 
(actual weight or relative wei^t). Correlation of the 
plasma phospholipid with actual weight gave correlation 
coefficients of +6,15 in male controls and +0.02 in male 
arterial disease patients.
IV. EFFECT OF HABITUAL CIGAEETTE-SMOKINC 
Male Controls
No significant difference was observed in plasma phospho­
lipid level between the 14 cigarette-smokers (193*4 ± 27.4  
mg. per 100 ml.) and the 11 non smokers (214*6 + 39*4 û^* 
per 100 ml.). The 5 heavy cigarette-smokers had a mean 
phospholipid concentration of,.206*2 + 17*9 nig* per 100 ml.
Male Arterial Disease Subjects
Similar plasma phospholipid levels were recorded in the 
23 cigarette-smokers (216.8 + 33*8 mg. per 100 ml.) and the 
5 non-smokers (216.0 + 13*2 mg. per 100 ml.). The 13 heavy 
cigarette-smokers had a mean phospholipid level of 225.8 +
31.9 per 100 ml.
Yü
V. EFFECT OF FAMILY HISTORY OF ISCHAEMIC HEART DISEASE
Plasma phospholipid levels in the 24 male arterial 
disease patients with a positive family history of ischaemic 
heart disease (219*2 + 35*2 mg. per 100 ml.) were similar 
to those in the 22 patients with no family history of ischaemic 
heart disease (223*9 ±29*5 mg* per 100 ml.). Insufficient 
phospholipid estimations were carried out in male controls 
with a positive family history of ischaemic heart disease 
to allow comparison with the rest of the group.
VI. EFFECT OF ÂTHEROSCIERQTIC ARTERIAL DISEASE
(a) Comparison of Controls and Arterial Disease Subjects
Althou^ the mean phospholipid level in male controls 
was somewhat lower than that in the male arterial disease 
subjects (Table v), a significant difference between the 
groups was observed only in the older subjects. In the 55 
to 64 year age group, the mean phospholipid concentration 
in the 5 controls was 183*6 + 31*6 mg. per 100 ml., while in 
the 25 arterial disease patients a higher level was recorded 
(219.2 + 35*1 mg. per 100 ml. F <0.05). Similarly, the level 
in the 8 female controls of 50 years and over (229*6 + 24*2 
mg. per 100 ml.) was lower than that in the 5 arterial disease
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patients (259*6 + 28.8 mg. per 100 ml. P< 0.10 > 0.05) # 
althou^ owing to the smallness of the numbers this difference 
does not achieve statistical significance.
(b) Comparison of Different Types of Arterial Disease
No significant differences in mean plasma phospholipid 
concentrations were observed in the three types of arterial 
disease patients (Table V).
SUMAPY OF FACTORS AFFECTING PLA.SM PHOSPHOLIPID
The main factors found to influence the plasma phospho­
lipid level were the age and sex of the subjects, and the 
presence of atherosclerotic arterial disease. No correlation 
was found between plasma phospholipid concentration and body 
weight, cigarette-smoking, or the presence of a family histoiy 
of ischaemic heart disease.
In male controls a parabolic effect of age on plasma 
phospholipid was observed. No age effect was discernible in 
the male arterial disease patients, nor was any age effect 
observed in the female control or arterial disease subjects, 
who were few in number. In both control and arterial disease 
groups, older females had hi^er levels than males of corresponding 
age* Subjects with atherosclerotic arterial disease tended 
to have hi^er phospholipid concentrations than controls.
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Phospholipid levels were similar in the myocardial infarction, 
angina pectoris, and peripheral arterial disease subjects.
PASTING PLASMA TRIGLYCERIDE
The mean fasting triglyceride levels for the various 
groups are shown in Table VI*
I .  EFFECT OP AGS 
Male Controls
As in the case of the plasma cholesterol and phospholipid, 
a parabolic effect of age on fasting plasma triglyceride 
concentration was observed, although there was considerably 
more scatter in the results (Fig. 16). The maximum triglyceride 
level was seen in subjects aged between 40 and 50 years.
Female Controls
There was a slight, statistically insignificant, tendency 
for plasma triglyceride levels to increase with age (Table TV).
Male Arterial Disease Subjects
Plasma triglyceride concentrations were highest in the 
younger subjects, and decreased sli^tly but significantly 
with age (Pig* I7). As in the case of the plasma cholesterol,
TABIiB VI. Pasting Plasma Triglyceride (mean + S.P'i )
Subjects No. of 
observations
Pasting Plasma TriglyoericLe 
mg. per 100 ml.
Controls 
male - all ages 50 89.4 + 32.0
Controls ....
male - aged 40 and over 34 93.4 ± 31.7
Arterial Disease 
male 72 108.4 + 42.0
Iityocardial Infarction 
male 27 102.6 + 41.6
Angina Pectoris 
male 19 105.1 + 56.0 .
Peripheral Art. Disease 
male 26 116.7 + 46.4
Controls 
female « all ages 22 , 80.3 + 16.6
Controls 
female - aged 50 and over 9 87.6 + 19.8
Arterial Disease 
female 14 85.7 + 18.3
Fasting Plasma 
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mg /100 ml 
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y =5’99dc"0‘0669dc“36*4
604020
AGE in YEARS
l6* Kffect o f age on plasma triglycéride 
concentration in male controls 
(t » 2.84» P<0.01).
Fasting Plasma 
T riglyceride 
mg./lOOmI
250-1
200-
# #1 5 0 -
100 -
50 —
705040 60
AGE in YEARS
Fig# 17* Fffoot of age on plaotna triglyoerido
concentration in male arterial diaeaoe 
patients (r -0,31, P<0#01),
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this trend was more marked in the myocardial infarction and 
angina pectoris groups, and was statistically insignificant 
in the peripheral arterial disease group (Table lY).
Female Arterial Disease Subjects
No variation of fasting plasma triglyceride with age 
was observed in female arterial disease patients (Table IV).
II, EFFECT OF SES
(a) Comparison of Male and Female Controls
In the younger subjects, plasma triglyceride levels in 
males tended to be higher than in females, although the 
differences were not statistically significant. In the 40 
to 44 year age group, for example, the mean for the 11 males 
was 94*1 + 30*5 mg* per 100 ml. as compared with 67*2 + 10.9  
rag. per 100 ml, in the 6 females (P< 0,10> 0.05)* As in the 
case of the plasma cholesterol, the increase in triglyceride 
with age in females, and the corresponding decrease in,males, 
led to slightly higher levels in the .5 females in the 55 
to 64 year age,group (86,8 + 22,7 nig. per 100 ml,) than in 
the 9 males (76,7 + 20,1 mg, per 100 ml.).
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(b) Comparison of Male and Female Arterial Disease Subjects
No significant difference was observed between the plasma 
triglyceride concentrations in the 14 female patients (85*7 +
18,3 mg. per 100 ml,) and in the 44 male patients aged 50 
and over (99-3 ± 41*2 mg, per 100 ml,),
III, EFFECT OF BODY WEIGHT
(a) Controls
No significant correlation of plasma triglyceride levels 
with either actual wei^t or relative weight was observed in 
male controls (correlation coefficients -0,06 and +0,11 res­
pectively), In the femeile controls the corresponding correlation 
coefficients were +0,01 and +0,19»
(b) Arterial Disease Subjects
The male arterial disease patients showed a slight, 
statistically insignificant, tendency for the fasting plasma 
triglyceride to increase with increasing relative weight,
A relationship between weight and plasma triglyceride was 
more readily demonstrated when plasma triglyceride was 
correlated with actual wei^t. In the male arterial disease 
group as a whole the correlation, although low-grade, was 
statistically significant (r = +0.27» P<0,05)» Of the three
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groups of arterial disease patients, a significant relationship 
was demonstrated only in the peripheral arterial disease subjects 
(r = +0#49> P<0#05)* Female arterial disease patients showed 
no such correlation between wei^t and plasma triglyceride 
(r - -0.12).
IV. EFFBCT OF HABITTTAL CIQARETJB-SMOKIWa
' No significant difference in plasma triglyceride con­
centration was observed between smokers and nonsmokers in 
male controls (93.0 + 32*4 and 85.4 + 29,4 mg. per 100 ml. 
respectively). In the male ischaemic heart disease group, 
the mean fasting plasma triglyceride was 100.2 + 37*9 mg. 
per 100 ml, in the cigarette-smokers, and 109*8 46.0 mg.
per 100 ml. in the nonsmokers,
V. EFFECT OF FAMILY HISTORY OF ISCHAE1VÎIC HEAHT DISEASE
In the four male controls with a positive family history 
of ischaemic heart disease the fasting plasma triglyceride 
level (98.0 + 58*7 mg. per 100 ml.) was similar to those of 
corresponding age in the rest of the control group (94*7 ±
30.1 mg. per 100 ml.). In the 53 arterial disease patients 
with a positive family history of ischaemic heart disease 
it was 105*3 + 45*0 mg, per 100 ml, as compared with 114*4 +
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41,9 ing* per 100 ml, in the 35 subjects with a negative history,
VI, EFFECT OF ATHBROSGLEROTIC ARTERIAL DISEASE
(a) Comparison of Controls and Arterial Disease Subjects
At all ages, male arterial disease subjects had higher 
fasting triglyceride levels than controls. The difference, 
however^ was statistically significant only in the 40 to 
44 year age group. The 11 controls had a mean level of 
94*1 + 30,5 mg* per 100 ml,, whereas the 9 arterial disease 
subjects had a mean fasting triglyceride concentration of 
151*0 + 50-1 mg. per 100 ml. (P<0,05)* In the female subjects, 
however, similar fasting triglyceride concentrations were 
recorded in arterial disease and controls (Table Vl),
(b) Comparison of Different Types of Arterial Disease
No significant differences were observed in mean fasting 
triglyceride levels in the three groups (Table Vl),
S U M M Y  OF FACTORS AFFECTING PIASMA TRIGLYCERIDE
Plasma triglyceride levels were influenced by the age, 
sex, and^weight of the individuals, and by the presence of 
atherosclerotic arterial disease. They appeared not to be 
affected by cigarette-smoking, or by the presence of a family
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history of ischaeraio heart disease.
Male controls showed a parabolic effect of age on plasma 
triglyceride level. Female controls, on the other hand, showed 
only an insignificant trend towards increasing plasma triglyceride 
concentrations with increasing age. In male arterial disease 
patients, the highest levels were recorded in the younger 
patients, and there was a progressive decrease in triglyceride 
level with advancing age. Female arterial disease subjects 
showed no significant effect of age on plasma triglyceride.
Male arterial disease subjects were found to have a low-grade, 
but statistically significant, correlation between increased 
body wei^t and increased plasma triglyceride concentration.
Plasma triglyceride levels tended to be lower in young 
females than in young males, but in the older age groups 
females had higher triglyceride levels. Young male arterial 
disease subjects (aged 40 to 44 years) had significantly 
higher triglyceride levels than male controls of the same 
age, but no significant differences were observed between 
the males of the other age groups, nor between female arterial 
disease and control subjects.
FASTING PLASia TOTAL NEFA
The mean fasting plasma total NEFA concentration for 
the various groups are shown in Table VII.
TABLE VII. Fasting Plasma Total NEFA (mean + S.D.)
Subjects No. of observations
Fasting Plasma NEFA 
microeq. per 1.
Controls 
maie - ail ages 50 507 ± 150
Controls 
maie - aged 40 and over 54 491 + 156
Arterial Disease 
male 72 481 + 255
Jjjyocardial Infarction 
male 27 437 + 240
Angina Pectoris 
male 19 515 + 239
Peripheral Art. Disease 
male 26 503 + 228
Controls 
female - all ages 22 539 ± 175
Controls 
female - aged 50 and over 9 579 + 204
Arterial Disease 
female 13 1 490 + 162
tiü
I. EFFECT OF AGE
No significant influence of age on plasma NEFA concen­
tration was seen in any of the groups (Table IV).
II.- EFFECT OF SEX
(a) Comparison of Male and Female Controls
Pasting plasma NEFA levels were similar in the 50 male 
controls and 22 female controls (Table VIl).
(b) Comparison of Male and Female Arterial Disease Subjects
There was no significant difference in fasting plasma 
NEFA concentration between the 44 male arterial disease subjects 
of 50 years and over (456 + 191 microeq. per 1.) and the 
13 female arterial disease subjects (490 + 162 microeq. per 
1.).
III. EFFECT OF BODY WEIGHT
No correlation between fasting plasma NEFA and weight 
(actual weight or relative weight) was observed in any of the 
groups. Correlation of the plasma NEFA with actual wei^t 
gave correlation coefficients of +0.09 in male controls and 
+0.19 in male arterial disease patients.
OJ.
IV. EFFECT OF HABITUAL CIGAKSTTE-SMOKING
(a) Male Controls
The 27 cigarette-smokers had significantly lower fasting 
plasma NEFA levels (450 + 128 microeq. per 1.) than the 
20 non-smokers (569 + 159 microeq. per 1., P<O.Ol). This 
difference was even greater when NEFA levels in the 9 subjects
who smoked 20 or more cigarettes per day (414 ± 128 microeq./l.)
were compared with those of the non-smokers (P<(0.01).
(b) Male Arterial Disease Patients
In these subjects also the 55 cigarette smokers had 
lower fasting plasma NEFA levels (45^ + 214 microeq. per 1.) 
than the 8 non-smokers (606 + 362 microeq. per 1. P< 0.10> 0.05) > 
but in this case the difference did not attain conventional 
levels of statistical significance. The I9 patients who 
smoked 20 or more cigarettes daily had a mean fasting plasma 
NEFA level of 444 + 157 microeq. per 1. .
V. EFFECT OF FAMILY HISTORY OF ISCHAEMIC HEART DISEASE
No significant differences were observed in fasting 
plasma NEFA between subjects with and without a family history 
of ischaemic heart disease. Male controls with a positive 
family history had a mean level of 544 + 75 microeq. per 1.,
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and those without a family history of ischaemic heart disease 
a mean level of 486 + 145 microeq, per 1, The corresponding 
values in male arterial disease patients were 462 + I5I microeq. 
per 1. and 489 + 250 microeq. per 1.
VI. EFFECT OF ATHEROSCLEROTIC ARTERIAL DISEASE
(a) Comparison of Controls and Arterial Disease Subjects
' Controls and arterial disease patients, both male and 
female, had similar fasting plasma NEFA levels (Table VII).
(b) Comparison of Different Types of Arterial Disease
The plasma NEFA levels did not differ significantly 
in the three groups of male arterial disease subjects (Table VIl).
SUMMARY OF FACTORS AFFECTING FASTING PLASM NEFA
Of the various factors exeunined, the only one which 
appeared to influence the fasting plasma NEFA level was 
habitual cigarette-smoking. Cigarette-smokers, after an 
interval of approximately 12 hours since their last cigarette, 
had significantly lower plasma NEFA levels than non-smokers.
No significant effect on fasting plasma NEFA levels of 
age, sex, body weight, family history of ischaemic heart 
disease, or the presence of atherosclerotic arterial disease
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could be detected.
VARIATION IN FASTING PIASMA LIPID ESTIMATIONS
In. the majority of subjects two fasting plasma lipid 
estimations were carried out at an interval of 24 to 48 hours. 
The . two results available for each of the plasma lipids were 
correlated separately for the controls (male and female) and 
the arterial disease patients (male and female).
Results
The correlation coefficients are shown in Table VIII.
The plasma cholesterol showed the least day-to-day variation, 
but a good correlation was obtained also in triglyceride, . 
phospholipid and NEFA estimations.
CQRREIATION OF PIASMi LIPID LEVELS
In all subjects, the results of cholesterol, triglyceride 
and NEFA estimations were available. In addition, phospholipid 
measurements were performed in the majority of subjects. An 
analysis was carried out of the correlations between pairs 
of lipid estimations on the same blood samples.
TABLE VIII. Variability of Fasting Plasma Lipid Estimations
on Two Occasions (correlation coefficients)
Plasma Lipid Control Subjects Arterial Disease Subjects
***
Plasma cholesterol +0.87 +0.91
(n = 40) (n " 51)
**-*
Plasma phospholipid +0.77 +0.73
- (n > 27) (n - 37)
*** ***
Plasma triglyceride +0.84 +0.82
(n - 40) (n = 52)
, *** ***
Plasma NEFA +0.69 +0.85
(n » 39) (n = 52)
***
P< 0.001
n » no. of pairs of observations
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Results
The correlations between fasting plasma lipid levels 
for male and female controls and male and female arterial 
disease patients are shown in Table IX*
The strongest correlation was that between cholesterol 
and phospholipid, a fairly close correlation being obtained 
in each of the four groups. The correlation between phospholipid 
and triglyceride was next in order of magnitude, followed by 
that between cholesterol and triglyceride, which was statistically 
significant only in male controls and male arterial disease 
patients*
No evidence was found of any relationship between the 
plasma NEFA level and plasma concentrations of the other lipids.
SUMMARY OF RESULTS
An assessment was made of the effect on the fasting 
plasma lipids of five factors;- age, sex, weight, habitual 
cigarette-smoking, -and a family history of ischaemic heart 
disease. A comparison was then made of plasma lipid levels 
in healthy control subjects and patients with atherosclerotic 
arterial disease, both male and female.
TABLE IX* Correlations between Pairs of Plasma Lipids
(correlation coefficients)
Controls
male
Controls
female
Arterial
disease
male
Arterial
disease
female
Cholesterol and 
Phospholipid
Cholesterol and 
Triglyceride
Cholesterol and 
NEFA . - -
Phospholipid and 
Triglyceride
Phospholipid and 
NEFA
Triglyceride and 
NEFA
+0,58 
(n = 28)
***
+0.50  
(n = 50)
+0.01 
(n = 50)
**
+0.54
(n = 28)
+0.14
(n = 28)
-0.05
(n = 50)
+0.67  
(n = 15)
+0.08 
(n = 22)
+0 . 3 5
(n = 22) 
*
+0.48 
(n = 15)
+0.13
(n = 15)
- 0.20 
(n = 22)
***
+0.73
(n = 5Ù)
_ * 
+0.25
(n = 72)
+0.11 
(n = 72)
+0 * 41 
(n = 50)
- 0.20 
(n = 50)
- 0.02 
(n = 72)
*
+0,85 
(ix = 5)
- 0.11 
(n = 14)
- 0.02 
(n = 13)
+0.41
(n = 5)
+0.62 
(n = 4)
+0 .2 4
(n = 13)
n = no* of observations 
*
**
P<0.05,
P<0.01,
p <  0.001
85
Effect of Age and Sex
The age and sex of the individuals appeared to exert 
a marked influence on plasma lipid levels, as summarised 
in Table IV*
In male controls a parabolic effect of age on cholesterol, 
phospholipid, and triglyceride was observed* The plasma 
concentrations of these lipids increased with age up to 
between 40 and 50 years, and then decreased* Female controls 
showed a similar increase up to middle age, but thereafter 
the plasma lipid levels, instead of declining, continued 
to increase* This trend was statistically significant.only 
in the case of cholesterol. In male arterial disease patients 
cholesterol and triglyceride levels were highest in the 
younger subjects, and decreased with age. Female subjects 
with arterial disease, who were all aged 50 years or over, 
showed no significant age trends* In subjects under 40 
years of age, plasma concentrations of these lipids were 
higher in males than in females. Over 40 years, however, the 
concentrations in female control and arterial disease patients 
increased progressively to reach levels higher than those of 
males of the same age*
No effect of age or sex on plasma NEFA levels was observed.
ou
Effect of Weight
The fasting plasma triglyceride showed a low-grade, but 
significant, correlation with body wei^t in male patients 
with arterial disease. This effect was not seen in the other 
groups, nor in relation to other plasma lipids.
Effect of Cigarette-Smoking
Habitual cigarette-smokers had lower fasting NEFA levels, 
after overnight abstention from smoking, than non-smokers 
in male control and arterial disease groups. There was also 
evidence to suggest that cigarette-smokers, particularly 
those with moderate or heavy cigarette consumption, had higher 
cholesterol levels tk^n non-smokers.
Effect of Family History of Ischaemic Heart Disease
Subjects with a family histoiy of ischaemic heart disease 
did not have any definite plasma lipid .abnormality. Although 
cholesterol levels were higher in male controls with a positive 
family history than in others of the same age group, the 
numbers were too small to allow any firm conclusions to be 
drawn. Plasma lipid concentrations were similar in male arterial 
disease patients with and without a family history of ischaemic 
heart disease.
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Comparison of Controls and Arterial Disease Patients
Subjects with atherosclerotic arterial disease, both 
male and female, tended to have higher fasting levels of 
cholesterol, phospholipid, and triglyceride than controls.
This effect was more marked when young arterial disease patients 
were compared with controls of the same age. Plasma NEFA 
levels did not differ significantly in controls and arterial 
disease patients.
Effect of Type of Arterial Disease
Plasma lipid concentrations were similar in the three 
clinical types of arterial disease - myocardial infarction, 
angina pectoris, and peripheral arterial disease.
Variability of Plasma Lipid Estimations
Pasting lipid estim^ations on two occasions in the same 
individuals showed that the least variable of the plasma lipids 
was cholesterol. Good correlations between the two estimations 
of phospholipid, triglyceride, and NEFA were obtained.
Correlation of Plasma Lipid Levels
In descending order of magnitude the following correlations 
between fasting plasma lipids were demonstrated:- cholesterol 
and phospholipid, phospholipid and triglyceride, cholesterol
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and triglyceride. No correlation was found between the plasma 
NEPA concentration and the plasma levels of other lipids.
DISCUSSION
Fasting Plasma Lipids in Healthy Subjects
The present study has shown comparatively low cholesterol 
levels in young men, similar to those in other series (Kritchevsky, 
1958b), with progressively increasing levels up to middle age.
In the past two decades a considerable number of publications 
from Western countries have reported higher cholesterol levels 
in middle aged than in young men (Gertler ab al., 1950; Keys 
et al., 195O; Jones ejk , 1951; Malmros ejk , 1956; Lawry 
et al,, 1957; Lewis , 1957; Thomas and Eisenberg, 1957;
Carlson, 1960a). There have been very few reports, however, 
of serial observations on individuals followed through the . 
period of early adulthood although Clark et in 19&7 published 
a twelve-year follow-up study on four hundred men, aged 17 
to 22 years at time of entry to the study, and demonstrated 
a rapid, progressive rise in cholesterol with age in these 
subjects.
In the present study, healthy males showed a falling-off 
in plasma cholesterol levels beyond the age of 45 to 50 years.
The majority of published reports have indicated that the mean
cholesterol concentration is lower in elderly than in middle 
aged men (Keys , 1950; Lawry ^  , 1957; Searcy et al. ,
i960). In a co-operative study in approximately ten thousand 
men (Lewis ^  , 1957) the data were subjected to a curvi­
linear regression analysis, and a maximum cholesterol level 
was observed about the age of 50 years. Some Scandinavian 
workers, however, have shown a progressive increase in serum 
cholesterol up to the age of 60 or 70 years (Lund 'et ,
I96I; Berge and Nicolaysen, I965).
As reported in the results section (page 64), healthy 
young females had significantly lower cholesterol levels than 
young males. The effect of age on cholesterol in females 
differed from that in males, in that the increase in cholesterol 
continued beyond middle age. This resulted in higher plasma 
cholesterol levels in healthy females than in males in the 
fifth and sixth decades. Similar observations have been 
made in several other studies. Jones et (1951) aud
Adlersberg et (1956) found that the rise in serum cholesterol 
in the third decade in females was less than that seen in males. 
These authors, in addition to others (Lawry ^  al• > 1957;
Searcy jet al., i960), reported hi^er cholesterol levels in 
males between 50 and 50 years than in females in the same age 
group. They also stated that in females the cholesterol 
concentration continued to increase in the fourth to sixth
decades, while those of males had levelled off. This resulted 
in lipid levels in postmenopausal females which were equal 
to, or greater than, those of males of corresponding age.
Several other investigations (Keys ^  aJL,, 1950; Block e t al,, 
1951; Barr ^  al,, 1952) did not find sex differences in 
cholesterol level prior to the fortieth year, hut were in 
agreement with the above-mentioned authors in recording higher 
cholesterol levels in postmenopausal women than in men of 
similar age.
The influence of age and sex on plasma phospholipid levels 
in the control series (page 69) was similar to that in the case 
of cholesterol, although no data were available on phospholipid 
levels in females under J+O years of age. The information 
in the literature on plasma phospholipids is much less abundant 
than that on plasma cholesterol, Carlson (1960a) found that 
the serum phospholipid concentration increased rapidly up to 
the age of 40 years, with a much smaller and more gradual 
increase with age in older individuals. Cramer (1962) reported 
significantly higher phospholipid levels in normal males in the 
55 to 65 year age group than in those aged 20 to 40 years.
Conflicting reports have been published on phospholipid 
concentrations in females. Barr (1953) found higher phospholipid 
levels in females than in males under 35 years of age, while
Havel et (1955) found no significant difference in 
phospholipid between the sexes in this age group, Adlersberg 
et al. (1956) reported that females had.higher serum phospho­
lipid levels than males during early adulthood as well as 
beyond the fifth decade; during the third and fourth decades, 
however, the reverse held true. Cramer (1962) found similar 
phospholipid levels in normal females’ and males below the 
age of 40j but in the 55 to 65 year age group females had 
higher levels (274 i 8 mg. per 100 ml.) than males (236 +
10 mg, per 100 ml.). Hallberg ^  al. (1966) showed a steady 
phospholipid increase in healthy females up to the age of 
50 years, with a plateau thereafter. Subsequently Hallberg 
and Svanborg (196?) demonstrated that serum concentrations of 
phospholipid, as well as of cholesterol and triglyceride, were 
higher in postmenopausal women aged 50 years than in pre­
menopausal females of the same age.
In the present series a curvilinear relationship of age 
with fasting triglyceride was seen in male controls, whereas 
in females there was a small, statistically insignificant, 
tendency for triglyceride to increase with age. Earlier studies 
in males (Page e t , 1935, Peters and Man, 0943; Man and Peters, 
1953) were reported to show no variation in serum neutral fat 
with age, Antonis and Bersohn (i960), however, found a steady
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increase in triglyceride up to the fifth and sixth decades 
in healthy white males, hut no significant change in their 
group of Bantu controls. A rapid increase with age up to 
40 years, with a much more gradual increase thereafter, 
vras reported by Carlson (1960a) in a group of I5I healthy, 
males aged 26 to 75 years. An age effect similar to that 
in the present male control series was reported by Albrinic ^  
al. (1961). They found an increase in serum triglyceride levels 
up to the fifth or sixth decades, with lower levels in older 
healthy males, with the result that figures obtained for 
subjects aged 70 and over were similar to those for their 
20 to 29 year age group.
The reported age trends for plasma triglyceride levels 
in females differ from those in males, and are similar to those 
in the present study. Antonis and Bersohn (I960) found no 
significant increase with age in premenopausal European females 
up to the age of 46 years, but considerably higher triglyceride 
levels were recorded in three postmenopausal females (15O to 
158 mg. per 100 ml,, as compared with a mean triglyceride value 
of 68 + 20 mg. per 100 ml, for the younger subjects). Cramer
(1962) found higher triglyceride levels in eleven females aged 
55 to 65 years (mean 84 mg. per 100 ml.) than in eight females 
aged 20 to 40 years (mean 68 mg. per 100 ml.). In ninety-nine
95
females aged 17 to 90 years, Feldman ejb (1965) found 
a stepwise rather than a continuous increase in serum triglyceride 
with age, Hallberg et al, (1966) reported a very similar 
stepwise,increase in their group of 36O women selected at 
random from the general population. In a further study,
Hallberg and Svanborg (1967) showed that postmenopausal women 
aged 50 years had higher levels of triglyceride as well as of 
other plasma lipids than premenopausal women of the same age.
As in this series (page 75), comparison of healthy males 
and females by Antonis and Bersohn (i960) and Albrink et 
(1961) showed _that under the age of 40 years triglyceride levels 
were slightly but not significantly, higher in males, whereas 
the reverse was the case in older age groups.
In contrast to the marked effect of age on cholesterol, 
phospholipid, and triglyceride, plasma NEFA levels did not 
vary with age in the subjects in this series, whose ages ranged 
from 18 to 68 years (page 80)• Information in the literature 
on this subject is sparse. Children, however, appear to have 
higher fasting NEFA levels than adults (Corvilain et al., I96I; 
Heald et al., 1965), No difference in fasting NEFA levels 
between males and females was detected in this study. This 
is in agreement with the majority of the small number of 
relevant publications. Although Moorhouse ^  ,(1965) reported
that fasting NEFA levels were higher in female than.in male
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diabetics, others have found no sex difference in NEFA 
levels in normal subjects (Svanborg and Svennerholm, 196I;
Shah et , 1963; Glennon ^  al,, 1967).
This comparison of plasma lipids in our healthy subjects 
revealed a large measure of agreement with those reported in 
the literature from other Western countries, some of which 
were from very large co-operative studies. This would suggest 
that our control series is representative of the general 
population, and that their plasma lipid figures form a valid 
basis for comparison with those of subjects with atherosclerotic 
arterial disease.
Reason for Age-Associated Lipid Changes
A marked variation with age in plasma lipids, with the 
exception of plasma NEFA, has beoa described in our subjects.
The most strildLng of these was the increase in plasma lipids 
with age in young adults, both male and female, These age 
prends in serum cholesterol have been attributed to a high 
dietary fat intalee in Western communities. In economically 
underdeveloped racial groups, who eat little fat and in whom 
atherosclerosis is uncommon, the rise in cholesterol with age 
is reported to be insignificant (Bronte-Stewart, 1958). Further 
evidence in support of this theory has been provided by the large 
number of experiments, reviewed by Hilditch and Jasperson (1959), 
showing that certain types of fat (mainly saturated and of
animal origin) may raise sérum cholesterol levels, while other 
fats (mainly unsaturated and vegetable in origin) have a. hypo- 
cholesterolaemic effect. Serial studies in young adult males 
by Clark _et _al. (1967) showed that the increase in cholesterol, 
phospholipid, and triglyceride in their subjects was accompanied 
by weight gain*- It appears likely, therefore, that the age- 
associated rise in plasma lipids in young adults is due to 
environmental factors such as diet, and possibly lack of exercise 
and cigarette smoking.
The lower levels seen in older control males may be due 
to the loss from the group of subjects with high plasma lipid 
levels and consequent high susceptibility to ischaemic heart 
disease in middle age. In females, the continued rise in 
lipids beyond middle age has been investigated by Hallberg 
and Svanborg (1967), who concluded that it was due mainly to 
hormonal changes associated with the menopause, but also 
contributed to by weight gain.
Effect of Atherosclerotic Arterial Disease
More than thirty years ago, it was shown that patients 
with angina pectoris had higher serum cholesterol levels than 
healthy subjects (Davis et , 1937). Subsequent investigations 
confirmed the presence of raised cholesterol levels in survivors
of myocardial infarction as well as in patients with angina 
pectoris, although most investigators emphasised the considerable 
overlap between patients and apparently healthy controls,
(Gertler _et , 1950; Oliver and Boyd, 1953> Lawiy _et al.,
1957; Carlson, 1960b; Mioolaysen and Westlund, I963)* More 
recently, lipid estimations in peripheral arterial disease 
have suggested elevated serum cholesterol concentrations in 
these patients also (Juergens ^  al., I96O; McPherson et al*, 
1963; Begg, 1965)* This study has again demonstrated a hi^er 
mean plasma cholesterol level in arterial disease patients■ 
than in healthy controls and, in addition, has shown that the 
lipid abnormality is similar in the three types of arterial 
disease studied - myocardial infarction, angina pectoris, and 
peripheral arterial disease (Table III), This study also 
showed that the elevation of plasma cholesterol was greatest 
in the younger subjects. This was the case particularly in 
those with myocardial infarction and angina pectoris, but was 
much less marked in peripheral arterial disease subjects.
Several other workers have noted that younger patients with 
ischaemic heart disease appear to have higher serum cholesterol 
concentrations than older subjects (Little at , 1956; Lawry 
^  , 1957; Albrinlc et al., I96I).
The observation that myocardial infarction in itself 
may produce alterations in plasma lipid levels (Biorck et al.,
'i(
1957; Dodds and Mills, 1959) has emphasised the importance 
of carrying out prospective studies to establish whether or 
not plasma lipid elevations are causally related to athero­
sclerosis. A large-scale co-operative study organised by the 
National Advisory Heart Council in the United States has shown 
for the first time, that coronary heart disease is associated 
with antecedent elevation of the serum cholesterol level 
(Gofman et al., 1956). Another study, commenced by the 
United States Public Health Service in 194-6, has shown that 
the risk of developing ischaemic heart disease increases with 
increasing serum cholesterol concentration, as well as with 
increasing blood pressure level (Kannel e t , 19&4).
Arterial disease patients in this study showed, in addition 
to an elevated plasma cholesterol, a tendency to higher phospho­
lipid levels than controls (page ?2). Approximately twenty 
years ago it was thought that the important lipid disorder 
in atherosclerosis was an increase in the cholesterol:phospholipid 
ratio. Ahrens and Kunkel (1949) considered that phospholipids 
played an important part in maintaining cholesterol in solution 
since they found that, in sera with a high lipid content, those 
which were optically clear had a high phospholipid concentration, 
whereas those which appeared turbid tended to be low in phospho­
lipid. Steiner ^  (1952) reported an increased serum
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choiesterol;phospholipid ratio in coronary patients, and suggested 
that the concentration of circulating phospholipid in these 
subjects might be insufficient to maintain all the cholesterol 
in solution, with resultant deposition of cholesterol in the 
arterial intima. Oliver and Boyd (1953) also found elevations 
of cholesterol, phospholipid, and cholesterol;phospholipid 
ratios in two hundred patients with ischaemic heart disease 
as compared with a control series. Although in the majority 
of investigations, patients with ischaemic heart disease have 
been shown to have elevated cholesterol and phospholipid levels, 
it is now appreciated that an elevated cholesterol:phospholipid 
ratio merely reflects an increased concentration of low-density 
lipoproteins (Bragdon et al., 1956). As shown in Table I, these 
low-density lipoproteins have a much i^gher content of cholesterol 
than of phospholipid.
Male arterial disease patients in this study had not 
only higher cholesterol and phospholipid levels but also higher 
fasting triglyceride concentrations than controls (page 78).
This difference was most pronounced in the younger patients 
(40 to 44 year age group)., Female arterial disease patients, 
who were all aged 50 years or over, did not have higher 
triglyceride levels than female controls of the same age.
As in the case of cholesterol and phospholipid, this study
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showed that similar fasting triglyceride concentrations were 
present in patients with myocardial infarction, angina pectoris, 
and peripheral arterial disease (Table VI). That elevated 
serum triglyceride levels were common in coronaiy heart disease 
was first pointed out by Hauss and Bohle (1955). Other workers 
subsequently suggested that serum triglyceride levels gave a 
more clear-cut separation between patients with ischaemic 
heart disease and controls than serum cholesterol (Albrink and 
Man, 1959; Schrade ^  , 1959, I960, and 1961; Albrink ^  al..
1961). In a Swedish series of myocardial infarction survivors, 
Carlson (1960b) found that hypertriglyceridaemia was more common 
than hypercholesterolaeraia in patients under 50 years, while 
over 50 years the reverse was the case, Nicolaysen and Westlund
(1963), however, pointed out that plasma triglycerides may be 
temporarily elevated after recent myocardial infarction.
In their group of patients with old infarction, triglycerides 
were not more frequently elevated than the serum cholesterol.
In the present series, in both males and females, the plasma 
cholesterol gave better separation at all ages of arteiial disease 
patients from controls than did the fasting plasma triglyceride.
In male arterial disease patients, hypertriglyceridaemia was 
more common in young than in older subjects. Final evaluation 
of the relative merits of triglyceride and cholesterol measurements
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in atherosclerosis must, however, await the findings of a 
prospective study such as that in Framingham, Massachusetts 
(Kannel £t al., I964) or the study commenced more recently 
in Stockholm (Havel and Carlson, I962),
- ' In contrast to the other plasma lipids, KEFA levels were 
similar in arterial disease patients and controls (page 82).
The three groups of arterial disease patients also showed 
similar, plasma KEFA concentrations (Table VIl). In the past 
ten years, since accurate methods for the measurement of NEFA 
levels were described (Dole, 1956; Gordon, 1957) u number 
of reports on fasting 1ŒFA levels in patients with atherosclerosis 
have appeared. Several investigations on small numbers of 
subjects have shoTO no difference in NEFA levels between 
patients with clinical atherosclerotic disease and controls 
(Havel and Peterson, 1958; Waddell and Field, I960;
Schrade et , I96I; Aleksandrow al., I962). On the other 
hand, Kershbaum and Bellet (I964) found slightly higher NEFA 
levels in seventeen patients with old myocardial infarction 
than in ten normal subjects, and Rifkind (I966) reported 
significantly higher values in forty males with a history 
of myocardial infarction than in forty healthy male controls.
The apparent discrepancy in these findings might be due to 
the conditions under which the tests were carried out. In
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view of the well-loiown lability of the plasma NEFA level 
(Hollister and Overall, I964), and its elevation by stress 
(Bogdonoff. et al., I960), the talcing of blood samples at an 
outpatient visit, as was the case in most of Rifkind*s (I966) 
subjects, mi^t result in higher NEFA levels than those obtained 
under basal conditions. If patients with a previous myocardial 
infarction react more strongly to stress than controls, as 
suggested by Horwita and Bronte-Stewart (1962) and Kershbaum 
et al. (1963), this mi^t be sufficient to cause a significant 
difference in NEFA levels in the two groups.
The results of plasma lipid estimations in our arterial 
disease patients, therefore, appear to be in accord with the 
majority of those published. Patients with ischaemic heart 
disease had higher mean cholesterol, phospholipid, and triglyceride 
concentrations than controls, and the highest lipid levels 
occurred in the younger patients. Elevated plasma cholesterol, 
phospholipid, and triglyceride levels also occurred in patients 
with peripheral arterial disease. There was, however, a 
considerable overlap in lipid levels between arterial disease 
patients and apparently healthy controls. Plasma NÏÏFA levels 
were similar in controls and patients with arterial disease.
As shown in Table II, the arterial disease patients in 
this series differed from the controls in certain characteristics
which might affect plasma lipid levels,- These characteristics 
were body weight, the frequency of a family history of ischaemic 
heart disease, and the proportion of cigarette-smokers. An 
analysis of their relation to plasma lipid concentrations was 
therefore carried out,
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Effect of Body Weight
In this study, the only lipid which showed an association 
with body weight was the plasma triglyceride. . A lowgrade 
positive correlation was demonstrated in male arterial disease 
patients between fasting triglyceride and actual weight.
The correlation with relative weight, a better index of obesity 
than actual weight, was smaller and statistically insignificant. 
Evidence has accumulated in recent years of an association 
between plasma triglyceride levels and various measures of 
body fatness, including relative weight, in both arterial disease 
and healthy subjects (Schrade ^  , I96O; Feldman et al,.
1963; Waxier and Craig, 1964; Rifkind and Begg, I966; Sailer
, 1966; Hollister et al,, 1967). Plasma cholesterol 
has been shown to have a very low-grade association with body 
weight, which is as a rule demonstrable only in very large 
series such as that of Montoye e t al. (I966). No evidence 
has been found of a correlation between body weight and plasma 
phospholipid (RifldLnd and Begg, I966; Sailer at al,, I966;
Hallberg and Svanborg, 1967), or between body weight and plasma 
NEFA (Sailer ^  1966) except in the very obese.
It has been stated that subjects with ischaemic heart 
disease are frequently overweight (Stamler ^  , I960; Brown,
1962; Dawber e t a l * , 1962). Men with peripheral arterial disease 
on the other hand,, have been found not to be obese, using relative 
weight and skinfold thicknesses as criteria (Begg, I965). In 
our series, the heaviest subjects occurred in the angina pectoris 
group (Table II), whose mean relative weight was significantly 
greater than that of the myocardial infarction, peripheral 
arterial disease, and male control groups of the same age.
Deapite the low-grade association already mentioned between 
weight and plasma triglyceride, levels of triglyceride or of 
other plasma lipids were not higher in the angina pectoris 
patients than in myocardial infarction or peripheral arterial 
disease patients* There was'therefore no evidence in this 
study that the higher plasma lipid levels in the arterial disease 
groups were due to a greater proportion of overweight subjects 
in that group. In elucidation of the connection between over­
weight and ischaemic heart disease the most recently published 
findings of the Framingham Study might be of interest (Kannel 
et , 1967). They e:xplored the interrelationships between 
weight change, serum cholesterol, blood pressure levels, and 
the risk of developing ischaemic heart disease in 5,127 men
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and women followed over twelve years for signs of initial 
development of ischaemic heart disease. Antecedent relative 
weight and weight gain after the age of 24 years proved to 
he strongly related to risk of angina pectoris and sudden 
death, but were unassociated with development of myocardial 
infarction. An. excess risk of angina pectoris and sudden 
death appeared to exist in obese men both with and without 
elevations of blood pressure and serum cholesterol, indicating 
an independent contribution of obesity to the rate of development 
of these manifestations of coronary heart disease. Unless 
accompanied by an increase in blood pressure and serum cholesterol 
level, obesity appeared to play a negligible role in women.
Effect of Family History of Ischaemic Heart Disease
Heredity has been stated to be an important factor pre­
disposing to ischaemic heart disease, and a correlation between 
myocardial infarction in parents and children has been shown 
(Boyd, 1953). In our series (Table II) there was a markedly 
greater proportion of subjects with a family history of ischaemic 
heart disease in the male arterial disease group than in the 
controls. The proportion of positive family histories was high 
in patients with peripheral arterial disease as well as in the 
myocardial infarction and angina pectoris patients. The difference 
between the female control and arterial disease patients in
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this respect was much less striking. In subjects with a 
positive family history the increased risk of ischaemic heart 
disease, whether determined by genetic or environmental factors, 
might be mediated by plasma lipid abnormalities. The significantly 
higher plasma cholesterol levels seen in male controls with a 
positive family history (page 66) suggest that this is the case, 
although a large series of subjects in the same age group 
would be required to give a definite answer to this question.
Since plasma lipid concentrations were elevated equally in arterial 
disease patients with and without such a family history, it would 
appear that environmental factors are at least as important 
as genetic factors in the determination of plasma lipid abnor­
malities.'
Effect of Cigarette-Smoking
A higher proportion of cigarette smokers was found in 
the arterial disease group than in the controls (Table II).
This was most strilcing in the peripheral arterial disease group 
which contained no non-smokers, the only patient who did not 
smoke cigarettes being a pipe smoker. In several population 
studies, the serum cholesterol has been observed to be higher 
in smokers than in non-smokers (Gofman ^  al• ^ 1955; Thomas,
1958 and I960* Miller et , 1958; Karvonen et al., 195.9;
Dawber et al., 1959; Blackburn et al.^ I960; Bronte-Stewart,
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1961). The reason for this association is not known, and 
short-term smolcing tests have shorn no significant effect on 
the cholesterol level (Page e t , 1959; Kershbaum e t al,,
1961), The results of the present study showed no difference 
in plasma cholesterol between cigarette smokers and non-smokers 
in male controls, '-In male arteiial disease patients cholesterol 
levels, particularly in older subjects, appeared to be higher 
in smokers than in non-smokers. This association between 
habitual cigarette-smoking and raised plasma cholesterol con­
centration might account for some of the difference between 
plasma cholesterol levels in older arterial disease patients 
and controls. As already mentioned, however, the most striking 
differences in cholesterol level between arterial disease and 
control subjects were seen in the younger age groups. There 
was no correlation between smolcing and plasma triglyceride or 
phospholipid levels.
In both control and arterial disease subjects after 
overnight abstention from smoking, habitual cigarette-smokers 
had lower fasting NEFA levels tlian non-smokers (page 71). This 
unexpected finding has not been reported previously. Cigarette- 
smoking in the fasting state has been shown to cause elevation 
of plasma NEFA levels due to catecholamine release (Kershbaum 
et , 1963). A possible explanation of the lower fasting 
plasma NEFA levels recorded in habitual cigarette-smokers in
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this study is withdrawal of the repetitive nicotine-induced 
stimulation of the adrenal glands to which these subjects have 
become adapted, with reduction in circulating catecholamines, 
and consequent fall in plasma NEFA level.
Variability of Plasma Lipid Levels
There was a fairly high correlation between two fasting 
plasma cholesterol estimations in the same individuals at an 
interval of 24 to 48 hours (Table VIII), Large fluctuations 
in plasma cholesterol level from day to day, and even from 
hour to hour, have been reported in certain individuals, whereas 
others appear to have a stable cholesterol level (Thomas and 
Eisenberg, 1957; Peterson ^  , I96O), Some, observers
(Steiner and Domanski, 1943; Morrison et al,, 1949) have 
suggested that the serum cholesterol of patients with ischaemic 
heart disease is inconstant and fluctuates widely, in contrast 
to normal persons in whom the level is relatively stable. This 
has not been borne out by the findings in this study of a 
rather closer correlation between plasma cholesterol levels 
in arterial disease patients than in controls.
Day to day variations in plasma levels of other lipids 
have received little attention. Our figures showed a fairly 
good reproducibility of phospholipid and triglyceride levels 
in individuals. Repeated estimations of fasting plasma NEFA
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levels in our subjects also showed a fairly high correlation. 
Hollister and Overall (1964) reported a marked variability 
in fasting NEFA estimations in the same individuals on several 
outpatient visits. The higher correlation in our subjects 
is almost certainly, due to the controlled basal conditions 
under which the blood samples were talcen for estimation of this 
very labile plasma constituent.
Interrelation of Fasting Plasma Lioids
Correlation of the different plasma lipid concentrations 
in the same blood samples showed relationships between cholesterol, 
phospholipid, and triglyceride levels, while plasma NEFA levels 
appeared totally unrelated (Table IX). The closest relationship 
observed was that between cholesterol and phospholipid, and 
the next in magnitude that between phospholipid and triglyceride. 
These results might be explained by consideration of the mechanisms 
for transport of lipid in fasting blood. Cholesterol, phospho­
lipid, and triglyceride are distributed among the lipoproteins 
in the globulin fraction (Table I) and it might be anticipated 
that alterations in one lipid would be associated with alterations 
in the others. An increase in low-density lipoprotein would 
be shown by an increase in cholesterol and a rather lesser 
increase in phospholipid, but would have little effect on
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triglyceride.. An increase in very low-density lipoprotein, 
on the other hand, would he reflected by an increase in 
triglyceride, a considerably smaller increase in phospholipid, 
and a still smaller increase in cholesterol. Plasma KEFA, on 
the other hand, are transported by albumin, and plasma levels 
may therefore fluctuate widely independently of the other 
lipid levels.
Bmmmx A m  conclusions
1, Plasma cholesterol, phospholipid, and triglyceride 
■concentrations showed marked changes with age in healthy
male and female subjects* Young males had higher levels of these 
lipids than females, whereas in older subjects the situation 
was reversed. Plasma non-esterified fatty acids showed no 
variation with age or sex.
2. Young male subjects v/ith arterial disease had higher plasma 
levels of cholesterol, phospholipid, and triglyceride than 
controls of the same age. Differences in plasma lipid levels 
between older male and female arterial disease patients and 
controls were small in magnitude. Plasma non-esterified fatty 
acid levels did not differ significantly in arterial disease 
patients and controls.
3. Similar elevations of plasma cholesterol, phospholipid, 
and triglyceride were present in patients with three different 
clinical types of atherosclerotic arterial disease - myocardial 
infarction, angina pectoris, and peripheral arterial disease,
4. A low-grade association was demonstrated between body weight 
and plasma triglyceride concentration in arterial disease 
patients only. There was no association between body weight 
and the other plasma lipids.
5. Cigarette-smokers showed significantly lower plasma NEFA 
levels than non-smokers after overnight abstention from smoking. 
There was some evidence that cigarette-smokers, particularly 
those with moderate or heavy cigarette consumption, had higher 
cholesterol levels than non-smokers, but the results were 
inconclusive*
6. Plasma lipid concentrations were similar in arterial disease 
patients with and without a family history of ischaemic heart 
disease. The small number of male controls with a positive 
family history had higher plasma cholesterol levels than others 
in the same age group,
7. Variations in plasma cholesterol and plasma triglyceride 
concentration were each associated with a similar change in . 
plasma phospholipid level.
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Chapter IV. ' FAT TOLERANCE TESTS 
INTRODUCTION
Alimentary lipaemia is caused by the presence in the blood 
of newly-absorbed neutral fat in the form of fairly large particles 
known as chylomicrons. This phenomenon has been the subject 
of intensive study in the past sixty years. Earlier workers 
(Gage and Fish, 1924; Frazer and Stewart, 1937a) used it to 
make fundamental observations on the mechanisms of fat digestion 
and absorption, while more recently it has aroused interest 
because of its alleged role in the causation of atherosclerosis. 
Following Hueper*s (1942) experiments demonstrating that macro- 
molecular substances injected intravenously in animals were 
deposited in lesions in the arterial intima, Moreton (1947) 
advanced his hyper- and macrochylomicronaemic theory of athero­
sclerosis. He found that in clinically healthy subjects there 
were considerable differences in the height and duration of 
chylomicron counts following a fat meal. He suggested that 
prolongation of alimentaiy lipaemia following repeated ingestion 
of fatty meals over a period of years was an important athero­
genic factor. The finding that chylomicron counts were higher 
and more prolonged in elderly than in young subjects (Marder 
,et al., 1952) was considered to support this theory, as was
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the observation by Einn and Griffith (1950) of an increased 
proportion of large chylomicrons in fasting and postprandial 
blood samples in atherosclerotic individuals. These findings 
stimulated further investigations of fat tolerance in athero­
sclerotic subjects, most often the survivors of myocardial 
infarction. In general, atherosclerotic subjects were found 
to have more intense and prolonged alimentary lipaemia than 
persons with no clinical evidence of atherosclerosis (Schwartz 
et , 1952; Pomeranze et , 1954; Barritt, 1956).
In this section an outline of the development of knowledge 
of alimentary lipaemia will be given, followed by a description 
of the various methods of quantitating lipaemia and of the fat 
load used. The results of a standard fat tolerance test in 
healthy and atherosclerotic subjects will then be presented, 
and compared with those reported in the literature,
EARLY INVESTIGATIONS OF ALIMENTARY LIPAEMIA
For more than three hundred years it has been known that 
the serum may become lactescent after ingestion of food. The 
earliest studies of this phenomenon were reviewed by Gage and 
Fish (1924)# Asellius in 1622 observed that, when food was 
present in the intestine, the mesenteries lymphatics were 
rendered visible by the milky appearance of the absorbed food.
xxp
In 1650 Pecquet traced the lymphatic channels to the great 
veins of the neck, and thus showed that the milky fluid absorbed 
from food in the intestine travelled directly to the blood vessels, 
and not to the liver as had been thought by Asellius. It was 
Boyle, however, in I665 who first discovered that the serum 
itself may become lactescent as a result of the abundance of 
absorbed food poured into it through the lacteals and the 
thoracic duct. In 1774 Hewson observed that the milky serum 
when examined under the microscope showed numerous fine particles. 
He also demonstrated that it contained much fat, since it left 
a grease spot when dried upon paper, and recognised that there 
were two possible sources of these fat particles: namely the 
fat in the food, and that remobilised from the fat reservoirs 
of the body. Hewson *s observations were later confirmed and 
amplified by Gulliver (I84O), who showed that the small particles 
in the lacteal fluid were the same as those in the blood stream. 
Edmunds in 1877 used the darkfield microscope to study the 
particles. The first attempt to quantitate the blood lipid 
changes following a fat load by counting the particles appears 
to have been made by Neumann in 1907. In 1920 Gage suggested 
the term chylomicron to designate these fat particles. In 
collaboration with Fish (I924), he described a technique for 
chylomicron counts, which they used.to obtain information about
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the digestibility and absorption of fat in animals and man. 
Although they presented evidence that the particles were 
composed of fat, this appears to have been disputed for some 
years. In 1939 Elkes et concluded as a result of further 
experiments that they consisted of fat, with possibly a layer 
of adsorbed protein at the oil-water interface. It is now 
well established that the chylomicron contains protein as an 
integral part of the particle and is, therefore, a lipoprotein 
(Borgstrom, i960).
MTHOItS OF QUANTITATING ALIIvMTARY LIPAMIA
Until Van Handel and Zilversmit (1957) described their 
technique of triglyceride estimation there was no simple, 
reliable, direct method available for measuring neutral rat.
A wide variety of methods were introduced for the quantitation 
of alimentary lipaemia, and an outline of some of these methods 
■ is given below.
(a) Cliylomioron Counts
A semiquantitative measurement of lipaemia may be obtained 
by diluting plasma in some standard way, and counting the 
chylomicrons in a shallow chamber. This technique, pioneered by 
Neumann (1907)> was developed further by Gage and Fish (1924),
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and Frazer and Stewart (1936), and remained in use until the 
1950*8 (Harder et , 1952; Gruner and Hilden, 1953). It had 
the advantages over the somewhat crude chemical methods for blood 
lipid estimations available thirty years ago of being rapid, 
and of requiring only small volumes of blood. When done 
carefully, the counts were sufficiently reproducible to reflect 
changes in particle content of blood- during alimentaiy lipaemia, 
parallelism being obtained between curves from chylomicrographs 
and quantitative determination of blood neutral fat by other 
means (Frazer and Stewart, 1937b; Burr et ^ . , 1954). This 
technique was later superseded, when it was recognised that the 
counts were at best only relative values on an arbitrary scale.
It proved impossible to obtain absolute values, as in the 
counting of blood cells, for a number of reasons; the difficulty 
of counting particles in Brownian motion (which caused particles 
to fluctuate in and out of focus): the indeterminancy of the 
lower size limit (making the number of particles that could be ^ 
counted depend on conditions of lighting and focus): and an 
apparent increase in the number of particles with dilution 
(Dole and Hamlin, 1962).
(b) Measurements of Turbidity
The clarity of turbidity of plasma or serum is determined 
by the size of the fat particles, since particles of more than
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one quarter the wavelength of visible light (or 0.1 p.) interrupt 
light rays, thus giving the serum the appearance of turbidity 
or lipaemia (Ahrens and Kunkel, 1949)• Albrinlc et al, (1955) 
showed by ultracentrifugation studies that neutral fat is the 
only serum lipid consistently associated with lactescence. In 
order to measure the size as well as the number of fat particles 
in lipaemic serum, Moreton described a nephelometric method 
which measured reflected light (Moreton, 1947)* A somewhat 
simpler method introduced later was measurement of the 
optical density by spectrophotometry; that is, the estimation 
of the degree of light absorption by lipaemic serum, usually 
at a wavelength of 6^0 mp (range 610-700 mp). The latter 
method was the one more commonly used (Barritt, 1956; Bronte- 
Stewart and Blackburn, 1958; Benborough, 1965)* There was 
general agreement that optical density measurements provided 
a fairly reliable indication of postprandial' changes in serum 
neutral, fat content (Barritt, 1956; Damon at al., 1957; Jones 
and Bobrilovic, 1963).
(c) Chemical Estimations
The direct chemical estimation of triglyceride in 
alimentary lipaemia has been carried out only in recent years 
(Nikkila and Konttinen, 1962; Benborough, I963). Earlier 
chemical means used were measurement of total plasma lipid by
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gravimetric or colorimetric methods ^ Ikes et al., 1939;
Barritt, 1956), or plasma total fatty acids (Chaikoff et al., 
1934; Brown et al., 196I). Albrink (1959) described an 
indirect method of triglyceride estimation by subjtraction 
of cholesterol and phospholipid fatty acids from total plasma 
fatty acids, and this method was used by a number of investi­
gators (Sullivan, 1962; Talbott and Keating, I962).
(d) Radioactive Fat Tolerance Tests
Thannhauser and Stanley (1949) introduced the use of I
1^1labelled fat in fat tolerance tests, using I olive oil.
This method had the advantages that the amount of labelled fat 
required was small and well tolerated, and the radioactive 
iodine that split off the fatty acid molecule could be determined 
and information gained as to the speed of catabolism of the 
labelled fat. The first systematic study of alimentary 
lipaemia in coronary heart disease using I labelled triolein 
was carried out by likoff and co-workers (1958), and subsequent 
reports have been published by investigators using this method 
(Seller 1959; Berkowitz and Croll, I962). The lipid-
bound radioactivity curve has been found to have a close 
relationship to the fat tolerance curve obtained by other 
methods, such as optical density and total fatty acids (Brown
£t al., 1961).
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(e) Vitamin A and E loading Tests
Although the fat soluble vitamin A has been employed 
as an indicator in the study of fat absorption since the 
1930’s (Ghesney and Me Coord, 1934) > it has been used in only 
a few investigations of fat metabolism in hyperlipaemia,
Beaumont and his colleagues carried out extensive studies 
of vitamin A metabolism in patients with ischaemic heart 
disease, and attributed the frequent occurrence of high plasma 
vitamin A curves in these subjects to faulty metabolism of 
chylomicrons (Beaumont and Ardaillou, 1939; Beaumont and 
Lenbgre, 1959)* Pelkonen (1963) pointed out that, since vitamins 
A and E were purely exogenous lipids, they might be used to 
facilitate interpretation of alimentary lipaemia by eliminating 
disturbances in endogenous synthesis of lipids* From his 
findings of high and prolonged plasma vitamin A and E curves 
in coronary heart disease patients he concluded that the 
disappearance rate of exogenous lipids was impaired in these 
subjects.
(f) Additional Lipid Analyses
A number of other methods of lipid analysis have been 
used in the study of plasma neutral fat in alimentary lipaemia: 
for example, lipoprotein separation by paper electrophoresis
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(Talbott and Keating, I962), starch electrophoresis (Swahn,
1953* Bierman al^, 1962a) ultracentrifugation (Havel,
1957; Pelkonen and Hikkila, 1965), and differential 
flocculation in polyvinylpyrrolidone density gradient columns 
(Bierman ^  al,, 1962b)* These methods have been used to 
characterise the heterogeneous fat particles which, as described 
by Gage and Pish (I924), are present in the blood during 
alimentary lipaemia. The chylomicrons are small (about 0*5 p) 
at the beginning and end of the fat tolerance curve, but larger 
(about 1 p) at maximal lipaemia.
Numerous investigators of alimentary lipaemia have 
measured, in addition to neutral fat, the other blood lipids 
such as cholesterol (e.g. Osmon et , 1957; Kingsbury ^  al., 
i960), phospholipids (Man and Gildea, 1932; Pomeranze et al., 
1954), &ud, more recently, the plasma nonesterified fatty 
acids (Bhle, 1956; Albrink and Neuwirth, I960).
TECHNIQUE OP THE PAT TOLERANCE TEST
No single method of performing oral fat tolerance tests 
has yet achieved widespread acceptance, and almost every 
investigator has developed his own technique* In most cases 
this has taken the form of the feeding, after an overnight 
fast, of 50 to 100 g. of fat, either as a fixed standard load
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or on a body weight basis. The fat has usually been of animal 
origin (eggs, bacon, or cream), and in most cases has been part 
of a mixed meal, with or without standardisation of the amounts 
of protein and carbohydrate. When fat alone has been given it 
has usually been in the form of cream (Brown ^  , 1961;
Pelkonen and Nikkila, 19^5) or a vegetable oil (Eggstein and 
Sohettler, 1958; Iiikoff et al., 1958)*
Effect of Size of Pat Load on Lipaemia
As might be anticipated, the degree of lipaemia was 
found to increase with an increase in the amount of the fat 
load (Gage and Pish, 1924; Marder et al., 1952). Although a 
fat load of 20 to 55 8* was suitable for the study of ali­
mentary lipaemia by the technique of chylomicron counting,
(Gage and Pish, 1924; Marder ^  , 1952), it was much
less satisfactory for chemical lipid estimations. Kingsbury 
et al. (i960) stated that plasma lipid changes after fat meals 
of less than 30 g. were often small and inconsistent, and they 
recommended a fat load of 50 g. Brown et al. (I963), comparing 
the effect of meals of 10, 30, 50, and 70 g. in healthy young 
males, found no significant change in lipids after the 10 g. 
meal, but consistent elevation after meals of 30 g. fat or 
more. A few workers used much larger fat loads. Talbott and
Keating (1962) used 177 £• and Pomeranze et (1954)
204 S* of fat, while Man and Gildea (1952) gave their subjects ■ 
5*5 to 4 g. per kg. of body weight. It was subsequently pointed 
out by Kingsbury (i960) that fat loads much greater
than TO g. did not cause a proportionate increase in plasma 
lipids and had the disadvantage of frequently producing nausea*
Effect of Type of Fat
Bang (I9I8) pointed out that the degree of alimentary 
lipaemia was affected by the type of fat fed. Eggstein and 
Sohettler (1958) found that lipaemia reached its peak earlier 
and declined more quickly when liquid oils were fed instead 
of hard fats. On the other hand Jones and Dobrilovic (1963) 
reported a delay in peak rise of optical density when c om 
oil replaced dairy fat* Kingsbury and Morgan (i960) found 
similar rises in triglyceride but markedly differing effects 
on cholesterol and phospholipid on feeding different types 
of oil (araohis oil, heated and crude tobacco seed oils). 
Emulsification of the lipid in the study of Brown ^  al.
(I96I) gave an earlier peak in the plasma lipid concentration 
curve. Different fats have been shown to give rise to specific 
types of chylomicrons (Swank and Levy, 1952)* Chylomicrons 
seen after feeding of tristearin and cream varied in shape 
and were small, whereas triolein gave large, distinctive,
J.^4
spherical chylomicrons.
Effect of Carbohydrate
There is general agreement that ingestion of carbohydrate
along with fat reduces lipaemia. Bang (I918), in his
experiment on fat-feeding in dogs, noted that when bread
was substituted for meat in the fat meals, the degree of
lipaemia was sometimes reduced. Albrink and her co-workers
demonstrated that alimentary lipaemia in humans could be
reduced by simultaneous oral or parenteral administration
of glucose (Albrink and Man, 1956; Man and Albrink, 1956;
Albrink et al., 1958)* Berkowitz et al. (1959) found that
a lower triglyceride curve was obtained when glucose was given 
1^1
with I  ^ labelled triolein than when triolein alone was 
given. Sullivan (1962) confirmed that the lipaemia occurring 
after ingestion of a standard fat meal was depressed or 
eliminated by the addition of glucose to the meal.
Effect of Protein
Bang (19I8) in his experiments on dogs found that, 
although meat alone did not cause lipaemia, the addition of 
meat to fat meals frequently produced lipaemia greater than 
that resulting from fat meals alone. Sullivan (1962) also 
produced prolongation and intensification of alimentary
lipaemia in 4 of his 6 subjects by the addition of protein 
to a_ fatty meal,-
Effect of Previous Diet on Fat Tolerance
Alimentary lipaemia has been shown to be influenced by 
the composition of the diet prior to fat loading. Total 
starvation was found by Gage and Fish (1924) and Albrink and 
Neuwirth (i960) to cause a lowering in postprandial lipaemia. 
Reduction of the dietary fat intake had a similar effect in 
the subjects studied by Pomeranze e t (1954) and Bronte- 
Stewart and Blackburn (1958), The substitution of vegetable 
oils for animal fats in the diet for several weeks was also 
found to lower fat tolerance curves (Bronte-Stewart and 
Blackburn, 1958; Denborough, 1963). On the other hand, an 
increase in the amount of fat in the diet was found by Blix 
(1926) and-Havel (1957) to cause an exaggeration of lipaemia 
following a fat load, although Horlick (1957) found no change 
following a smaller dietary fat increase, and Bouchier and 
Bronte-Stewart (I96I) demonstrated no fat tolerance differences 
in three racial groups with, widely differing fat intakes.
REPRODUCIBILITY OF FAT TOLERANCE CURVES IN INDIVIDUALS
A number of investigators have tested the repeatability 
of the fat tolerance curve in individuals at varying intervals 
of time. The consensus of opinion appears to be that, although 
the reproducibility is as a rule fairly close, considerable 
unexplained variations may occur. Osmon ^  al. (1957) found 
good reproducibility in tests performed one week apart in two 
normal young males. Repeated tests in fifteen coronary patients 
and ten controls by Bronte-Stewart and Blackburn (1958) showed 
considerable individual variations but the mean curves for the 
two groups were unchanged. Jones and Dobrilovic (1963) carried 
out 62 fat tolerance tests in five patients on diets of different 
fat content. They found that the shape of the fat tolerance 
curve was dependent on, among other factors, the previous dietary 
fat intalee, and also commented on the fact that unexplained 
variations occurred in the curves. Denborough (1963) repeated 
fat tolerance tests in twelve subjects after six weeks to 
nine months. In ten subjects the curves were very similar 
to those obtained previously, whereas in the other two 
subjects the second curve was much lower. The explanation 
in one case was thought to be marked loss of weight in the 
intervening period, while no reason for the difference was 
evident in the other case. Hollister (1963) carried out duplicate
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fat tolerance tests one week apart in 12 subjects. He found 
that, though the pattern of lipaemic response tended to be 
repeated from one trial to another, the replication was poor 
at 2 and 4 hours after the meal, A.good correlation was 
obtained between the increases in triglyceride at 6 hours 
postprandially in the two tests,
PREVIOUS INVESTIGATIONS OF FAT TOLERANCE IN ATHEROSCLEROSIS
In this section are reviewed the reports of fat tolerance 
tests in atherosclerosis published before the present study was 
commenced in I964. Most of these investigations were carried 
out before a relatively simple, reliable method of triglyceride 
estimation came into general use, and so indirect methods of 
measuring neutral fat such as optical density or serum fatty 
acids were used. In most cases it was found that the lipaemia 
produced by a fat load in survivors of myocardial infarction, 
or in patients with angina pectoris, was greater than that 
produced in persons with no clinical evidence of ischaemic 
heart disease,
Schwartz et al, (1952) compared 24 male and female controls 
(aged 17 to 79 years) with 23 patients who had recently sustained 
an acute myocardial infarction, and found in the coronary group 
higher optical density readings in the fasting state and 3
J.(CO
and 5 hours postprandially. There was, however, a considerable 
overlap between the curves obtained in the two groups. They 
suggested that the lipid abnormality might have been related 
to the recent myocardial infarction, or to the diet taken by 
the infarct patients, Woldow ot (1954) also found increased 
and prolonged plasma optical density levels in 21 patients 
with coronary disease, although the ages of the coronary group 
(mean 55 years) and the control group (mean $1 years) were not 
comparable. In the same year Pomeranze ^  (1954) reported
increased lipaemia, measured as serum fatty acids, in an 
elderly atherosclerotic group as compared with a younger 
control group. Barritt (1956) confirmed the presence of 
increased alimentary lipaemia as measured by serum total 
lipids in 35 oorônary patients four to eight weeks after a 
myocardial infarction, with again a wide overlap between the 
fat tolerance curves of the coronary and control subjects.
He also drew attention to the fact that intense, prolonged 
lipaemia occurred in those subjects who already had high 
fasting lipid levels. Delayed lipaemic pealcs were recorded by 
Kuo _et (1956) in the majority of their coronary heart disease 
patients, as well as in hyperlipaemic and hypercholesterolaemic 
individuals, Bronte-Stewart and Blackburn (1958) also 
found, despite considerable overlap in the results, significant
1 2 9
differences in optical density between twenty-three patients 
six months to two years after a myocardial infarction and thirteen 
controls. They commented on the absence of any correlation 
between the serum cholesterol level and the degree of lipaemia 
as measured by optical density, and emphasised that the 
differences between the coronary and control groups were 
more prominent in the latter part (or ’clearing phase’) of 
the fat tolerance test than in the earlier, primarily absorptive, 
phase. These optical density differences were confirmed in 
subsequent investigations (Bouchier and Bronte-Stewart, I96I;
Maries et_ ad., 1962). Althou^ the total fatty acids in oases 
of coronary heart disease remained elevated longer than in 
healthy young male controls, Horlick (1956 and 1957) found 
that in his series the high fat test meal failed 'to uncover 
or exaggerate a lipid metabolic defect in individuals with 
atherosclerosis. Stutman £t (196I) demonstrated a delay 
in return to normal of optical density values after fat loading 
in thirteen coronary patients under 40 years, and suggested 
that the 9 hour serum optical density offered a simple, 
practical, and effective tool for separating atherosclerotic 
from healthy subjects in large populations. Brovm £t 
(1961) observed that the 9-hour total fatty acid levels gave 
better separation of their coronary patients from healthy subjects
than either the 9-hour optical density values, the cholesterol, 
or the fasting total fatty acid levels. Denborough (1963) 
confirmed by optical density and triglyceride estimations that 
fat tolerance curves were elevated in some post-myocardial 
infarction patients and emphasised that high postprandial 
triglyceride levels were related to high fasting triglyceride 
levels, and that reduction of the fasting triglyceride level 
resulted in a reduction in aliraentaiy lipaemia.
Increased alimentary lipaemia in ischaemic heart disease 
patients was also observed when the lipid-bound blood radio­
activity level was used as an' index of lipaemic response after 
ingestion of I ^^^-labelled fat (Likoff ^  , 1958; Seller
et al.. 1959; Brown et I96I).
METHODS
Subjects
The subjects for the fat tolerance tests were the same 
as those whose fasting plasma lipid levels were described 
in Chapter III: namely, 50 healthy male controls aged 20 to 
64 years; 22 healthy female controls aged 18 to 68 years; 72 
male patients with atherosclerotic arterial disease (myocardial 
infarction 27, angina pectoris 19, peripheral arterial disease
26) aged.36 to 70 years; and 14 female patients with athero­
sclerotic arterial disease aged $0 to 70 years. Further details 
of these subjects were given on page 57,
Composition of Test Meal
This was a semiliquid meal of the following composition:
y iÿ.
Fat 75 g* - as cream (Nestle‘s Sterilised Cream' 325 g.)
Carbohydrate 35 g. - as glucose (dextrose)
Protein 15 g. - as milk protein (Casilan).
In addition to the 35 g. of glucose and 15 g. Casilan, a further 
12 g. (approx.) of carbohydrate and 9 g. (approx.) of protein 
were present in the cream.
The ingredients were weighed and mixed with water in 
a blender on the day before use. The mixture was stored over­
night in a refrigerator, and made up to a volume of 750 ml. 
with water immediately before use.
Procedure
The subjects, having fasted overnight, had a blood sample 
talien for estimation of fasting lipids, as described in Chapter 
III. They were then asked to drinlc the test meal'within a 
period of 30 minutes. Blood samples were taken at 2, 4, 6, and
Nestle Company Ltd., St. George’s House, Wood St., London, B.C.2.
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8 hours from commencement of the meal. In some cases an 
additional blood sample was talien at one hour. No further 
food or drinlc was taken, and cigarette-smoking was not 
permitted until the test was completed. Light activity in . 
the ward was allowed during the test, but subjects returned 
to bed for 30 minutes before each venepuncture.
Estimations
BloOd samples for estimation of plasma triglyceride, 
total cholesterol, phospholipid, and total NEFA were processed 
as described in Chapter II, In a number of cases the 
haematocrit was measured by centrifugation of blood, anti­
coagulated with sodium EDTA, in haematocrit tubes at 3,000 
r.p.m. for 30 minutes in a centrifuge with swing-out head of 
15 cm, radius,
RESULTS
CHANGES IN PLASMA TRIGLYCERIDE DURING EAT TOLERANCE TESTS
(a) Male and Female Controls
The mean triglyceride values obtained in male and female 
controls of all ages during the fat tolerance tests are shown 
in Table X and Fig. IS. The peak triglyceride level was
TABLE X, Fat Tolerance Tests in Control and Arterial 
Disease Subjects (mean + S.D,)
Plasma Triglyceride mg. per 100 ml.
Time
of
Sample
Controls 
male 
all ages
Controls 
female 
all ages-
Arterial 
■ Disease 
male
Arterial
Disease
female
Fasting 89.4 1 32.0 80.3 + 16.6 108.4 + 42.0 85.7 1 18.3
(n = 50) (n = 22) (n = 72) (n = 14)
1 hour 106.6 ± 33.4 83.7 + 16.4 129.2 + 54.8 100,7 + 17.8
(n =. 24) (n = 6) (n = 33) (n = 10)
2 hour 131.2 1  48.5 107.3 + 20.9 151.2  + 63.2 125.9  1  26.8
(n = 50) (n = 22) (n = 72) (n = 14)
4 hour 172.6 + 81.2 139.0 + 48.1 194.2  + 90.0 143.9  1 36.2
(n = 50) (n = 22) (n = 72) (n = 14)
6 hour 157.5 + 88.5 126.8  + 60.4 181.4 ± 92.0 136.2 1 36.9
(n = 50) (n = 22) (n = 72) (n = 14)
8 hour 103.7 ± 63.1 94.0 1  42.1 134.7  + 80.8 107.1 + 42 .6
(n = 50)
. . .  ________________
(n = 21) (n = 72) (n = 14)
n = no. of observations
a g e  g r o u p : all ages
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Pigs, 18 to 20, Comparison of fat tolerance tests in male and
female controls (mean + S.E.M.)
attained 4 honre after ingestion of the fat load. On 
comparison of male and female controls of all ages, the fasting 
triglyceride level v/as higher in the males. The differences 
in mean triglyceride level between males and females became 
more marked at 2, 4 smd 6 hours after the meal, but at no time • 
were the differences statistically significant. On subdivision 
of the controls into the different age groups, it was evident 
that the greatest differences in fat tolerance curves between 
males and females were present in the 40 to 44 year age group 
(Fig. 21), in which the males had a significantly higher 
4«hour level, and in the 45 to 54 year age group (Fig. 22) 
when the 2-hour level in the males was significantly higher.
In subjects under the age of 40 years, the fat tolerance curves 
tended to overlap (Fig. I9), while in the 55 to 64 ye-ar age 
group both fasting and postprandial triglyceride levels were 
slightly higher in the females (Fig. 23).
(b) Male and Female Arterial Disease Patients
The mean triglyceride values obtained during fat tolerance 
tests in male and female arterial disease patients are shown 
in Table X. Comparison of the fat tolerance tests of arterial 
disease females with those of males of corresponding age (Fig. 24) 
revealed slightly higher fasting levels in males. During
P l o s m a
T r i g t y c e r k î e
mg/lOOmI
Pie. 21
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Figa. 21 to 25. Comparison of fat tolerance tosta in male and
fekile controls (moan j; S.E.M.). -
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the fat tolerance test the differences between males^and 
females were increased at 4 s-nd 6 hours, but at no time did 
they attain levels of statistical significance.
Comparison of fat tolerance tests in male patients with 
myocardial infarction, angina pectoris, and peripheral arterial 
disease revealed no significant differences in the three groups 
(Table Xl).
(c) Comparison of Controls and Arterial Disease Sub.iects
Comparison of fat tolerance tests in 70 male arterial 
disease patients with those of the 34 male controls aged 40 
years and over (Pig. 25) revealed similar plasma triglyceride 
curves in the two groups. Both fasting and postprandial 
triglyceride levels were slightly higher in the arterial 
disease patients than in controls, but the differences were 
not statistically significant. The 8-hour triglyceride level 
gave a separation of arterial disease patients from controls 
that was only marginally better than that given by the fasting 
triglyceride level.
On subdivision into age groups, it became evident that 
the distinction in fat tolerance tests between controls and 
arterial disease patients was greater in the 40 to 44 year age 
group (Fig. 26). Although there was still some overlap in
TABI*S XI. Fat Tolerance Tests in the Three Groups of Male 
Arterial Disease Patients (mean + S.D.)
Time
of
sample
Plasma Triglyceride mg. per 100 ml.
Myocardial
Infarction
Angina
Pectoris
Peripheral
Arterial
Disease
Fasting
1 hour
2 hour 
4 hour 
6 hour 
8 hour
102.8 +41.6 
(n = 27)
124.1 + 56.2 
(n = 16)
137.6 + 61.8 
(n = 27)
173.8 + 91.3 
(n = 27)
163.2 1 89.8 
(n = 27)
128.3 + 70.4 
(n = 27)
105.1 
(n =
134.0 
(n :
149,5 
(n :
212.2 
(n :
192.3 
(n =
118.3 
(n =
+ 36.0 
= 19)
1 55.8
= 7)
1 53.3 
= 19)
+ 85.9 
= 19)
1 82.7 
= 19)
1 56.3 
= 19)
116.7 i 46.4 
(n = 26)
134.0 !• 57.1 
(n = 10)
166.5 + 69.8
(n = 26)
202.3 1 90.9
(n = 26)
192.5 1 100.8
(n = 26)
153.3 + 102.5 
(n = 26)
n = no. of observations
AGE GROUP : 40years & over
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T r i g l y c e r i d e
iig/lOOmI
Plasma
Triglyceride
mg/K)Oml
250-1
Arterial d isease-m ales (70 )  
(3 4 )Controls -  males
200-
1 5 0 -
100-
S,
0 2 84 6
TIME in HOURS
Fig. 25
AGE g r o u p ; 4 5  to 54  years
250 “ I
200 -
150 -
100 -
A — A Arterial disease-males (26)
(14)# — # Controls -  males
20 4 86
TIME in HOURS
Fig. 27
Plasma
Triglyceride
mg./lOOmI
250-1
200-
150-
100-
A — A  a r t e r ia l  d is e a s e - male C9) 
•  CONTROLS-males (11)
P<0-05 P<0-01
0 2 864
TIME in HOURS
Fig. 26
AGE GROUP: 55  to 6 4 years
Plasma 
Triglyceride 
mg/100 ml
250 ^
A—^  Arterial disease -moles (30 ) 
Controls-males ( 9 )
200 .
150
100 _
TIME in HOURS
28
Figs* 25 to 28. Comparison of fat tolerance tests in male 
controls and arterial disease patients (mean + S.E.M*)
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fasting and postprandial triglyceride levels between controls 
and arterial disease patients (Figs. 29 and 30), the mean fat 
tolerance curve in patients was higher than that in healthy 
controls. In patients the 4" and 6-hour triglyceride levels 
were similar, whereas in controls there was a considerable 
fall in triglyceride between 4 and 6 hours. The différai ces 
in triglyceride level between patients and controls were 
statistically significant in fasting blood, and in the 8-hour 
sample, and the 8-hour level gave a rather better separation 
of patients from controls than did the fasting level. In the 
45 to 54 year age group (Fig. 27) triglyceride concentrations 
in patients were only slightly higher than those in controls, 
and the difference was even smaller in the 55 to 64 year age 
group (Fig. 28).
Comparison of female arterial disease patients with 
female controls of the same age (Fig. 31) revealed similar fat 
tolerance curves in the two groups. Triglyceride levels in 
the controls tended, for the most part, to be higher than 
those in arterial disease patients.
(d) Correlation of Fasting and Postprandial Triglyceride Levels
I
On ' examination ..of the fat tolerance curves, it was evident 
that the highest postprandial triglyceride levels occurred in
A rteria l d is ea s e -m o le s : 4 0  to 4 4 y e a rs
CONTROLS -  male: 40 to 44 years
Plasma 
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m g/lOOml
500 n
4 0 0 -
3 0 0 -
200-
100-
TIM E In HOURS
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5 0 0 -1
4 0 0 -
3 0 0 -
200-
TIM E  in HOURS
Fig. 29 Fig* 30
Figs, 29 and 30. Individual fat tolerance curves in 
male controls and arterial disease patients aged 40 to 
44 years.
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subjects with initially high fasting triglyceride concentrations. 
This was confirmed by correlating postprandial with fasting 
triglyceride levels (Table XII). A similar close correlation 
between fasting and postprandial triglyceride levels was seen 
in controls and arterial disease patients at all times after 
the fat load. . .
SUI#1ARY OF PLASM TRIGLYCERIDE GMGES
In healthy controls postprandial triglyceride concentrations 
during fat tolerance tests tended to be higher in males than 
in females, but statistically significant differences were 
observed only in the 40 to 44 and 45 to 54 year age groups.
The differences in the 8-hour levels were smaller than those 
in the other postprandial levels. In the 55 to 64 year age 
group, plasma triglyceride concentrations in the females were 
at all times slightly ‘higher than in the males. Wo statistically 
significant differences in fat tolerance tests were seen between, 
male and female arterial disease patients, or in the three 
clinical types of male arterial disease patients.
Comparison of arterial disease and control subjects 
revealed that young male arterial disease patients had sig­
nificantly higher fat tolerance curves than healthy males 
of corresponding age, and the greatest differences were seen
TABIiB XII* Correlation of Postprandial with Fasting
T r ig ly c e r id e  Levels (c o r re la t io n  c o e ff ic ie n ts )
Controls  
male and female
A r te r ia l  
Disease P a tie n ts  
male and female
1 hour and +0*89 +0 . 9 3
fa s t in g  t r ig ly c e r id e (n = 50) (n = 43)
2 hour and +0*76 +0.88
fa s t in g  tr ig ly c e r id e (n = 72) (n = 8b)
-K-H-K-
4 hour and +0 . 7 5 +0 * 88
fa s t in g  tr ig ly c e r id e (n = 72) (n = 86)
**«•
6 hour and +0 . 7 3 +0*85
fa s t in g  t r ig ly c e r id e (n = 72) (n  86)
-X-K-X"
8 hour and +0 . 7 5 +0 . 7 7
fa s t in g  t r ig ly c e r id e (n = 71) (n = 86)
P<0.001
n s no. o f p a irs  o f observations
in the 8-hour sample. The differences in fat tolerance between 
arterial disease and control subjects became progressively 
less with age. There were no significant differences in fat 
tolerance between female controls and female arterial disease 
patients, who were all aged 50 years or over.
The highest postprandial triglyceride levels occurred 
in subjects with the highest fasting triglyceride levels.
Both in controls and in arterial disease patients there was 
a close correlation between fasting and postprandial triglyceride 
levels.
CHANGES IN PIASM CHOLESTEROL DUPING FAT TOLERANCE TESTS
All four groups of subjects showed a small increase in 
plasma cholesterol concentration one hour after ingestion of 
the fat load (Table XIIl). In male controls the cholesterol 
concentration at other times during the fat tolerance test 
was not significantly different from the fasting level, but 
in the other subjects it remained slightly elevated.
CHANGES IN PIASMA PHOSPHOLIPID DHHING EAT TOLERANCE TESTS
In all four groups of subjects there was a progressive 
increase in plasma phospholipid concentration during the fat 
tolerance test.up to the time of the 6-hour estimation (Table XIT,
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Pig, 52). The plasma phospholipid level had decreased by 
8 hours, but still remained well above the fasting level.
There was no significant correlation between the fasting 
and the 6-hour phospholipid level. In all subjects there 
was a weak positive correlation between the increases in 
phospholipid and triglyceride at the 6-hour estimation.
This correlation was statistically significant only in the 
group of 28 male controls ( r « +50, P^O.Ol).
CHANGES IN PLASM NEFA DURING FAT TOLERANCE TESTS
Ingestion of the test meal was followed by a reduction 
in plasma NEEA level. This was obvious at one hour after 
the meal, but in most cases the plasma NEEA concentration 
reached its lowest level at two hours (Table XV, Pig. 55).
By the time of the 4-^o^r estimation a rebound rise in NEPA 
to levels above the fasting concentration had occurred, and 
the 6-hour estimation showed a continued rise. By the 6th 
hour the NEPA concentration had commenced to fall again, 
but remained significantly above fasting levels. The plasma 
NEPA curves obtained in the course of the fat tolerance 
tests showed no significant differences between males and 
females, or between controls and arterial disease patients 
(Pig. 55).
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CHAKGES Ilf HAEMTOCRIT DURING PAT TOLBRAKCE TESTS
The changes in haematocrit in the course of the fat 
tolerance tests are shown in Fig. 54* The only significant 
changes in all 34 subjects in whom the haematocrit was recorded 
was a transient mean increase of 1#3 + 2.0 per cent at one 
hour (P<0.001). The male arterial disease patients showed 
a further sli^t increase at 2 hours, but in the other subjects 
the haematocrit had returned to fasting levels by two hours, 
and showed no significant change thereafter.
The magnitude of the increase in haematocrit at one hour 
correlated positively with the increase in plasma cholesterol 
concentration which occurred at the same time (r » +0.49, 
?<0.01).
SUmARY OF EESÜLTS OF FAT TOLERANCE TESTS
I. Changes in Triglyceride
(a) Differences between Arterial Disease Patients and Controls
The fat tolerance curves of young male arterial disease 
patients (40 to 44 years) were significantly higher than those 
of male controls of the same age. Both fasting and 8-hour 
triglyceride concentrations were significantly, higher in':the 
arterial disease patients, but the difference between the
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two groups in 8-hour triglyceride levels was greater than 
that in fasting triglyceride. In older male subjects, there 
was no significant difference in fat tolerance between arterial 
disease patients and controls.
Ho differences in fat tolerance were found between female 
arterial disease patients and female controls. Pat tolerance 
curves were similar in myocardial infarction, angina pectoris, 
and peripheral arterial disease patients.
(b) Sex Differences
Male controls tended to have hi^er fat tolerance curves 
than females in the 5th and 6th decades. In older subjects, 
however, triglyceride levels in females were slightly higher 
than in males.
No sigaifleant differences were found in fat tolerance 
between male and female arterial disease patients.
(c) Relationship between Pasting and Postprandial Triglyceride 
Levels
Subjects with elevated fasting triglyceride levels had 
the highest postprandial levels. There was a close correlation 
between fasting and postprandial triglyceride concentrations.
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II. Changes in Other Plasma Lipids and Haematocrit
(a) Plasma Cholesterol
All groups of subjects showed a small increase in plasma 
cholesterol at one hour. In male controls the cholesterol 
than returned to fasting levels, while in other subjects it 
remained slightly elevated.
(b) Plasma Phospholipid
In both arterial disease and control subjects there was 
a progressive increase in plasma phospholipid concentration 
up to six hours, with a slight fall thereafter.
(o) Plasma NSFA
All subjects showed a similar fall in NEPA, maximal 
at 2 hours, with a subsequent rise to concentrations approxi­
mately 40 per cent above the fasting level at 6 hours, followed 
by a small decrease.
(d) Haematocrit
There was a small but significant increase in haematocrit 
at one hour following ingestion of the meal. This increase 
correlated positively with the increase in plasma cholesterol 
concentration which occurred at this time. ^
DISCUSSION
Many observers have reported coronary arteiy disease 
to be associated with an exaggerated and prolonged postprandial 
rise in blood neutral fat. It has been suggested that a 
prolonged response to a fat meal may provide a better indication 
of the fat defect in coronary artery disease than the fasting 
triglyceride level or other lipid parameters (Seller et al., 
1959; Brown et al., I96I; Albrink, 1962). In this study, 
only young male subjects with arterial disease were found to 
have fat tolerance tests significantly different from those 
in apparently healthy subjects (Pig. 26). Pat tolerance 
curves in older male arterial disease patients were lower than 
in young patients, and indistinguishable from those in healthy 
controls. Similarly, fat tolerance curves in female arterial 
disease patients, who in the present series were all aged 50 
years or more, did not differ from those obtained in healthy 
females of the same age (Pig. 51). Even in the group of young 
male subjects in whom significant differences were found in 
the mean plasma triglyceride curves there was no clear 
demarcation between the lipaemic responses of patients and 
controls. Several patients had very high plasma triglyceride 
levels and several controls very low plasma triglyceride levels 
throughout the test, but in the majority the curves appeared 
similar in the two groups (Pigs. 29 and 50).
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There have been few attempts to define a normal fat 
tolerance curve. Sklarin ^  (196I) stated that the most
useful criterion for a normal response was the return of the 
serum triglyceride to fasting levels by nine hours after a 
fat meal (109 g# fat). Brown et al. (19^3) suggested that, 
in normal young, men, a fasting serum triglyceride level of 
more than $.2 meq. per 1. or a postprandial level exceeding 
9.0 meq. per 1. after a 70 g. fat meal were probably abnormal. 
Hatch et (I966) adopted a modification of Sklarin* s criteria. 
They suggested that a fat tolerance curve should be considered 
abnormal if the triglyceride level had not returned to within 
BO mg. per 100 ml. of the fasting level by nine hours after 
the 109 g* fat meal. If Sklarin*s standards were applied to 
our 40 to 44 year old subjects, making no allowances for the 
differences in size of fat load and in timing of the last 
blood sample, seven of the nine arterial disease patients 
and three of the eleven controls were abnormal. By Hatch’s 
standards, only three patients and one control had abnormal 
fat tolerance curves. These criteria were unsatisfaotoiy, 
however, in their assumption that all subjects with elevated 
plasma triglyceride concentrations showed a delayed return 
to fasting levels. In our series, the subjects with the 
greatest alimentary lipaemia in both arterial disease and 
control groups had normal fat tolerance curves by these criteria
J.44
since their 8-hour levels were similar to their high fasting 
triglyceride levels.
The close correlation in the subjects in this study 
between fasting and postprandial triglyceride concentrations 
at all stages of the fat tolerance test was in accord with 
Denborough's (19^3) observation that the fasting and maximal 
postprandial triglyceride levels correlated well* More 
recently Brown ^  (1966) suggested that the prolonged
alimentary lipaemia frequently seen in ischaemic heart disease 
' patients was a function of an elevated fasting triglyceride 
concentration in these subjects* Subjects with low or normal 
fasting triglyceride levels would therefore be found to have 
low plasma triglyceride concentrations throughout the course 
of a fat tolerance test, whereas an exaggerated lipaemic 
response to a fat load would be anticipated in persons with 
already elevated fasting triglyceride levels. These observations 
cast doubt on the value of fat tolerance tests. Denborough 
(1965) stated that measurements of either plasma optical 
density or triglyceride concentration after a meal had no 
advaUtage over the estimation.of fasting plasma triglyceride* 
Pelkonen and Nilckila (I965), who carried out a large 
series of fat tolerance tests in 95 coronary patients 
and 78 healthy persons, were of the opinion that basal lipid
tv
levels separated coronary from healthy individuals as well 
as did the fat” tolerance test. Our results showed that the 
8-hour triglyceride gave wider separation of arterial disease 
patients from controls, but did not produce significant 
differences in triglyceride levels between patients and 
controls where they did not already exist in the fasting state. 
The fat tolerance test therefore did not uncover any latent lipid 
abnormality. In view of the wide overlap between patients 
and controls, the fat tolerance test appears to be of no value 
in detection of lipid abnormalities in the individual. It 
has only a minor advantage over the fasting triglyceride 
estimation in the comparison of groups of arterial disease 
patients with healthy subjects, and this advantage must be 
outweighed by the time-consuming nature of the test.
The finding in this study of increased alimentary lipaemia 
in only the younger subjects with atherosclerotic arterial 
disease is in keeping with other observations suggesting that 
the lipid abnormalities in ischaemic heart disease are greater 
in the younger patients. This was noted with respect to 
serum cholesterol concentration (Little _et al., 195^5 Lawry 
et al., 1957; Albrink et al,, 196I) and possibly also \Tith 
respect to fasting triglyceride (Oliver, I966). The data on 
fasting plasma lipids reported in Chapter III showed higher 
fasting plasma levels of.triglyceride as well as cholesterol
A
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in younger patients. The fat tolerance results in the present 
study do not confirm the suggestion (Seller ^  al., 1959?
Brown et al.$ I96I; Albrink, 1962) that the fat tolerance 
test is a better indicator of abnormal lipid metabolism in 
atherosclerosis than the other plasma lipid parameters. In 
all age groups,- the fasting plasma cholesterol level permitted 
distinction between arterial, disease patients and controls 
as w811 as, and in most cases better than, the fasting or 
6-hour triglyceride level. It has been suggested that 
apparently healthy persons with h i ^  fat tolerance curves 
have a high risk of ischaemic heart disease (Brown et ,
1965)* Definite conclusions on these points can be reached 
only after analysis of the results of large scale prospective 
studies, such as are already in progress (Kannel ^  ,
1964; Havel and Carlson, I962), of the influence of plasma 
cholesterol and triglyceride levels on the development of 
ischaemic heart disease.
The differences in fat tolerance between arterial 
disease patients and controls in this series was less marked 
than that reported in some other studies. This might be due 
to several factors. In a considerable number of publications, 
arterial disease patients were compared with a control series 
of much younger persons (Schwartz ^  al. » 1952; Pomeranze 
et , 1954; Woldow et al., 1954; Horlick, I956 and 1957;
Likoff > I95&)* By virtue of their age, plasma lipids
in these ’controls’ would he lower than those of persons of 
similar age to the ischaemic heart disease patients# Other 
investigators used as their control series convalescing hospital 
inpatients (Mitchell and Bronte-Stewart, 1959) or longterm 
inmates of mental .hospitals (Bronte-Stewart and Blackburn,
1958), whose plasma lipids could not be assumed to be the 
same as those of the healthy population. In this series, 
as in some others (Barritt, 195&; Pelkonen and Nikkila, 19&5), 
controls were selected from healthy active individuals prior 
to their admission for minor surgical operations. An additional 
factor reducing the differences in plasma lipids between 
arterial disease patients and controls in this series might 
be the fact that in a population such as this with a very 
high prevalence of atherosclerotic disease, a considerable 
proportion of apparently healthy controls must have clinically 
undetected atherosclerosis.
The small increase in plasma cholesterol found in all 
groups in the present series one hour after ingestion of the 
fat load was presumably a haemoconcentration effect, since 
the magnitude of the cholesterol increase correlated positively 
with the magnitude of the haematocrit increase. With the 
exception of the male controls, the subjects in this study 
showed smaller increases in cholesterol in the later stages
±40
of the fat tolerance test. Reports in the literature of the 
effect of fat loading on plasma cholesterol levels were con­
flicting. Nevertheless it was generally agreed that changes 
in plasma cholesterol sifter a fat meal were small in comparison 
with those in other plasma lipids, and could not he used as 
an index of fat absorption and removal,
A large number of investigators found that plasma cholesterol 
levels were unchanged following fat meals varying in amount 
from 20 g. to 204 g» fat (Blix, lg26; Pomeranze et al., 1954;
Albrink et al., 1958; Hollister, 1963). Others reported that 
fat loading caused small but significant increases in plasma 
cholesterol level (Talbott and Keating, 1962; Brown al.
1963)* Havel (1957) found no significant change in cholesterol 
in normal males, but in seven out of eight test meals in two 
normal females the serum cholesterol rose I5 mg. per 100 ml. 
or more. Yet other workers recorded a significant fall in 
serum cholesterol during fat tolerance tests (Nikkila and 
Konttinen, 1962; Angervall, I964; Kallio, I967).
Some of the apparently contradictory results might be 
accounted for by the fact that some of the series are small 
in number, and others by the differing compositions of the 
test meals used, Kingsbury and Morgan (i960) administered 
various types of oils to healthy subjects and showed that some 
types of oils produced a consistent rise in serum cholesterol
J.4?
levels, while others produced a consistent fall. That the 
contradictions could not all be resolved on this basis, 
however, was evident from the fact that in the various experi­
mental series quoted above, meals of cream or butterfat were 
shown to cause a rise, a fall, or no change in plasma cholesterol 
levels. Recent studies of cholesterol absorption in man showed 
intestinal absorption of cholesterol to be slower than that 
of triglyceride, the peak appearance of absorbed cholesterol 
in thoracic duct lymph being approximately eight hours after 
a meal (Heilman et , I960) • The small but significant 
increases in cholesterol seen during the latter phases of fat 
tolerance tests in most of the subjects in this series might 
be due in part to cholesterol absorbed from the test meal.
It might, however, be a reflection of the increased plasma 
concentrations of lipoproteins concerned in triglyceride 
transport, which contain small amounts of cholesterol in 
addition to triglyceride and phospholipid,
The plasma phospholipids in all groups of subjects in 
this study showed a progressive increase in concentration 
up to the time of the 6-hour estimation, and had only decreased 
slightly at the time of the 8-hour estimation. Man and G-ildea 
(1932) reported considerable increases in phospholipid after 
a fat load of 3*5 to 4 g* per kg. of body weight, but little 
or no change in phospholipid following a standard 60 g. fat
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meal. Several other workers recorded increased phospholipid 
concentrations following meals of 177 ê* fut (Talhott and 
Keating, I962) and 80 g. fat (Angervall, 1964), while Albrink 
and Man (1956), Osmon et al. (1957) and Stutman £t (196I) 
stated that serum phospholipids were unchanged after fat loads 
of 60 to 70 g. ■ In the present series the maximum phospholipid 
concentration occurred later than the lipaemic peak, and 
phospholipid levels remained considerably elevated at 8 hours 
when the triglyceride concentration in most cases had returned 
to fasting levels. Havel (1957) also noted that raised 
phospholipid levels persisted longer than the lipaemia, and 
Kallio (1967) found elevations of serum phospholipids as long 
as 10 hours after the fat meal. There was some evidence 
in the present series of a weak correlation between the 
magnitudes of the phospholipid and triglyceride increases, 
and Angervall (I964) found a similar correlation in his subjects 
The increase in plasma phospholipids during alimentary lipaemia , 
was presumably due partly to the phospholipid content of 
chylomicrons, and partly to the proportionately greater 
phospholipid component of the very-low-density lipoproteins 
which transported triglyceride (derived from chylomicrons) 
from the liver to the fat depots. It mi^t therefore be 
anticipated, as was found in this study, that the correlation
J.2J.
between plasma phospholipid and triglyceride would be less 
close during alimentary lipaemia than in the fasting state, 
when these lipids were present only in the form of lipoprotein.
Ingestion of the test meal in all subjects in this study 
resulted in an initial fall in plasma NEFA lasting one to two 
hours, with a subsequent rise above fasting levels. A similar 
pattern of NEFA response to mixed meals has been reported by 
a number of other workers (Dole, 1956; Albrink et 'al., 1958; 
Shah et al., 1963; Konttinen and Rajasalmi, I963; Hollister, 
1963)' The administration of carbohydrate alone causes an 
abrupt fall in plasma NEFA within half-an-hour ^nd lasting 
for several hours (Dole, 1956; Gordon and Cherkes, 1956; 
Bierman £t al., 1957&; Rothlin ui* > 1962; Castelli _et al.,
1966). A similar, thou^ less marked, fall in NEFA concen­
tration follows ingestion of protein (Castelli £t , I966). 
On the other hand, after administration of fat alone NEFA 
levels are unchanged or show a gradual rise similar to that 
seen when fasting is continued for the same length of time 
(Dole, 1956; Gordon and Cherkes, 1956; Albrink and Neuwirth, 
i960). The initial fall in NEFA level after ingestion of 
a mixed meal appears, therefore, to be due to its carbohydrate 
content. The decrease in plasma NEFA level has been shown 
to be due to decreased output of NEFA from fat depots (Carlson 
and Oro, I965), the mechanism probably being inhibition of
lipolysis, or promotion of re-esterifioation of NEFA within 
the fat depots.
The origin of the plasma NEFA idiich cause the delayed 
rise in alimentaiy lipaemia is disputed. In the fasting state, 
changes in plasma NEFA concentration are believed to be due 
almost entirely to-changes in the rate of fatty acid liberation 
from adipose tissue. During alimentary lipaemia, however,
NEFA may be released by intravascular hydrolysis of chylo­
micron triglyceride. It is known that fatty acids are liberated 
by lipolysis of chylomicrons during the in vitro clearing of 
lipaemic serum (Robinson and French, 1953)» and that plasma 
. NEFA levels are elevated during the enhanced clearing of 
lipaemia induced by heparin injection ^  vivo (McDaniel and 
Grossman, 1955; Fredrickson and Gordon, 1958b). Intravenous 
infusions of triglyceride emulsions have been followed by 
a prompt and marked rise in NEFA levels (Forbes, 1965).
The relevance of these observations to the normal mechanisms 
of clearing of alimentaiy lipaemia is doubtful. However, 
since Dole ^  al. (1959) have shown that the arterial NEFA 
pattern during the lipaemia induced by a fat load may vary 
according to the fatty acid composition of the ingested fat, 
it is probable that some of the NEFA are derived from freshly 
absorbed fat. On the other hand. Dole (1956) found that the 
NEFA rise during lipaemia induced by fat alone was no greater
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than that of continued fasting, and that an abrupt decrease 
in plasma NEPA level could be produced by glucose administration 
during alimentary lipaemia without delaying clearance of the 
lipaemia. These findings suggest that the NEPA level in the 
lipaemic as well as in the fasting state is dependent mainly 
on mobilisation of' endogenous fatty acids. It would appear, 
therefore, that the elevated M P A  levels after a mixed meal 
are due to M P A  derived partly from fat- depots and partly 
from hydrolysis of newly-absorbed triglyceride. There is 
some evidence, also, that the liver may play a major part 
■ in the clearing of alimentary lipaemia, and may release M P A  
into the circulation (Dole and Hamlin, 1962).
In the present study the inhibition of M P A  release 
produced by the test meal was similar in arterial disease 
patients and controls, and in the myocardial infarction, angina 
pectoris, and peripheral arterial disease patients. The 
rebound increases in M P A  demonstrated in the latter half 
of the fat tolerance tests were also similar in arterial 
disease patients and controls, and did not vary with the 
degree of alimentaiy lipaemia, M P A  release has been reported 
to be much greater in ischaemic heart disease patients than 
in controls in response to the stimulus of cigarette-smoking 
(Kershbaum ^  al., I962). No such difference in KEPA release 
between patients with atherosclerotic arterial disease and
XU4
controls has been demonstrated during alimentary lipaemia. 
SÏÏMMAJRY AND CONCLUSIONS
1. The fat tolerance curves of male arterial disease patients 
aged 40 to 44 years were significantly higher than those of 
healthy men of the same age. Patients with myocardial 
infarction, angina pectoris, and peripheral arterial disease 
showed similar abnormalities in alimentary lipaemia. Pat 
tolerance tests in older male and female patients did not 
differ from those of controls of corresponding age.
2. There was a close correlation between fasting and post­
prandial triglyceride levels, both in controls and in arterial 
disease patients. High fat tolerance curves occurred in persons 
with elevated fasting triglyceride levels.
3. In arterial disease patients of all ages, elevation of 
the plasma cholesterol was more common .than elevation of the 
fasting triglyceride or 8-hour triglyceride levels.
4. An increase in plasma cholesterol in all groups of subjects 
one hour after ingestion of the test meal was associated with 
an increase in haematocrit. In male controls the plasma 
cholesterol then returned to fasting levels, but male and 
female patients and female controls showed a small but
±:j:)
significant increase in cholesterol in the later stages 
of the fat tolerance test.
6. In all subjects the plasma phospholipid increased during 
the fat tolerance test, reaching its maximum at six hours, and 
decreased slightly thereafter. The increase in phospholipid 
was much smaller than the increase in triglyceride, but 
persisted for longer,
7* Ingestion of the test meal caused a fall in plasma REPA 
for one to two hours, followed by a rise to above the fasting 
level, maximal at six hours. Plasma REPA curves were similar 
in arterial disease patients and controls.
Chapter V. GASTBIC FUNCTION IN BELATIOM TO 
FAT'tolerance AND ATHEROSCLEROSIS
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Chapter V. GASTRIC FUNCTION
INTRODUCTION
The observation of increased and prolonged alimentary 
lipaemia in patients with ischaemic heart disease led to much 
speculation as to the cause of this abnormality. Although 
defective heparin-activated clearing of plasma lipids was 
reported in some studies (Block et al.^ 1951; Herzstein e t al., 
1954),this was not confirmed by others (Hood et 1954;
Baker, 1957), and in a four-way crossover experiment Mitchell 
and Bronte-Stewart (1959) detected no differences in plasma 
clearing activity or substrate between patients and controls,
A number of investigators showed that artificial fat emulsions 
administered intravenously were cleared at the same rates in 
patients and controls, in contrast to the greater lipaemia 
found in patients when the same fat emulsions were given 
orally (Berkowitz ^  al., 1961; Bouchier and Bronte-Stewart,
I96I; Feinberg ^  , I96I; Mayfield ^  , I962), It was
realised, however, that intravenously administered fat might 
be cleared by a mechanism different to that for orally fed 
fat, and Balodimos e t (1962) suggested that the fat 
emulsion particles were treated as foreign bodies and removed 
by the reticulo-endothelial system. This difficulty was overcome
i : ? 9
by Restel and his colleagues (I962), who injected C^^- 
labelled chylomicrons intravenously, and found similar 
clearance in two hyperlipaeraic subjects.
These findings ,v/ere considered by some investigators 
to indicate that impairment of fat tolerance was due to factors 
governing the entry of fat into the circulation, rather than 
to impaired fat clearing. It was postulated that increased 
alimentary lipaemia occurred in subjects whose intestinal 
lipolysis was defective, with the result that more fat 
entered the circulation in a particulate form which persisted 
for longer than normal (Frazer, 1945; Becker _et al,, 1950; 
Harder et. âl* > 1952; Tietz £t al., i960). Becker et al.
(1950) found prolonged ohylomicronaemia as .well as diminished 
gastric and pancreatic secretions in elderly subjects, and 
suggested that the diminished gastric acidity in these subjects 
was an index of inefficient gastro-intestinal function. It 
was suggested also that diminished secretion of acid by the 
stomach might be accompanied by diminished secretion of gastric 
lipase, leading to inadequate émulsification of fat prior to 
its encounter with pancreatic lipase, and thus to greater 
alimentary lipaemia (Bronte-Stewart and Krut, I962). Delayed 
gastric emptying was considered to be an additional factor 
contributing to prolongation of alimentary lipaemia (Frazer 
and Stewart, 1959; Harder et al., 1952).
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The main aspects of gastric function which have been 
implicated in abnormal fat tolerance in atherosclerosis, there­
fore, are deficient gastric secretion, delayed gastric emptying, 
and inefficient gastric lipolysis. In the present study an 
investigation has been made of each of these factors in controls 
and arterial disease patients. Since if these factors are 
important, an exaggeration of their effects might be anticipated 
in states with failure of gastric secretion as in Addisonian 
pernicious anaemia, or with gastric hypersecretion as in 
duodenal ulceration, subjects in these categories were also 
studied.
METHODS
An account of the methods used throughout this Chapter 
is given below.
SUBJECTS
The studies of basal gastric secretion, gastric emptying 
by the Hunt technique, and gastric lipolysis were carried out 
in the majority of the subjects described in Chapter III,
These were as follows;- 32 male controls aged 27 to 61 years 
(mean 45.2 years), of whom 23 were aged 40 years or more (mean 
50.3 years), 51 male arterial disease patients of mean age
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51.6 years (23 with myocardial infarction of mean age 50.0 
years, 14 with angina pectoris of mean age 52.8 years, and 14 
with peripheral arterial disease of mean age 52.9 years).
Studies were carried out in addition on 5 male arterial disease 
patients with duodenal ulcer demonstrated by barium meal 
examination (aged >41 to 55 years, mean 4&.4 years), and on 5 
male patients with Addisonian pernicious anaemia, proven by 
Schilling test, and treated for at least one year'prior to 
the gastric studies (aged 50 to 69 years, mean 60.0 years).
A further 10 patients (8 males and 2 females) acted 
as subjects for the radiological determination of gastric 
emptying. Their ages ranged from 17 to 61 years (mean 46,4 
years). They had no clinical evidence of gastrointestinal 
disease, and their diagnoses were as follows:- hypertension (3), 
chronic bronchitis (3.), epilepsy, hydronephrosis, gravitational 
ulcer, and atrial fibrillation.
PROCEDURES
(a) Basal Secretion
After an overnight fast, subjects were intubated by the ' 
nasal route using a Willi-Rusch radio-opaque gastric tube 
(no, 16, or in a few cases no, I4). The position of the tube 
was checked using an image intensifier with the patient in
the erect posture, and adjusted if necessary until the terminal 
portion of the tube lay along the greater curvature with the 
tip in the most dependent part of the stomach. Subjects remained 
sitting throughout the remainder of the procedure and were 
instructed to eject saliva into the carton provided. The 
stomach was emptied by aspiration of the fasting juice using 
a 50 ml. syringe, and the fasting juice was kept. The basal 
gastric secretion was then collected for 30 minutes, by 
continuous aspiration with a syringe. The volumes of the 
fasting and basal gastric juice were measured, and the following 
estimations carried out
pH. The pH was determined by use of a Radiometer pH meter.
Acid concentration. The acid content was measured by titration 
of 5 ml. of gastric juice with sodium hydroxide to a
pH of 7, using phenol red as indicator.
Chloride concentration. This was determined by potentiometrie 
titration of the chloride with silver nitrate as described 
by Sanderson (1952), using a Radiometer titrator.
(b) Gastric Emptying
After completion of the 30-minute collection of basal 
gastric secretion, a modification of the Hunt test meal technique 
(Hunt, 1954) was carried out, as described below.
Composition of the test meal
The test meal consisted of a combination of the phenol 
red solution described by Hunt with the semi-liquid test meal 
used for determination of fat tolerance in the same subjects. 
Phenol red stock solution
Phenol red powder (3 g.) was dissolved in 25 ml. of N 
sodium hydroxide by allowing to stand, and shaking the solution
I
occasionally. The solution was diluted to approximately a 
litre, filtered, and made up to two litres with water.
Test meal
On the day before use, the test meal was made up as 
follows 5-
80 g. fat (Nestle*s sterilised cream 34^ g.)
37 g. carbohydrate (dextrose)
16 g. protein (Casilan)
These constituents were homogenised with water in an 
electric mixer, and allowed to stand in a refrigerator overnight 
to allow frothing to subside. Immediately before use it was 
warmed to approximately 37^0, phenol red stock solution (28 ml. ) 
was added, and the mixture made up to 800 ml, with water.
The test meal consisted of 750 ml. of this mixture, and the 
remaining 50 ml. was reserved for comparison with the recovered
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gastric contents.
Determination of rate of gastric emptying
Subjects remained seated throughout the procedure, with 
a no. 16 Willi-Rusch radio-opaque tube in situ in the stomach. 
The 750 ml. test meal was poured down the tube by means of 
a glass' funnel. Sixty minutes later, Aspiration of the 
remaining gastric contents into a container surrounded by 
crushed ice was carried out, using a 50 ml. syringe. Three 
gastric washouts, each of 250 ml. warm tap water, were then 
carried out, and the tube was withdrawn.
The volumes of the recovered gastric contents and 
washouts were measured. The pH, acid concentration, and 
chloride concentration of the original test meal and recovered 
gastric contents were determined as described on page 162.
In 18 instances the glyceride-glycerol concentrations of 
extracts (l ml. in 250 ml. Bloor*s solution) of the initial 
watery phase (page 190) and the rest of the recovered test meal 
were measured, as described on page 42.
Determination of phenol red concentration
Measurement of the phenol red concentration of the 
original test meal, recovered test meal, and washouts was 
carried out as follows. Aliquots (10 ml.) of original test
meal, gastric contents, and the three washouts were each 
mixed with 50 ml. of trisodium phosphate buffer (trisodium 
phosphate 27.5 g. in 1 litre water), and made up to 250 ml. 
with distilled water in volumetric flasks. Duplicate 6 ml. 
aliquots of each of the solutions were pipetted into cellulose 
nitrate tubes and, centrifuged for 1 hour at 4*0,000 r.p.m. 
in a Spinco, model L, preparative ultracentrifuge. This separated 
the solutions into three layers - an upper, cream-like layer 
of fat particles, a middle zone consisting of a clear purple 
solution, and a protein precipitate at the bottom of the tube.
The tubes were divided horizontally below the fat layer, using 
a tube slicer, and the clear solution pipetted into 1 cm. 
cuvettes, taking care to avoid disturbance of the protein 
precipitate. The optical density of the purple colour was 
read at 570 mp in a spectrophotometer (Unicam S.P.600), 
and the concentration of phenol red obtained from a standard 
graph.
The phenol red concentration of the washouts was used 
to estimate their content of the test meal recovered at one 
hour. The volume of gastric contents present in the stomach 
at one hour, and the volume which had passed the pylorus during 
that hour were then calculated, as described by Hunt (1954).
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(c) Gastric Emptying of Fat
Determination of the fat content of the original test 
meal, recovered gastric contents, and washouts was carried 
out by the Gerber method. This technique is used for the 
measurement of total fat in milk and milk products, and 
the apparatus and procedure are described in detail in British 
standards 696 (1955). An outline of the method is given below.
Reagents
1. Sulphuric acid for milk testing (density 1.812 - 1.817)
2. Amyl alcohol.
Apparatus
1. ,Standard Gerber butyrometer for milk-testing.
2. Standard double-ended stopper, or lock stopper.
3. Standard, milk pipette to deliver 10.94
4. Standard pipette to deliver 10.0 ml. sulphuric acid.
5. Standard pipette to deliver 1.0 ml. amyl alcohol.
6. Centrifuge with spinning platform.
7. Water bath 65^0.
Procedure
Sulphuric acid (10 ml. ) was pipetted into the butyrometer, 
and 10.94 ml. freshly mixed test meal (or recovered gastric
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contents, or washout) added slowly. Amyl alcohol (l.O ml.) 
was then added, and the tube stoppered and shaken in a covered 
rack. The tubes were then centrifuged at approximately 1100 
r.p.m. for 4 minutes. After centrifugation the tubes were 
placed stopper downwards in a waterbath at 65^0 for at 
least 3 minutes.
When the tubes were removed from the waterbath the fat 
column .level (colourless liquid) was adjusted so that it lay 
between the calibration marks. The difference between the 
lowest point of the fat meniscus and the point of separation 
of _the fat from the acid solution (dark-brown to violet in 
colour) gave the percentage by weight of the fat in the test 
liquid. A small correction factor, which varied according 
to the length of the fat column, was applied to the butyrometer 
reading. By this method, the fat content of the 750 ml. test 
meal in 16 instances was found to be 72.8 ± 3*5 g., as compared 
with the expected value of approximately 75 g. calculated 
from the manufacturer*s figures for the composition of the 
cream used in the test meal,
(d) Gastric Lipolysis
The degree of lipolysis which occurred during the 60 
minutes the 75 g. fat meal remained in the stomach was measured
by estimation of NEFA release* The subjects were those controls 
and arterial disease patients whose gastric emptying was measured 
by the Hunt method.
As described in the previous section, the recovered test 
meal was cooled rapidly by collection in a container surrounded 
by crushed ice, in order to prevent further enzymatic lipolysis 
after removal from the stomach. Aliquots of the recovered 
gastric contents and of the original test meal were taken for 
estimation of NEFA, and processed as follows;- An aliquot 
of the original test meal (3 ml.) was pipetted into 5 ml. 
methanol and mixed on a Vortex mixer. The NEFA were then 
extracted by addition of 10 ml. petroleum ether (60^ - 80^).
An aliquot (3 ml.) of the petroleum ether extract was titrated 
for NEFA content as described in Chapter II. In the case of 
the recovered gastric contents, because of its very high NEFA 
content only 1 ml. was added to 5 ml. methanol, petroleum ether 
(20 ml.) was used to extract the NEFA, and 1 ml. of the 
petroleum ether extract was made up to a volume of 3 ml. 
with petroleum ether before titration.
(e) Radiological Determination of Gastric Emptying
Determination of gastric emptying was carried out using
1
enteric-coated barium granules , as described by Horton et a l .
1
Paines and Byrne Ltd., Pabym Laboratories, Greenford, Middlesex, 
England.
(1965). These barium granules were devised to avoid any 
possibility of irritation of the gastric mucosa by the barium 
sulphate, and to give a compound similar in specific gravity 
to food.
A standard breakfast, containing 75 g. fat, was given 
to all subjects. Its composition was as follows:- porridge 
(4 tablespoons), eggs (2), butter, cream, milk, 1 cup tea.
Barium granules (2 teaspoonfuls) were mixed with the porridge.
The subjects were asked to swallow the porridge at intervals 
during the meal in order to ensure even distribution of the 
granules throughout the food in the stomach. All food and 
drink was then withheld until the test was completed, but 
. the patients* activities were otherwise unrestricted.
Patients were screened in the erect posture, using 
•an image intensifier and commencing three hours after the 
meal. The outline of the greater curvature of the stomach 
was readily detected. Screening was carried out briefly 
at hourly intervals until emptying of the stomach was completed.
If the stomach was -seen to be almost empty at the hourly screening, 
the examination was repeated half-an-hour later. The gastric 
emptying time was taken as the time which elapsed from commence­
ment of the meal until the stomach was first seen to be empty.
As recommended by Horton ^  (1965), the presence of a few
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residual granules (approximately 10) in the stomach was 
ignored, since they were assumed to be trapped in gastric .. 
mucosal folds.
Hourly venepunctures were carried out for 8 hours, and 
plasma triglyceride estimated as described in Chapter II.
I, GASTBIC SECRETION
Since gastric acid is easily measured, it has been 
the component of gastric juice studied most extensively.
In addition to hydrochloric acid, however, gastric secretions 
are known to contain various inorganic ions, pepsinogens, other 
proteins and polypeptides^ mucus, and intrinsic factor 
(Farrar and Bower, 1967). The measurements of gastric acid 
secretion most frequently employed are those of basal acid 
output (that is, acid secretion without identifiable stimu­
lation other than that provided by the presence of the tube), 
and the maximal (histaminé-stimulated) acid output of the 
stomach. The basal acid secretion fluctuates to a greater 
extent than the maximal acid secretion and, of the measurements 
made on basal secretion, the volume of gastric juice shows the 
greatest reproducibility and the amount of free acid the least 
(Baron, 1963). Hunt and Kay (1954) and Murray ^  a l , (1957)
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have found that the basal acid secretion occupies about 
one-fifth of the maximal power.
GASTRIC SECRETION IN RELATION TO ALIMENTARY LIPAEMIA AND 
ATHEROSCLEROSIS
There is some evidence suggesting diminished gastric 
secretion in subjects with prolonged alimentary lipaemia and 
atherosclerosis, Becker et al. (1950) reported decreased 
acid and pepsin secretion, in addition to low pancreatic and 
blood lipase levels, in elderly subjects who also showed 
prolonged chylomioronaemia following fat loads. Patients with 
ischaemic heart disease were found to haye lower basal and 
maximal acid outputs than age-matched controls, and an inverse 
correlation was demonstrated between mean basal acid secretion 
and the degree of lipaemia following 75 g, fat tolerance tests 
(Marks at al., I962), Oliver (1962) also found evidence of 
reduced gastric secretion in ischaemic heart disease. In his 
series, 44 per cent of patients and only 16 per cent of controls 
failed to secrete free acid in response to a small dose of 
histamine.
Since the addition of pancreatic extract to fat meals 
in these subjects was found to reduce postprandial lipaemia
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(Frazer, • 1943; Becker ^  , 1950), it was suggested that
the diminished gastric secretion indicated a reduced ability 
to digest fat, either in the stomach because of gastric lipase 
deficiency, or in the small intestine because of pancreatic 
lipase deficiency (Harder ^  âi*, 1952; Bronte-Stewart and 
Krut, 1962). This was thought to result in absorption of a 
greater part of the dietary fat in particulate form, thus causing 
exaggerated alimentary lipaemia.
RESULTS
Collections of fasting and basal gastric juice were 
carried out in controls, arterial disease patients, pernicious 
anaemia patients, and duodenal ulcer patients as described 
on page I60. The results for all subjects are shown in 
Tables XVI to XIX.
(a) Effect of Age on Fasting and Basal Gastric Secretion
Both fasting and basal gastric secretion showed a tendency 
to decrease with age. In the case of fasting, juice, male 
arterial disease patients showed a low-grade but significant 
negative correlation between age and the volume of fasting 
juice (r = -0.33, P< O.O5) while in male controls there was 
a similar, but statistically nonsignificant, trend (r = -0.18).
TABLE XVI. Fasting Gastric Secretion in Controls, and 
in Duodenal Ulcer and Pernicious Anaemia 
Patients (mean + S.D.)
Controls 
male 
.all ages
• Controls 
male 
40 and over
Arterial 
Disease 
with D.ÏÏ.
Pernicious
Anaemia
Volume
(ml.) +16,6
(n=25)
20.%
+17.7
In=17)
65.2
fn=5)
24.5
+22.7
Xn“4)
pH
(mean and 
range)
2.65
1. 28- 7.80
(n=22)
2.60
1.55-7.60
(n=15)
2.26
1.45-5.65
(n=5)
7.62
7.19-8.20
(n=4)
Acid
concentration
(meq./l.)
20.1
+18.6
(n=2l)
28.7
+15.1
tn=15)
‘ 22.4 
+20.7 
Xn=5)
0
(el=4)
Acid
output
(meq.)
1.27
+1.02
(n=21)
1.16
+0.92
tn=15)
1.92.
+2.96
Xn=5)
0
(a=4)
Chloride
concentration
(meq./l.)
107.6
+22.2
Xn=2l)
107.2
+27.9
Xn=15)
97,-0
+17.8
tn=5)
77.3
+15.5
Xn=4)
Chloride
output
(meq.)
2.85 
+1.86 
(n=21)
2.52
+1.90
(n=15)
6.78
+5.29
Xn=5)
1.51 
+1 • 45 
Xn=4)
n « no. of observations
TABLE XVII. Fasting Gastric Secretion in Arterial
Disease Patients (mean + S.D.)
Arterial
Disease
males
kiyo cardial 
Infarction
Angina
Pectoris
Peripheral
Arterial
Disease
Volume
(ml.)
' M î i
+22.4
Tn=43)
41.4
Tn=22)
26.0
+17.7
Xti=ii)
30.2
+16.0
Xn=10)
pH
(mean and 
range)
2.65
1. 22- 8.20
(n=27)
2.96
1.32-8.15
(n=18)
4 - 20 
1.40-8.20
(n=9)
4.30
1.40-7.60
(n=10)
Acid
concentration
(meq,./l.)
22.2
+25.4
Xa=26)
25.2
+22.5
In=17)
53.7
+30.2
tn=9)
26.2
+27.3
Xn=10)
Acid 
output 
(meq.)
1.12
+1.26
tn=26)
1.51
+1.59^
Xn=17)
0.68
+1.09
Xn=9)
0.85
+1.02
Xn=10)
Chloride
concentration
(meq./l.)
109.4
+24.6
Xn=22)
111.2
+28.9
Xn=17)
107.7
+27.7
X»-=7 )
107.1
+22.5 
, X“=8)
Chloride
output
(meq.)
2.78
±2.02
(n=22)
4.59
+3.35
Xn=17)
2.49
+2.57
Xa=7)
+2.34
Xn=8)
n « no. of observations
TABLE XVIII. Basal Gastric Secretion in Controls, and 
in Buodenatl Ulcer and Pernicious Anaemia 
Patients (mean + S.D.)
Controls 
male 
all ages
Controls 
male 
40 and over
Arterial 
Disease 
with D.ÏÏ.
Pernicious
Anaemia
Volume
(ml./50 mine.)
45.6 
+21.0  
■ tn=32)
45.7,
+23.5
Xn=23)
63.0
fn=5)
21.4
j:5.2
Xn=5)
pH,
(mean and 
range)
2.89
1.17-7.91
(n=32)
3.06
1.24-7.91
(n=23)
2.33.
1.24-4.83
(n=5)
7.84 
7.18-8.77
(n=5) ,
Acid
concentration
(meq./l.)
34.2
+24.9
T^=32)
31.3
+22.5
Xn=23)
34-0
+56.2
Xn=5)
0
(n=5)
Acid
output
(meq./30 mins.)
1.71 
+1 # 44 
In=32)
1.37
+1.32
(n=25)
2.37
+2.42
Xn=5)
0
(n=5)
Chloride 110.4 111.7 104.4 63.2
c oncentrat ion 
(meq./l.)
+23.5
Xn=3l)
+25.6
Xn=25)
+35.5
Xa=5) tn=5)
Chloride
output
(meq./30 mins.)
3.01
+2.12
Xn=30)
4.92
+2.19
Xn=23)
6.67 ■
+3.38
Xn=5)
1.42
■ +0.75
Xn=5)
n = no. of observations
TABLE XIX. Basal Gastric Secretion in Arterial Disease 
Patients (mean + S.D.)
Arterial
Disease
Myocardial
Infarction
Angina
Pectoris
Peripheral
Arterial
males Disease
Volume
(ml./jO mins)
40.4
tZsi)
44.0 
' +29.Ü 
Xn=23)
29.1
+20.6
Xn=14)
43.6
+28.1
Xn=14)
pH (mean 
and range)
2.-41
1.16-8.07
(n=51)
3.40
1.30-8.07
(n=23)
3.48 ,
1. 38- 7. 7 8 .
(11=14)
3-39
1.16-7.70
■ (n=14)
Acid
0 one entration# 
(meq./l.)
33.1
+26.3
jn=5l )
31.2
+25.4
Xn=23)
37.1 
+26.2 ' 
Xn=14)
32.2
Xn=i4)
Acid
output
(meq./3Û.mins)
1.46
+1.55
Xn=51)
1.63
+1.63
Xn=23)
1.20' 
+1 . 48 
Xn=14)
1.43
Xn=14)
Chloride 
concentration 
(meq./l.)
111.6
+28.4
Xn=49)
113.0
+26.7
Xn=23)
113.3
+31.1
Xn=13)
103.8
+29.6
Xn=13)
Chloride
output
(meq./30 mins)
4.33
+2.93^
Xn=49)
3.02
+3.19
Xn=23)
3.41
+2.49
Xn=13)
4-78 ■ 
+2.75 
Xn=13)
n « no. of observations
In the case of basal juice, in male controls over the age of 
40 years a significant negative correlation between age and 
volume was demonstrated (r = -0.42, P<0.05)j but in male 
patients the falling-off in basal secretion did not reach 
levels of statistical significance (r = -0.27). There was 
a fairly close relationship between the volumes of fasting juice 
and basal juice obtained in individuals, both controls 
(r =+0.55, P<'0.01) and arterial disease patients (r = +O.67, 
P<0.001).
(b) Comparisons of Gastric Secretion in Cigarette-Smokers and 
Non-Smokers
There were no significant differences in fasting or basal 
secretion between cigarette-smokers and non-smokers, although 
in the ischaemic heart disease group the smokers had a slightly 
greater volume of basal secretion (40.1 + 28.7 ml.) than the 
non-smokers (5O.5 ±  15*6 ml.). Amongst the controls the differences 
between the volume of basal secretion in smokers (44*6 +22.2 
ml.) and non-smokers (4O.8 + 14*8 ml.) were even smaller.
(c) Comparisons of Gastric Secretion in Controls and Arterial 
Disease Patients
The volume and composition of the fasting and basal 
gastric secretions in arterial disease patients were almost
«H-
identical with those obtained in controls in all the characteristics 
examined, namely:- pH, acid content, and chloride content 
(Tables XVI to XIX).
(d) Comparisons of Gastric Secretion in Three Clinical Types 
of Atherosclerotic Arterial Disease
No significant differences were found in myocardial 
infarction, angina pectoris, and peripheral arterial disease 
patients in the volume or composition of the fasting and basal 
gastric secretions (Tables XVII and XIX). There was no 
difference in gastric secretion in the myocardial infarction 
patients between those receiving long tern treatment xdLth 
phenindione and the rest of the group.
(e) Comparison with Gastric Secretion in Duodenal Ulcer and 
Pernicious Anaemia Patients
The five male patients with proven duodenal ulceration 
produced a greater volume of fasting juice (65.2 + 38.5 ml.) 
than the ten male controls (33.0 + 17.2 ml., P<Q.05), and 
the 27 arterial disease patients aged 4-0 to 54 years (41.0 +
24.8 ml., P < 0.10 >0.05). The duodenal ulcer patients also 
had fasting juice of lower pH, and higher fasting acid and 
chloride .outputs than the other subjects (Tables XVI and XVII),
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but these differences did not attain levels of statistical 
significance. The basal gastric secretion in the duodenal 
ulcer patients showed similar differences in composition from 
that of controls and arterial disease patients, but the 
differences were not statistically significant (Tables XVIII 
and XIX). .....
The volumes of fasting and basal juice produced by the 
five pernicious anaemia patients was less than that produced 
by controls and arterial disease patients of 5O years and 
over, but not significantly so. The pH of the gastric secretion 
was, of course, alkaline, and the acid content zero. The 
pernicious anaemia patients had a lower chloride concentration 
in fasting juice, and in the basal juice there was a highly 
significant difference in chloride concentration between the 
pernicious anaemia patients (63.2 + 24-5 meq.per 1.) and the 
twelve controls of similar age (114.3 ± 20,3 meq. per 1., P< 0.001)
Discussion
The present study of basal gastric secretion showed 
no evidence of reduced secretion in atherosclerotic arterial 
disease such as was reported by Marks e t al. (1962) and 
Oliver (I962), Basal gastric secretion has been found to
show rather marked fluctuations from day to day (Levin et al. , 
1950)* It is likely, however, that if significant differences 
in gastric secretory capacity between arterial disease patients 
and controls had existed, they would, have been detected by 
this technique since the e^tpected gastric hypersecretion was 
found in the small.group of arterial disease patients with 
duodenal ulceration, and gastric hyposecretion in the pernicious 
anaemia patients (Tables XVI and XVIII). The present study did 
not show an inverse correlation between basal acid secretion 
and postprandial lipaemia as reported by Plarks ^  §1, (I962).
It tended, in fact, to show the reverse effect. The younger 
arterial disease patients, in whom postprandial lipaemia. was 
abnormally high, had a higher basal acid output than the older 
patients in whom alimentary lipaemia was less marked. In 
addition, there was no demonstrable difference in gastric 
secretion between young arterial disease patients and controls 
of similar age, although significant differences ,between these 
two groups in fat tolerance had been found. There is no 
obvious explanation for the difference between the results 
of this study and those of Marks e t al. (1962) in patients with 
ischaemic heart disease. The peripheral arterial disease 
patients in the present series did not differ from the 
ischaemic heart disease patients with respect to gastric
-t-l {
secretion (Table XIX) or alimentary lipaemia (Table XI).
The majority of patients in Marks’ series were receiving long­
term treatment with phenindione, whereas only a minority 
of the subjects in this study were being treated with anti­
coagulants. However, Marks at (I962) measured gastric 
secretion before and after commencement of phenindione in 
three subjects and found it unchanged. Similarly, in the 
. patients in this series on long-term phenindione therapy 
no effect on gastric secretion could be demonstrated.
Both controls and patients in this series showed a 
decrease in basal acid secretion with age. A number of 
investigators (Levin et al., 1951? Vakil and Mulekar, I965) 
have found a similar falling-off of both basal and histamine- 
stimulated acid secretion in older healthy males and females.
Vakil and Mulekar (1965) showed that cigarette-smokers had 
a tendency to greater gastric secretion than non-smokers, although 
the differences were not statistically significant. A similar 
trend was seen in the present study (page 175j*
II. GASTRIC miPTYIHG
HISTORICAL REVIEW
The wellloaown observations by Beaumont (1655) on gastric 
function in Alexis St,-. ÎÆartin, a subject with a traumatic 
gastric fistula, include an account of intermittent contractions
fof the stomach. In 1686 Hofmeister and Schütz published their 
classic description of gastric peristalsis occurring in excised 
■ canine stomachs, and in I898 Cannon described the same, phenomenon 
in unanaesthetised cats. Following these observations many 
studies designed to elucidate the mechanisms controlling gastric 
emptying were carried out by physiologists both in experimental 
 ^animals and in man. Hirsch (1695) showed that the gastric 
emptying rate was more rapid in dogs v/ith h i ^  than with low 
duodenal fistulas. Similar experiments on gastric emptying 
in animals with duodenal fistulas were carried out by Cohnheim 
and Dreyfus (I9O8), f?ho found that re-injection of the chyme 
into the intestine in these animals slowed the rate of gastric 
emptying. Moritz (I9OI), who carried out many experiments on 
himself, noted that beer and thin soup left his stomach more 
rapidly than thick soup or solid foods. The information 
obtained from numerous subsequent experiments on the factors 
controlling gastric emptying will be summarised in a later 
section.(page 161).
METHODS OF MEASURING GASTRIC MFTYING
(a) Intubation Techniques
Gastric intubation for the assessment of gastric function 
was introduced by Leube (I885), and the earliest studies of
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gastric emptying in man were carried out by a single recovery 
technique - the withdrawal by gastric tube of residual gastric 
contents at a fixed interval of time after ingestion of the 
liquid test meal (Moritz, 190I). In a modification of this 
Method, some workers carried out repeated aspiration and 
measurement of■the gastric contents at intervals after the same
r
test meal, the whole recovery minus a small sample being 
returned to the stomach after each withdrawal (Folley and 
Abbott, 1942; Vendel, 194^). A further elaboration of this 
method ia the serial test meal technique, in which the gastric 
contents are withdrawn on different days at different times after 
taking standard meals containing a marker, and the various 
measurements are then synthesised against time. Several 
modifications of this method have been used. The most widely- 
used is that of Hunt (1954), in which a liquid test meal is used 
containing phenol red as a marker to determine the degree of 
dilution of the original test meal by gastric secretion.
(b) Radiological Techniques
Cannon (lü98, I9O4) used the then newly-developed X-ray 
technique to study gastric emptying of bismuth meals in animals. 
Radiological methods have also been used to determine gastric 
emptying rates in humans, the size of the shadow projected on 
thèhX-ray plate by radio-opaque material in the stomach being
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taken as an index of thé volume of the gastric contents, 
(Hellehrandt and Tepper, 1954)- Serial radiological studies 
have proved to be one of the most popular methods of obtaining 
information on the rate and pattern of gastric emptying (Hawkins 
et al., 1955)"
The use of barium sulphate has been criticised on the 
grounds that it may separate from the rest of the food in the 
stomach (Griffith et , I966), and that it is a gastric 
irritant and promotes early emptying of the stomach (Horton 
et al., 1965)• The first criticism has been met by feeding 
an ordinary meal of Icnovm composition, using only a small 
quantity of barium emulsion to outline the stomach (Annegers 
and Ivy, 1947)- The use of enteric-coated granules of barium 
sulphate along with a standard meal, as described by Horton 
et al. (1965), avoids any possibility of irritation of the gastric 
mucosa, and also gives a compound similar in specific gravity 
to food. Another major drawback of these radiological methods 
is the fact that a two-dimensional image of the stomach on an 
X-ray plate cannot give an accurate measurement of the volume 
of gastric contents, and these methods can therefore be used 
only to determine accurately the time taken by the stomach to 
empty completely and not to give information about the pattern 
of gastric emptying. A radiological technique by which the
pattern of gastric emptying could be determined was described 
by Weir and Card (I965). introducing known volumes of a 
radio-opaque meal and measuring the resulting areas from a 
series of X-ray films, a calibration curve connecting volume 
and area could be constructed for a given subject. On another 
day, a radio-opaque meal was given and films were talc en at known 
time intervals thereafter* %y reference to the calibration 
curve, the volume of the meal remaining in the stomach at any 
given time could be determined.
(c) Radio-isotope Techniques
A more recently-developed method of assessing the rate 
of gastric emptying involves the use of radio-isotopes (Griffith 
et al.,1966). Chromium^^ is incorporated in a standard breakfast, 
and the stomach is scanned at half-hourly intervals until almost 
empty. The exponential pattern of gastric emptying shown by 
the methods described previously has been confirmed by this 
method.
PHYSIOLOGICAL MECHANISMS COHTRQLLING GASTRIC miPTYING
Gastric emptying occurs for the most part as the result 
of rhythmic peristaltic waves which force chyme into the 
duodenum, although occasional emptying of liquids without 
evident gastric peristalsis has been reported (Shay and
Gershon-Cohen, 1954)* The peristaltic waves, which at first 
are initiated about the incisura angularis and later at a higher 
level, involve in sequence the pyloric antrum, the pyloric 
sphincter, and the proximal duodenum.'- These structures, as the 
antral peristaltic wave approaches, are relaxed, open, and 
receptive (Quigley and Louckes, 1962). Peristalsis is initiated 
primarily by distension of the stomach by ingested food, and is 
influenced by vagal activity. Since the pattern of gastric 
peristalsis returns to normal soon after vagotomy, however, 
the intactness of the myenteric plexus is believed to be a 
more important factor.
The regulation of gastric emptying is thought to depend 
on varying degrees of inhibition of gastric motility. This 
inhibition is mediated by neural and hormonal mechanisms brought 
into action by cephalic pathways, or by stimulation of the 
precardial or postcardial receptors in the alimentary tract 
(Hunt, 1959)* The receptors which play the most important 
part in regulating gastric emptying are found in the duodenum, 
and have been shown to be sensitive to pH, osmotic pressure, 
chemical .changes, and volume changes (Hunt, 1959). The rate 
of gastric emptying is regulated by weakening the force of 
peristalsis or abolishing it altogether (by vagal reflexes or 
by hormonal action such as that of enterogastrone) rather than
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by altering the frequency of peristaltic waves (Jungmann 
and Venning, 1952),
Pattern of Gastric Emptying
In 1898 Marbaix observed that in the healthy stomach the 
rapidity of emptying was proportional to the degree of distension 
of the stomach. This observation has been confirmed on numerous 
occasions since then (Hawkins et al., 1953; Hunt and McDonald, 
1954)' By the serial test meal technique, it was shovai that 
the pattern of emptying of liquid test meals is exponential; 
that is, a constant fraction of test meal and secretions leaves 
the stomach every minute, so that a plot of the volume of meal 
remaining in the stomach against time on a linear scale gives 
a straight line. Because the emptying^of the meal is 
,exponential in form, the time required for the volume of the 
meal in the stomach to fall by half is a constant for any 
given stomach (Hunt, 1959)*
Emptying of Different Foods
It has been shown that test meals fed in a homogeneous 
form may dissociate within the stomach into different phases 
which leave the stomach at different rates. In order to 
demonstrate this phenomenon, Wiggins and Dawson ( I 9 6 I )  used 
finely emulsified test meals containing carbohydrate, fat,
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protein, and the water-soluble unabsorbable marker substances 
phenol red and polyethylene glycol. They found that this meal 
tended to separate into a solid phase rich in fat and poor 
in marker, and a liquid phase poor in fat and rich in marker. 
The liquid phase was preferentially emptied from the stomach, 
and was also more readily sampled by a small-bore gastric tube. 
The findings of Bergstrom et al. (1962) confirmed'these results. 
Harkins e t (I964) studied gastric emptying of mixed test- 
meals in rats and demonstrated that Carbohydrate emptied from 
the stomach more rapidly than fat or protein.
Factors affecting Rate of Gastric Emptying
This subject has been reviewed in detail by Thomas (1957)- 
Various properties of the gastric contents are known to affect 
the rate of gastric emptying: the physical state of the food 
(large food particles are retained for longer than small 
particles); the osmotic activity (isotonic solutions leave the 
stomach more rapidly than either hyper- or hypotonic solutions); 
the pH of the gastric contents (acid solutions delay gastric 
emptying, weak alkaline solutions accelerate, whereas strongly 
alkaline solutions delay gastric emptying); and the presence 
of fats' (numerous observers have found that fat coming into 
contact with the duodenal or upper intestinal mucosa inhibits 
gastric tone and motility). Other factors icnown to influence
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the rate of gastric emptying include exercise, emotional disturbances, 
changes in oxygen tension, environmental temperature, various 
pathological conditions (such as haemorrhage, certain vitamin 
deficiencies, gastritis and enteritis and visceral irritations), 
and certain drugs. Malhotra (196?) has recently produced evidence 
that admixture of. saliva with the test meal slows the rate of 
gastric emptying,
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GASTRIC ET/IFTYING IN RELATION TO ALimE?ARY LIPAEMIA ADD 
ATHEROSCLEROSIS
It has been suggested by a number of investigators that 
the degree and duration of alimentary lipaemia are influenced 
by the rate at which the stomach makes the fat meal available 
to the intestine for digestion and absorption. Frazer and 
Stewart (1939) observed a shift of the peak of chylomicron 
curves to the right in some subjects, and attributed it to 
delayed emptying of the stomach. Annegers and. Ivy (1947) 
carried out serial radiographs following a radio-opaque fatty 
meal, and found variations in different persons in the rates 
of gastric emptying of the meal. These differences were 
reproduced on repeated examinations. They concluded that 
such differences could be a factor in determining the time of 
maximal chylomicronaemia, but that they did not explain why
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some persons regularly exhibited chylomicron curves of twice 
the height and of considerably longer duration than others* 
Becker at al. (^ 1950) also noted a shift to the right in chylo­
micron curves in several young persons who had been very 
apprehensive during the test, and suggested that in these 
subjects emotional stimuli had caused an inhibition of gastric 
motility* Marder et (1952) found that fat tolerance tests, 
measured by chylomicron counts and nephelometry, showed a 
higher curve and a later peak in elderly as compared with young 
subjects* They demonstrated a delay in gastric emptying of a 
barium meal in i their elderly as compared with their young 
subjects, and felt that this accounted for the delayed peak 
in their fat tolerance tests. Basset and Kuo (1965) studied 
duodenal motility after intraduodenal infusions of fat^mixed 
with.barium. They found that, as compared with normal persons, 
four subjects with hypertriglyceridaemia shovæd evidence of 
duodenal stasis and a prolongation of emptying time of the 
second part of the duodenum.
KESULTS
(1) IKPEBMMATIOIT OP GASTRIC HÎFPYItrG BY THE EOM? TECHMIQ.DE
Comparisons of gastric emptying rates were made in controls 
and arterial disease patients, as well as in small groups of
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patients with duodenal ulcer and pernicious anaemia. The 
degree of gastric emptying in one hour of a 750 ml. semi-liquid 
test meal was measured by the intubation technique described 
on page 162. The results for all subjects are shown in 
Table XX.
Effect of Age and Sex on Subjects
There was some evidence that the rate of gastric emptying 
was affected by age. Male arterial disease patients showed a 
lowgrade but statistically significant negative correlation 
of age with the percentage (by volume) of the meal recovered 
at 60 minutes (r = -0.2g, P<0.05)* This was due mainly to 
the h i ^  recovery rates in the younger of the twelve peripheral 
arterial disease patients (r « -O.67, P<0.05)* In both meal 
and female controls there was a tendency for gastric emptying 
to be delayed in older subjects, but the correlation between 
age and the percentage of test meal recovered was not statistically 
significant (r = +0.2$). No differences were observed in 
gastric emptying rates between males and females in either 
controls or patients.
Effect of Habitual Cigarette-Smoking
In the arterial disease group, habitual cigarette-smokers 
appeared to have slower rates of gastric emptying than nonsmokers, 
but no such effect was demonstrated in the controls.
TABLE XX. Results in All Subjects of Determination of Gastric 
Emptying at One Hour by-Hunt Technique (mean + S.D.)
Subjects
Volume
recovered
ml.
Volume 
passing pylorus 
ml.
Volume
recovered
Controls - male- 
all ages 
(n = 31)
625 + 112 278 + 171 70.4 + 15.1
Controls - male 
aged 40 and over 
= 22)
657 + 114 273 + 187 71.4 + 16.4
Arterial Disease
male
(n = 47)
652.+ 130 272 + 165 70.7 + 15.4
Myocardial Infarct ■
male
(n = 23)
663 + 114 248 + 133 73.4 ± 13.1
Angina Pectoris
male
(n = 12)
559 + 151 519 + 167 64.3 ± 16.3
Peripheral Arterial 
Disease - mâle 
(n « 12)
,645 + 142 271 + 210 71.8 + 18.1
Arterial Disease 
+ Duodenal Ulcer 
(n = 5)
634 + 129 265 + 106 70.4 + 12.0
Pernicious Anaemia 
(,n = 5)
712 + 60 140 + 107 84.2 + 11.7
n = no. of observations
1 8 8
In the control group the percentage of test meal recovered 
at one hour was 66.9 ± 12.1 per cent in the 17 cigarette- 
smokers and 72.6 + 19.6 per cent in the 14 non-smokers 
(t = l.OO). In the ischaemic heart disease group, however, 
comparison of the percentage of the test meal recovered in 
the 27 cigarette-smokers (73.1 + I4.2 per cent) with that 
of the 6 non-smokers (60.3 ±  14-2 per cent) revealed 
significantly higher values in the cigarette-smokers,
(P<0.Q5). This difference was slightly accentuated when 
the recovery in the I6 smokers of 20 or more cigarettes daily 
(75*8 jr 9*3 per cent) was compared with that in the non-smokers 
(P<0.01). In the entire group of arterial disease patients 
whose cigarette-smoking history was recorded, a gradient in 
gastric emptying rate was observed accorded to the daily 
cigarette consumption. In the 23 subjects with a cigarette 
consumption of 20 or more daily the mean volume of test meal 
recovered at 60 minutes was 75*9 ± 12.8 per cent; in the 15 
cigarette-smokers whose consumption was less than 20 daily it 
was 67.9 + 18.3 per cent; and in the nonsmokers 60.5 +14.2 per 
cent. The difference was statistically significant between the 
first and last groups (P\(O.Ol). In no case were these differences 
in gastric emptying rates, which were apparently related to 
differences in habitual cigarette-consumption, due to differing 
age structures of the groups. Nor were the age effects on
gastric emptying described in the previous section due in 
fact to differences in cigarette consumption since older 
arterial disease patients appeared to smoke as heavily as the 
younger patients.
Effect of Atherosclerotic Arterial Disease
The rates of gastric emptying were found to be very 
similar in controls and arterial disease patients, and in the 
myocardial infarction, angina pectoris, and peripheral arterial 
disease patients (Table XX). On subdivision into different 
age groups no significant differences were observed, although 
gastric emptying was rather slower in the 21 male arterial 
disease patients aged 40 to 49 years than in the 10 controls 
of the same age (volume recovered 75*5 + 15*0 per cent as 
compared with 66.9 + 16.1 per cent).
Comparison with Duodenal Ulcer and Pernicious Anaemia Patients
Gastric emptying in the 5 patients with duodenal ulceration 
was similar to that in controls'and other patients of the same 
age. Although in the 5 pernicious anaemia patients gastric 
emptying v/as slower than in the other groups, the volume 
recovered at 1 hour (84.2 + 11*7 per cent) was not significantly 
greater than that in male controls of 50 years and over (75.2 + 
16.2 per cent).
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Acid and Chloride Secretion during Test Meal
The pH, acid concentration, and chloride concentration 
of the recovered gastric contents are shown in Table XXI.
No significant differences were found between the controls 
and the arterial disease patients, nor in patients belonging 
to the myocardial 'infarction, angina pectoris, and peripheral 
arterial., disease groups. As anticipated, the pH was significantly 
higher and the acid and chloride concentrations lower, but not 
significantly so, in the pernicious anaemia subjects. The 
reverse was the case in the duodenal ulcer patients, but the 
differences were not statistically significant.
Gomoarison of Watery Phase with Rest of Recovered Test Meal
During recovery of the test meal it became evident that 
the test meal did not remain homogeneous in the stomach. In 
a number of subjects, if gentle suction was applied at the 
commencement _ of aspiration, it was possible to obtain approxi­
mately 10 to 30 ml. of non-turbid or only slightly turbid 
yellowish fluid before the rest of the semiliquid test meal 
appeared* The composition of this watery phase was analysed 
in 18 instances and is shown in Table XXII. On comparison 
with the rest of the recovered gastric contents it was found 
to have a markedly lower glyceride and NEFA content, an
TABLE XXI. Composition of Original Test Heal and of Gastric 
Contents recovered at One Hour (mean + S.D.)
Subjects. pH
Acid 
Concen­
tration 
meq./I.
Chloride
Concen­
tration
meq./l.
Original test meal •
All Subjects 6.45 ± 0.13 4-5 ± 1.7 11.7 ± 1.9
Recovered gastric contents
Controls - male 
all ages
4.70 + 0.48
(n =“31)
33.2 + 13.5
(n = 31)
32.8 + 11.6 
(n = 29)
Controls - male 
aged 40+
4.72 + 0.49
(n = 22)
32.5 + 15.4
(n = 22)
33.2 + 13.0
(n = 22)
Arterial Disease 
male
4.93 ± 0.65
(n = 48)
31.1 + 12.5
(n = 46)
32.8 + 11.1
(n = 46)
Myocardial Infarct 
male
4.91 + 0.78  
(n =“23)
30.7 ± 13.8
(n = 22)
31.7 + 12.3
(n = 23)
Angina Pectoris 
male
5.16 + 0.28 
(n = 13)
29.8 + 11.8
(n ="12)
32.8 + 8.3 
(n = 12)
Peripheral Arterial 
Disease - male
4.70 + 0.61
(n = 12)
33.3 ± 11.5
(n = 12)
34.9 + 11.6
in = 11)
Arterial Disease 
+ Duodenal Dicer
4.70 + 0.53
(n = 5)
34.8 + 16.7
(n = 5)
28.2 + 6.8  
(n ■= 5)
Pernicious Anaemia 5.46 + 0.18
(n = 5)
20.8 + 5.6 
(n = 5)
25.3 ± 7 .6  
(n = 4)
n = no. of observations
TABLE XXII. Composition of Watery Phase in 18 Subjects 
■compared with Rest of Recovered Test Meal 
(mean + S.D.)
Estimation Watery Phase Recovered Test Meal
pH 4* 68 + 0.96 4.91 ± 0.41
Acid
meq./l. 20.9 i 11.0 28.3 ± 12.3
Chloride 
meq. /l. 37.8 + 14.9 35.1 ± 12.5
Phenol red 
ug/ml.
#-x-%
1,38 + 0.29 1.83 ± 0.32
Glycerides 
g./lOO ml.
■K'-X-*
2.30 + 1.95 6.04 + 1.73
HEPA
meq./l. 5.81 + 3.20 19.62 + 9.13
Significantly lower than corresponding 
value for recovered test meal P<^0.001.
j-7 -1 -
appreciably lower phenol red concentration, and to be only 
slightly lower in pH and higher in chloride content.
Gastric Emptying of Fat
Because of this evidence that the test meal might 
separate into phases of different composition, and that the 
different components of the meal might therefore leave the 
stomach at different rates, estimation of the gastric emptying 
of fat was carried out in 16 subjects. The total fat concen­
trations of the original test meal and the recovered gastric 
contents and washouts were measured, and the percentage of 
fat remaining in the stomach at one hour was calculated.
No significant difference was found between the percentage of 
fat recovered in 7 controls (76.7 + 9,2 per cent) and that 
in 9 arterial disease patients (71.9 i 10,2 per cent). The 
somewhat higher mean value seen in the controls in this small 
series might have been due to the fact that they were rather 
older (53.9 i 10.8 years) than the arterial disease patients 
(47.4- ± 6.6 years).
Relationship of Gastric Emptying to Peak of Fat Tolerance Test
Despite the fact that the gastric emptying rate was not 
measured on the.same day as the fat tolerance test, there was
some evidence of a relationship between rate of gastric emptying 
and the time of maximal lipaemia during the fat tolerance test. 
The mean volumes of test meal recovered at 60 minutes was 
calculated for all subjects whose fat tolerance peak occurred 
at two hours, four hours, six hours and eight hours respectively 
(Table ZXIII). This showed that gastric emptying tended to be 
most rapid in those \fith a 2-hour peak, intermediate in those 
with 4-hour and 6-hour pealcs, and slowest in those with an 
8-hour peak.
(2) RADIOLOGICAL DSTEMNATION OF GASTRIC EMPTYING TIME
An attempt was made to demonstrate the relationship between 
gastric emptying and the time of the fat tolerance peak by a 
more direct method than that described above. A 75 g. fat 
tolerance test was carried out simultaneously with determination 
of the gastric emptying time by the use of enteric-coated barium 
granules, as described on page 168,
RESULTS
The relationship of the gastric emptying time to the 
plasma fat tolerance curve in the ten subjects is shown in 
Fig. 35. In order to eliminate differences in the fasting 
triglyceride concentrations, the plasma fat tolerance, curves
TABLE XXIII. Relationship between Time of Fat Tolerance Peak 
and Rate of Gastric Emptying (mean + 8.D.)
Time of maximal lipaemia 
during fat tolerance tests
Volume of test meal 
recovered at 60 minutes 
fo
2 hours 65.7- + 23.2 
(xT= 5)
4 hours 71.9 + 14.0
(n = 47)
6 hours 73.9 + 14.0
(n = 22)
8 hours 80.5 + 13.7
A  = 5)
n = no. of observations
%Change from fasting trigfyceride level 
Gastric emptying time
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Fig# 35» Relation, of plasma triglyceride changes
during fat tolerande tests to time refiuired 
for completion of gastric emptying.
are presented as percentage changes from the fasting level.
The figure shows that the fat tolerance curves appeared to 
return to fasting levels more rapidly in the subjects whose 
stomachs emptied rapidly. During screening it was evident 
that in some subjects gastric emptying did not occur at a 
uniform rate. .The size of the gastric shadow might remain 
apparently unchanged for several hoursand then rapid emptying 
might occur. The hourly plasma triglyceride determination 
showed that in a number of subjects the rise and fall in 
lipaemia were not' smooth, but showed more than one pealc, 
probably due to erratic gastric emptying. This phenomenon 
was most marked in the subject with the slowest gastric emptying 
time of 9g hours, when the 8-hour sample showed a considerable 
rise in triglyceride for the third time.
GASTRIC EMPTYING - SimARY OF RESULTS
(l) Hunt Test Meal (a) Volume -
Gastric emptying rates were similar in controls and arterial 
disease patients, in the groups of patients with myocardial 
infarction, angina pectoris, and peripheral arterial disease, 
and in those with duodenal ulceration. Gastric emptying was 
slower, but not significantly so, in the pernicious anaemia 
patients.
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The younger arterial disease patients had slower gastric 
emptying rates than the older patients, but the reverse ras 
the case in the controls. Habitual cigarette-smokers had 
slower gastric emptying rates than non-smokers.
(b) Gastric Secretion during Meal
No differences were found between controls and arterial 
disease patients in the pH and acid and chloride .content of the 
recovered test meal. In pernicious anaemia patients, the pH 
of the recovered test meal was significantly higher and the 
acid and chloride concentrations lower than in controls of 
corresponding age. The patients with duodenal ulceration 
showed evidence of greater gastric secretion during the 
time the meal was in the stomach, but the differences were 
not statistically significant.
(c) Gastric Emptying of Fat ' .
Evidence was found of separation of the test meal in 
the stomach into a low-fat watery phase and a high-fat phase.
No difference between controls and arterial disease patients 
in gastric emptying of fat were seen in a small series of 
subjects.
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(d) Relation of Gastric Emptying to Fat Tolerance Peak
Comparisons of rates of gastric emptying with the fat 
tolerance tests carried out in the same subjects on a different 
day indicated that the time of the fat tolerance peak was 
related to the rate of gastric emptying.
(2) Radiological Determination of Gastric Emptying Time
Simultaneous determinations were carried out of fat 
tolerance and of the time required for complete gastric emptying, 
using a 75 g. fat breakfast incorporating enteric-coated 
barium granules. In subjects ivith rapid gastric emptying the 
plasma triglyceride peak occurred earlier, and there was a 
more rapid return towards fasting triglyceride levels.
DISCUSSION
The studies of gastric emptying showed no evidence of a 
difference between controls and arterial disease patients in 
gastric motility, at least in the first hour after ingestion 
of the meal. This does not, of course, .completely rule out 
such a difference. Emotional stimuli are well-known to have 
a marked influence on gastric motility (Thomas, 1957), and 
a technique which involves the trauma of swallowing a gastric
tube.cannot be regarded as physiological. It is probable that 
in a number of subjects who showed little evidence of gastric 
emptying in the hour during which the test meal was in the 
stomach there was inhibition of gastric motility due to appre­
hension or nausea.
Previous- investigations have suggested a slower rate of 
gastric emptying in elderly than in young subjects (Harder 
et al.. 1952), and in the present study older male controls 
also showed a tendency to delay in gastric emptying. The 
reverse effect of age on.gastric emptying seen in the arterial 
disease patients in this series is difficult to explain. Because 
of the higher cigarette consumption in the patients, a comparison 
of gastric emptying in smokers and non-smokers was carried out 
to determine if this accounted for the differences between the 
two groups* Although cigarette-smokers were found to have a 
significantly slower rate of gastric emptying than non-smokers 
in the ischaemic heart disease group (page 187) there was 
little evidence of a reduction in cigarette-smoking with age 
to account for the increase in gastric motility with age in 
these patients. Nor is there an obvious explanation of why 
gastric emptying should be delayed in patients who were habitual 
cigarette-smokers. The effects of nicotine on the gastrointestinal 
tract are complex, being mediated by its action on the central
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nervous system, and by its stimulatory and inhibitory effects 
on autonomic ganglia. The effects of cigarette-smoking are 
even more complex, but Carlson (1916) and Schnedorf and Ivy 
(1939) found that a few puffs of cigarette-smoke inhibited 
gastric hunger contractions in man and dogs for up to an hour, 
although subcutaneous injection of nicotine (l mg.) had no 
effect. Subsequent experiments designed to demonstrate an 
acute effect of cigarette-smoking on gastric motility in humans 
yielded inconclusive results (U.S. Public Health Service, I964)* 
Inhalation of tobacco smoke in dogs with gastric and duodenal 
fistulae, however, resulted in a brief period of excitation 
followed by a long period of inhibition of gastric emptying 
(Chvoles and Skulov, 1936). The results in the present series 
suggest a reduction of gastric motility in habitual cigarette- 
smokers, even after overnight abstention from smoldLng. Smoking 
has long been believed to reduce hunger (Murray, 1793), and 
has been shown to interfere with weight gain (Brozek.and Keys, 
1957), and it may be that the mechanism of action is inhibition 
of the motility and hunger contractions of the stomach.
The dissociation of the homogeneous test meal into a 
fat-poor liquid phase and a more solid fat-rich phase, previously 
shown by Wiggins and Dawson (1961) and Borgstrom ^  ai. (1962) 
is also demonstrable in some subjects in this study. This
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suggested the importance of studying the rate of gastric emptying 
of fat as well as of the test meal as a whole, and in the small 
series available no significant differences between controls 
and arterial disease patients were demonstrated,
■ Although there is considerable variability in individual 
subjects, a relationship has been shoivn between the gastric 
emptying rate and the time of maximum postprandial lipaemia 
(Table XXIII, Fig. 35)* Such a relationship was suggested 
previously by Annegers and Ivy (1947). There is no evidence 
that the intensity of alimentary lipaemia is significantly 
influenced by the rate of gastric emptying, and the study 
reported earlier (Table XII) has shown that it is a function 
of the fasting triglyceride concentration.
III. GASTRIC LIPOLYSIS 
HISTORICAL REVIEW
Shortly after Claud Bernard's well known observations 
in 1850 on the emulsifying and digestive action of pancreatic 
juice on neutral fat in the small intestine, Marcet (1858) 
reported that digestion of neutral fat occurred in the stomach 
also. This finding was confirmed by Cash (1880), who demonstrated 
in addition that extracts of the gastric mucosa could bring
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about fat digestion in the test tube-. Volhard (19OO) also 
observed the in vitro lipolytic activity of gastric juice 
and extracts of gastric mucous membrane, and proposed that a 
specific gastric lipase was present. The properties and 
kinetics of the lipase in gastric juice were the subject 
of a series of .experiments by Stade (19O3 ). Several of these 
workers had suggested that a specific gastric lipase was present, 
but experiments jn. vivo to confirm this hypothesis yielded 
inconclusive results, owing to the difficulty of excluding 
the possibility of reflux of duodenal juice (Oppenheimer, 19365 
Borgstrom £t al., 1957) and the existence of a true gastric 
lipase has often been disputed. Studies on gastric juice 
obtained from Pavlov pouches in dogs (Hull and Keeton, 1917; 
Takata, 1921) showed the existence of a heat-labile, lipolytic 
factor, the activity of which was greatest in gastric juice 
of low acidity or where the acid was rapidly neutralised. 
Sch/nheyder and Volqvartz (1946) investigated gastric lipase 
obtained either from glycerol extracts of dried mucosa or 
from gastric juice, and found that under the conditions of their 
experiments it was active mainly against short-chain triglycerides, 
Siurala (1956), using the histochemical technique described 
by Gomori (I946), demonstrated distinct lipase activity in 
the zymogenic and mucous neck cells in the body of the human
stomach, as well as in the gastric mucosa in several other 
species. Bank et oX* (I964) investigated the lipolytic activity 
of gastric juice on a triglyceride emulsion, and reported that, 
though some of the lipolysis was caused by gastric hydrochloric 
acid, about 60^ of the activity was due to a heat-labile factor.
It appears therefore to be established that an appreciable 
degree of lipolysis occurs in the stomach, and that the greater 
part of this lipolysis is brought about by an enzyme rather 
that by gastric acid. It has not yet been established whether 
the enzymatic acitivy is due to a lipase originating in the 
stomach, or is due to regurgitation into the stomach of duodenal 
contents containing pancreatic lipase. There would appear, 
however, to be a considerable amount of evidence of the existence 
of a true gastric lipase, .since, as already mentioned, lipolytic 
activity in the mucosa as opposed to on the surface has been 
demonstrated in extracts of washed gastric mucosa, and by histo- 
cheraical techniques.
PROPERTIES OF GASTRIC LIPASE
The lipase obtained from human gastric mucosa has been 
stated to be remarkably stable (Gyotoloi, 1928). Sch/nheyder 
and Volqvartz (1946) reported that in a pH range of 3 to 7 
the half-time decomposition rate of the lipase from human gastric
juice was more than seven hours. Early investigations suggested 
that its optimum pH v/as in the region of pH5 (Davidsohn, 1912; 
Lichtenberg, 1952), but later work showed that it may vary, 
depending on the substrate and on the species investigated.
The optimum pH for hydrolysis of tripropionin or tributyrin 
by gastric lipase.was found to be 5*5 to whereas the
optimum for trilaurin or tristearin \ms 7.2 to 7*9 (Schpnheyder 
and Volqvartz, 1946). Popiela et al. (I965) demonstrated 
that 78 per cent inhibition of gastric lipase was produced 
by p-chloromercuribenzoic acid, but that, like pancreatic 
lipase, it was unaffected by di-isopropyl-fluorophosphate.
FACTORS AFPECTIKG GASTRIC LIPOLYTIC ACTIVITY
Gastric Acid Secretion
Hull and Keeton (1917) and Takata (I92I), in their 
investigations of gastric juice obtained from Pavlov pouches 
in dogs, found that lipolytic activity was greater in specimens 
which were of low acidity, or which were neutralised rapidly 
after collection. Panic ^  al. (1964), although they showed 
no direct correlation between the degree of acidity of human 
gastric juice and its lipolytic activity, reported that when 
acidity was low lipolytic activity tended to be high, and
vice versa. In contrast to this, Popiela et al. (1965) found 
a positive correlation between free acidity and the lipolytic 
activity of human gastric juice, and concluded that the pro­
duction or secretion of the enzyme was in some way dependent 
on the secretion of hydrochloric acid.
Type of Pat
The extent of lipolysis in the stomach may be affected 
by the degree of émulsification of the fat (Volhard, I9OO), 
and by the fatty acid chain length, being greatest in the - 
case of short-chain fatty acids.(Sch/nheyder and Volqvartz, 
1946). It may also be affected by the degree of saturation 
of the fatty acids. Herting and Ames (1955) found in rats 
greater lipolysis of saturated than unsaturated fats, whereas 
Bank et (I964) showed that human gastric juice was more 
active against unsaturated fats.
Effect of Age
Soh/nheyder and Volqvartz (1946) found no significant 
differences in the hydrolysis of triglyceride by gastric juice 
in vivo between children and adults. •
^Uj5
GASTRIC LIPOLYSIS IN RELATION TO ALIMENTARY LIPAEMIA AND 
ATHEROSCLEROSIS
Erazer (1943) shoved that, following ingestion of a 
pancreatic lipase preparation along with a 30 g* fat meal, 
the chylomicron curve was lower than that obtained following 
the 30 g. fat meal alone. If the pancreatic extract was 
inactivated by heating before addition to the meal, it caused 
no such change in the lipaemic curve. Becker et al. (1950) also 
showed depression of chylomicron counts following pancreatic 
lipase administration in older subjects with high curves.
In young people with low curves, on the other hand, addition • 
of lipase resulted in a shift of the curve to the right, with 
a delayed return of chylomicron counts to the basal level.
Tietz et ai. (i960) found a definite improvement in fat tolerance 
in 4 D'Ut of 14 individuals when pancreatic extract was fed 
along with a fat meal. Reports have appeared also of improvement 
in fat tolerance of patients with atherosclerosis after feeding 
of an aminopolysaccharide extracted from hog gastric mucosa 
(Rossi and Rulli, 1958; Gantone ^  oX», 1959). It has been 
suggested (Marks et al., 1962) that the greater alimentary 
lipaemia seen in patients with ischaemic heart disease may 
result from deficient lipolysis in the gastrointestinal tract, 
and that lipolysis of fat in the stomach may be an important
step in the preparation of fat for complete digestion by 
the more powerful pancreatic lipase.
RESULTS .
The gastric lipolytic activity was compared in controls. 
and arterial disease patients, as well as in small groups of 
patients ivith duodenal ulcer and pernicious anaemia. The degree 
of gastric lipolysis was determined by measurement of the NEFA 
concentration of the gastric contents recovered at one hour, 
as described on page I67. The results for all subjects are 
shown in Table XXIV,
All subjects showed evidence of lipolysis of the tri­
glyceride in the test meal. The NEFA concentration of the 
recovered gastric contents showed a marked variation, the 
lowest recorded level being 1.83 meq. per 1, and the highest 
93.60 meq. per 1. (Fig, 36). The degree of gastric lipolysis 
was not affected by the age of the individuals. The mean NEFA 
concentration of the recovered gastric contents was similar 
in controls and arterial disease patients, and in the three 
clinical groups of arterial disease patients (Table XXIV).
There was no evidence of any relationship between the basal 
gastric secretory capacity and the amount of fat-splitting 
of the test-meal, nor could any characteristic be discerned
TABLE XXIV. NEFA Concentration of Recovered Test Meal in 
All Subjects (mean ± S.D,)
Subjects
EEFA Concentration 
meq, per 1.
Original test meal
All Subjects 0.4s + 0.20
Recovered gastric contents
Controls - male 18.23 ± 16.12
all ages (n = 32)
Controls - male 19.07 1 18.44
aged 40+ (n = 23)
Arterial Disease 17.15 1 10.18
male (n = 48)
Myocardial Infarct 17.35 ± 7.70
male (n = 23)
Angina Pectoris 19.18 i 15.40
male (n = 13)
Peripheral Arterial 15.21 1 7.44
Disease - male (n = 12)
Arterial Disease 26.24 1 10.69
+ Duodenal Ulcer (n = 4)
Pernicious Anaemia 28.13 + 23.14 
(n = 5)
n = no. of observations
NEFA Concentration 
of Recovered M eal 
l e q / l
100 - I
mi
60-
40 - 
20 -
# # # #
C ontrols
A
A rteria l A rt. Disease Pernicious 
D isease +Duodenal Ulcer Anaemia
HEFA ooncGntx*ation of recovered test 
meal in all subjects.
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which distinguished subjects with marked degrees of lipolysis 
from others in the same group. The subjects with the highest 
NEFA concentrations in the control and arterial disease groups 
(Fig. 36) had basal acid outputs in thirty minutes of 2.70 
meq. and 0 meq, respectively. The mean NEFA level was higher 
in patients with duodenal ulcer than in controls, and an even 
higher level was seen in the pernicious anaemia patients. Owing 
to the marked variability in all groups, however, the differences 
were not statistically significant,
DISCUSSION
Our studies of NEFA release showed that gastric lipolysis 
took place in all subjects. The degree of lipolysis varied 
very markedly from subject to subject, 'and appeared to be 
entirely haphazard. No relationship could be demonstrated 
between gastric secretory capacity and lipolytic ability.
Gastric lipolysis took place to a similar extent in healthy 
controls and in patients with arterial disease.
Fat-splitting by gastric juice has been shovai to represent 
the effects of hydrolysis both by acid and by a heat-labile 
factor, presumably a lipase (Bank et , 1964). This may 
explain some of the contradictory reports in the literature, 
some workers stating that lipolytic activity was greater when
gastric acidity was low (Hull and Keeton, 1917; Takata, 1921), 
while others found that gastric juice of high acid content had 
greater lipolytic activity (Popiela et , 19&3). The greater 
mean NEFA release in our duodenal ulcer patients than in our 
controls is probably the result of greater acid hydrolysis, 
while the high levels in the patients with pernicious anaemia 
must be presumed to be due to enzymatic hydrolysis.
That patients with achylia gastrica were capable of 
gastric hydrolysis of fat was suggested many years ago (Pesthy, 
1906), and has been confirmed in the present study. Adult 
patients with pernicious anaemia have been described as having 
total gastric secretory failure, since acid, pepsin, and 
intrinsic factor are absent from the gastric secretions, and, 
in addition, gastric atrophy is usually present in biopsy 
studies of the gastric mucosa (Wenger et , 1967). It appears 
unlikely therefore that the gastric mucosa in these patients 
is capable of producing a lipase, and gastric lipolysis must 
be due to lipase regurgitated from the duodenum, or possibly 
to salivary lipase (Scheer, 1928). Despite the precautions 
taken in the present study (page 162), it is likely that some 
saliva was swallowed during the time the test meal was in the 
stomach. In the other subjects also, the marked variability 
in NEFA release, and its lack of correlation with gastric
isecretory capacity, suggest that a chance process such as 
regurgitation of the powerful pancreatic lipase, rather than 
gastric secretion of a fat-splitting enzyme, is responsible for 
most of the lipolysis which takes place in the stomach.
and conclusions
1. Basal gastric secretion was similar in volume and compo­
sition in healthy controls and arterial disease patients. 
Gastric secretion was greater in young than in older subjects, 
and slightly greater in cigarette-smokers than in non-smokers.
2o ■ The volume of test meal which left the stomach in 60 
minutes was similar in healthy controls and in arterial disease 
patients. Controls showed slowing of gastric emptying with 
age, whereas the reverse effect was seen in arterial disease 
patients. Gastric emptying was slower in habitual cigarette- 
smoke rs than in non-smokers.
3. Gastric emptying of fat was similar in healthy controls
and in arterial disease patients.
4» The peak in postprandial lipaemia occurred earlier in
subjects with a rapid gastric emptying rate.
5. Gastric lipolysis occurred to a variable degree in all 
subjects, but did not differ in controls and arterial disease 
patients. The extent of gastric lipolysis showed no relation 
to the degree of postprandial iipaemia, and the evidence was 
against a significant role of gastric lipase in man.
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Chapter VI CIGARETTE-SMOKING
ASSOCIATION BETWEEN CIGARETTE-SMOKING AND ATHEROSCLEROSIS
Cigarette-smoking has long been suspected to have harmful 
effects. The first convincing reports of an association between 
cigarette-smoking “'and ischaemic heart disease, however, were 
incidental findings in studies designed primarily to investigate 
the relationship between cigarette-smoking and lung cancer.
Some years earlier Pearl (195©) had suggested that total 
mortality rates increased with increasing numbers of cigarettes 
Smoked, and English ob al. (1940) showed a positive association 
between cigarette-smoking and ischaemic heart disease. Doll 
and Hill (l954 &od 1956) in Great Britain, and Hammond and 
Horn (1954j 1958a and 1958b) in the U.S.A. carried out large- 
scale prospective investigations of mortality ratios in men 
in relation to their smoking habits. The findings of these 
two independent studies were remarkably similar. The mortality 
ratios were greater in cigarette-smokers than in non-smokers, 
and increased with increased cigarette consumption. This 
excess mortality was due only in part to an increase in bronchial 
carcinoma; the larger part of the excess death rate was accounted 
for by deaths due to coronary artery disease. Mortality ratios 
in cigar- and pipe-smokers were much less than in cigarette- 
amokers, but greater than in non-smokers. There was a reduction
<1XX
in mortality from coronaiy artery disease in those who gave 
up smoking. Other reports were published subsequently which 
tended to confirm these findings (Buechley et , 1958)*
All the currently available evidence on the association 
between cigarette-smoking and ischaemic heart disease obtained 
from these and other investigations was summarised and evaluated 
in the report of the Royal College of Physicians of London 
(1962) on "Smoking and Health", and somewhat later in the 
report by the U.S. Public Health Service (1964)* In these 
reports it was concluded that the evidence strongly suggested 
that heavy cigarette-smoking contributed to, or accelerated, 
the development of coronary heart disease or its complications, 
at least in men under 55 years.
A causal relationship of cigarette-smoking to athero­
sclerotic arterial disease has been suspected for many years, 
but has been little investigated. It appears, however, that 
the association of cigarette-smoking with peripheral arterial 
disease is even stronger than that shown with ischaemic heart 
disease. Weinroth and Herzstein (I946} found that male 
diabetics who smoked had a 50 per cent greater incidence of 
peripheral arterial disease than non-smokers. Eastcott (I962) 
reported that all but 2 of II4 new patients with obliterative 
arterial disease of the lower limbs were regular cigarette- 
smokers. In a study of 100 consecutive male and female patients
C.A.C.
Operated on for peripheral atherosclerotic occlusive disease, 
Lord (1965) found that 94 were heavy smokers, compared with 
54 of 100 consecutive men and I9 of 100 consecutive women in 
the same age group with non-arterial lesions who showed good 
pedal pulses.
' ASSOCIATION BETWEEN CIGARETTE-SMOKING AND PLASMA LIPIDS
The reason for the association between cigarette-smoking ' 
and atherosclerotic arterial disease is not known. In several 
studies j however, smokers have been shown to have increased 
plasma levels of cholesterol and other lipids, which might be 
associated with an increased liability to ischaemic heart 
disease. Gofman and his associates (1955) reported higher serum 
cholesterol and lipoprotein levels in cigarette-smokers than 
in non-smokers in men aged 20 to 29 years. High plasma 
cholesterol concentrations occurred more frequently in smokers 
than in non-smokers in a group of medical students (Thomas, 
1958)# In the Framingham study*, cholesterol levels were found 
to be higher in cigarette-smokers, and to remain higher in 
those who stopped smoking (Dawber et al., 1959)* Significantly 
higher cholesterol concentrations in smokers than in non-smokers 
were found in subjects in Finland, but not in the United States 
(Blackburn ^  , i960). Karvonen ^  al. (1959) also reported
higher cholesterol values in cigarette-smokers, especially
in heavy smokers. In:-South Africa, hi^er total cholesterol
and heta-lipoprotein cholesterol concentrations were found in
heavy cigarette-smokers of all ages and races (Bronte-Stewart,
1961).
A few studies have shown no long-term effect of cigarette- 
smoking on plasma lipids. Konttinen (I962) in young men, and 
Acheson and Jessop (I961) in elderly men found no differences 
in serum cholesterol between smokers and nonsmokers#
The acute effects of cigarette-smoking on plasma lipids 
have also been studied. The main effect described has been
a rapid and consistent rise in plasma NEFA concentration
/
(Kershbaum et al., 196I; Soloff and Schwartz, 1964? Mlton,
1966), This rise in NEFA level has been shown to be due to 
stimulation of the sympathetic nervous system and adrenal glands 
by nicotine (Kershbaum ^  , 1963) • The NEFA response to
cigarette-smoking has been reported to be exaggerated in patients 
with healed myocardial infarction, the rise being more than 
double that observed in non-coronary patients and normal 
subjects (Kershbaum et al., 1962). There has been general 
agreement that cigarette-smoking results in no acute change 
in cholesterol, phospholipid, or triglyceride concentrations 
(Page et , 1959» Kershbaum et , I96I).
ASSOCIATION B B T W M  CIGARETTE-SMOKING AND BLOOD PLOTTING 
MECHANISMS
The link between cigarette-smoking and atherosclerotic 
arterial disease mi^t be provided by altered blood clotting 
mechanisms. Reports of the effect of cigarette-smoking on 
blood coagulation- are conflicting. It was found by Blackburn 
et al. (1959) to have no effect on plasma Stypven time, and 
by Mustard and Murphy (I963) to cause no change in various 
blood clotting mechanisms. On the other hand Ambrus and Mink 
(1964) reported hypercoagulability, using various clotting 
tests, and Engelberg (1965) found an increased thrombotic 
tendency ^  vitro following cigarette smoking. Platelet studies 
were reported to show decreased platelet survival times in 
smokers as compared with nonsmokers (Mustard and Murphy,
1965), and acute increases in platelet adhesiveness following 
cigarette smoking (Ambrus and Mink, I964? Ashby et , I965).
PURPOSE OF PRESENT INVESTIGATION
The factors responsible for platelet adhesiveness have 
not been completely established, but some which have been 
suggested are the blood glucose (Bridges ct , 1965)» and 
various plasma lipid components including triglyceride (philp 
and Payling Wright, I965) and fatty acids (Thompson, I966).
Since these are factors affected by cigarette-smoking, the
^15
present investigation was carried out in order to determine
the short term effect of cigarette-smoking on all these factors,
and the relationship between them.
This work has "been the subject of a 
previous publication (Murchison and Fyfe,
m m  1966).
(a) Patients
Twelve patients (8 males and 4 females) from a general 
medical ward who habitually smoked ten or more cigarettes 
daily were investigated. They were aged from 57 to 67 years 
with a meah age of 55 years. Their diagnoses were;
ischaemic heart disease (5), peripheral arterial disease (5),
\
hypertension, idiopathic diarrhoea, simple goitre, rheumatic 
heart disease, epilepsy, and pneumonia.
(b) Procedure
The patients fasted overnight and remained at rest in 
bed throughout the experiment. Two basal venous blood samples 
were .taken 20 minutes apart. The patients were then instructed 
either to smoke two of their usual brand of cigarettes during 
a 15-minute period, or to sham-smoke by puffing the unlit 
cigarette for the same length of time. A third blood sample 
was taken at the end of the 15-minute period, and three further 
blood samples at 10-minute intervals. Within the next few ' 
days the experiment was repeated with sham-smoking substituted
for smoking and vice versa. Seven patients smoked in the 
first experiment, and five in the second experiment.
The serum cholesterol and triglyceride, and total and 
individual NEFA were determined as described in Chapter II.
The following estimations were also carried put;-
Blood sugar, by an autoanalyzer method (Technicon method N-9)> 
measuring total reducing substances.
Platelet adhesiveness, by a method based on that of Payling 
V/right (1941)' 2 ml. of citrated blood (1 part 5.8^ sodium
citrate to 9 parts blood) was rotated in a spherical flask 
at' 3^ r.p.m. for 20 minutes, commencing 5 minutes after vene­
puncture. Platelet counts were done by direct counting of whole 
blood using 1^ ammonium oxalate and phase-contrast microscopy 
(Brecher and Cronkite, 1950). The percentage of adhesive 
platelets was expressed as:
Initial count - final count
Initial count x luu
*
RESULTS
Total Plasma NEFA
The mean plasma NEFA levels during the smoking and sham- 
smoking tests are shown in Table XXV.
There was a significant rise in the mean plasma NEFA
TABLE XXV, Changes in Plasma îïEFA during Smoking and
Sham-Smoking Tests (mean + 8,D.)
TIME OF SAMPLE
P lA S m HBFJ 
SMOKING
microeq./l. 
SHAM-SMOKING
BASAL PERIOD 0 min.
20 min#
395 1 U 9  
393 1 149
3 6 9 + 7 6  
359 + 69
AFTER SMOKING
OR SHA^SMOKING 35 min,
45 min,
\
55 min. 
65 min.
»»«
453 + 168 
**
496 1 176 
442 + 98 
399 + 95
381 + 72 
403 + 82 
386 + 83 
369 1 89
Significant difference from mean basal level 
P<0*01, P<0.001
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level after smoking, reaching a maximum 10 minutes after the 
end of the smoking-period, and falling again to the basal 
level over the succeeding 20 minutes. While the plasma BEFA - 
level increased to a variable extent in every case after 
smoking, after sham-smoking the plasma UEFA level rose 
in 5 cases, was unchanged in and fell in 4* The small 
mean increase after sham-smoking was not statistically signifi­
cant.
Individual Serum KSFA
The changes in proportions of the individual serum NEPA 
after smoking are shown in Table XXVI, and after sham-smoking 
in Table XXVII.
Both smoking and sham-smoking were followed by a significant 
increase in the concentration of oleic acid in the BEFA fraction, 
and a significant fall in the concentration of palmitic acid.
This effect was more notable after sham-smoking than after 
smoking, but did not correlate well with the magnitude of the 
changes in total plasma ffiFA. The other fatty acids in the 
ffiFA fraction showed a similar tendency for an increase in 
unsaturated at the expense of saturated fatty acids, but the 
individual changes were not significant.
TABLE XXVI. Changes in Proportions of Individual Serum HEPA
during Smoking Test (percentage mean + S.B.)
BEPA
BASAL 
0 min.
PERIOD 
20 min. 35 rain.
AFTER SI 
45 rain.
KOKim 
55 min* 65 min.
Myristic
C14%0
2.6 
4^ 0* 5
2.4
+0.5
2.7
+0.6
2.7
+0.9
2.5
+0.5
2.4
±0*4
Palmitic 
C16:0 -
29.5
+2.0
29.8
+2.4
*
28.5 27.7*
±1-7
28.4
+3.5
'28.4
+3.0
palraitoleic
C16:1
6.5
+1.0
6.6
+0.9
6.8 
4^ 0.8
6.6
±0*7
6.4 
+0.8
6.5
±0*7
Stearic
016:0
12.5 
+2.0
12.5
+2.0
11.8
+2.0
11.8
+1.8
12.6
±2.4
12.9
+1.8
Oleic
018:1
59.9
±5.8
59.7
+3.6
40.8
+3.5
*
41.7
±5.0
40.2
±4.9
40.8
±4.8
Linoleic 
016:2
9.2 . 
+lv5
8.9
±1.7
9.4
±1.3
9*4
+1.6
9-9  
+2 « 6
9.1
+1.8
*
Significant difference from mean basal level P<,0.05
TABLE XXVII. Changes in Proportions of Individual Serum
BEPA during Sham-Smoking Test (percentage mean + S.D.)
BASAL PERIOD • AFTER SHAM-SMOKIBO
BEFA 0 min. 20 min. 35 miu. 45 min. 55 min. 65 min.
Myristic 2.9 2.5 2.6 2.2 2.4 2.6
014:0 +1.2 +0.6 +0.8 ±0*5 ±0.6 +0.8
* *
Palmitic 50.7 29.8 29.7 27.8 28.8 29.4
016:0 +3.5 +2.5 ±3*2 ±2.3 ±1.7 +2.2
Palmitoleic 6.5 6.4 6.1 6.4 6.5 6.3
016:1 +0.9 +0.6 ±0.9 ±0*7 ±1.1 ±0*7
Stearic 12.4 ■ 12.4 12*5 12.4 12.4 11.9
018:0 +2.1 +1.8 +2.2 +1.6 ±2.4 +2.7
* * *
Oleic 37.5 40.0 40.5 41.4 40.5 41.0
018:1 ±3*5 +4.6 +5*2 +4.8 ±4.7 ±5.7
Linoleio 9*9 8.9 8.6 10.2 9*3 8.7
018:2 +2.6 +1.2 ±1*4 ±2.9 ±2.1 +1.7
Significant difference from mean basal level
* **
P<0.05, P<0,01.
218
Serum Cholesterol
Serum cholesterol values during smoking and sham-smoking 
tests are shown in Table XXVIII* Bo significant changes in 
serum cholesterol concentration occurred in either group*
Serum Triglyceride
Serum triglyceride values during smoking and sham-smoking 
testa are shown in Table XXIX* Bo significant changes in 
serum triglyceride concentration occurred in either group*
Blood Glucose
The changes in mean blood glucose level following 
smoking and sham-smoking are shown in Table XXX.
During both smoking and sham-smoking tests there was 
a small but significant increase in blood glucose between the 
first and second basal levels* For this reason, the 20-minute 
level was taken as the baseline in assessing the effects 
of smoking and shannsmoking on blood glucose.
Smoking was followed by a small but significant increase 
in blood glucose. This happened in every case and showed no 
tendency to return to the fasting level. There was no change 
after sham-smoking.
TABLE XXVIII. Serum Cholesterol Concentrations during Smoking
and Sham-Smoking Tests (mean + S.D.)
TIME OF SAMPIiES
CHOLESTERO:
SMOKING
L mg./lOO ml. 
SHAM-SMOKING
BASAL PERIOD 0 min.
20 min.
265 ± 44
266 + 40
253 + 52
259 + 52
AFTER SMOKING 
OR SHAM-SMOKING 55 min.
45 min.
55 min.
65 min.
266 + 40 
272 + 47 
270 + 4$ 
270 + 47
260 + 51 
258 + 52 
256 ± 47 
265 + 55
TABLE XXIX. Serum Triglyceride Concentrations during Smoking
and Sham-Smoking Tests (mean + S.B.)
TIME OP SAMPLE
TRIGLYCERI]
SMOKING
)E mg./lOO ml. 
SHAM-SMOKING
BASAL PERIOD 0 min.
20 min.
97 + 29
98 + 29
101 + 26 
102 + 32
AFTER SMOKING 
OR SEAM-SMOKING 35 min.
45 min.
■ 55 min.
65 min.
99 ± 31 
96 + 30 
94 + 31 
96 + 32
98 + 28 
96 + 26 
96 + 27
98 + 33
TABLE XXX. Changes in Blood Glucose during Smoking and
Sham-Smoking Tests (mean + 8.B.)
. TIME OF SAMPLE
BLOOD GLÏÏCO! 
SMOKING
3E mg./lOO ml. 
SHAM-SMOKING
BASAL PERIOD 0 min.
20 min.
68.2 + 8.6 
72.6 + 9.2
68.6 + 8.4 
71.3 + 8.6
AFTER SMOKING 
OR SHAM-SMOKING 35 min.
45 min.
• 55 min.
, 65 min.
73.6 + 9.2 
76.7%  9.2 
76.7*+ 8.0 
76.9*+ 7.1
70.8 + 9.0
70.4 ± 8.4 
70.1 + 7.3,
71.4 + 7.4
*
Significant difference from 20-minute level P<0.05.
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Platelet Count
The platelet counts during smoking and 
sham-smoking tests are shown in Table XXXI*
After sham*-smoking no change occurred in the . 
platelet count* Following smoking^ however» 
the small increase in total platelet count 
over the basal figure vms significant at the 
Ifo levelÿ as determined by the 0tudent * t * 
test for paired values (Bradford Hill 1967).
Platelet Adhesiveness
The mean platelet adhesiveness values during smoking 
and sham-smoking tests are shown in Table XXXII*
There was a mean rise in platelet adhesiveness in both 
smoking and sham-smoking .groups* In the sham-smoking group,
9 of the 12 subjects showed an increase, and in this group 
the mean rise was statistically significant (P<0.05)« The 
change after.smoking was more variable, a rise in 7 cases 
and a fall in 5 cases, and the mean rise was not statistically 
significant*
Comparison of Arterial Disease Patients with Other Subjects
»
There was no significant difference between the 6 patients 
with arterial disease and the others in basal lipid levels, 
blood glucose, and platelet adhesiveness, or in the magnitude 
of the responses to smoking* The maximum BBPA increase after 
smoking was 127 + 66 microeq*/!* in the arterial disease 
patients and 165 + 46 microeq./l* in the non-arterial disease
TABLE XXXI. Changes in Platelet Count during Smoking and
Sham-Smoking Tests (mean + S.B.)
TIME OP SAMPLE
PLATELET C( 
SMOKING
lUNT/cu.mm.
SHAM-SMOKING
BASAL PEEIOB 0 min. 157,600 165,000
+52,600 +43.800
20 min. 155,500 153,000
+41,800 +38,400
AFTER SMOKING
OR SHAM-SMOKING 55 min. - —
45 min. 166,300 161,400
+35,000 +47,500
55 min. — -
65 min. 157,100 160,400
+34,700 +50,100
**
Significant difference from mean basal level, P<0*01
as determined by the Student *t* test for 
paired values.
TABLE XXXII. Changes in Platelet Adhesiveness during Smoking
and Sham-Smoking Tests (mean + S.B.)
PLATELET ADHESIVENESS #
TIME OP SAMPLE SMOKING SHAM-SMOKING
BASAL PERIOD 0 min. 55.5 ± 14.1 41.0 + 8.3
20 min. 36.9 ± 13.3 43.7 + 7.9
AFTER SMOKING
OR SEAM-SMOKING 55 min. — -
45 min. 39.6 + 12.2 48.3*+ 7.3
55 min. — -
65 min. 35.1 + 13.0 47.3 + 11.1
*
Significant difference from mean basal level P<0*05
as determined by the Student  ^t^  test for 
paired values.
subjects.
Relationships between Changes in NEFA, Glucose and Platelet 
Adhesiveness
There was no correlation between basal platelet adhesiveness 
and basal levels of either plasma NEPA or blood glucose.
In the sham-smoking group it was evident that there was 
a good correlation between the percentage rise in NEPA and the 
rise in platelet adhesiveness, as shown in Fig. 57*
n-/ _•_. 45-minute level - Mean basal level
, rise - ------ Mean' basal level ' ■------ ^
This correlation was significant at the 1^ level (r « +0.7l)< 
There was a similar, but less significant, correlation between 
percentage changes in BEFA and platelet adhesiveness after 
smoking (r » +0.58, P<0.05), as shown in Fig. 58. These 
correlations of platelet adhesiveness changes with changes in 
total BEFA were greater than the corresponding correlations 
with changes in the individual fatty acids. In the smoking 
group, however, there was a rise in glucose, and Fig. 59 
illustrates the negative correlation between changes in blood 
glucose and platelet adhesiveness (r « -0.70, P<0.02).
The relationship between the percentage change in platelet 
adhesiveness (Y) and the percentage changes in BEFA (X^) and 
blood glucose (X2) after smoking can be expressed as follows:
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Fig# 57* Correlation between percentage changes in plasma 
Î'ÎFFA and platelet adhesiveness after sham smoking 
(y = 0,51 X + 9.19, r » +0.71).
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Fig# )8# Correlation between percentage changes in plasma 
KRPA and platelet adhesiveness after smoking 
(y = 0.86 X -8*22, r « +0.58)#
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Fig, 39, Correlation between percentage changes ■ 
in blood glucose and platelet adhesiveness 
after smoking (y « 3.6 % -i- 46, r =-0,70).
2 2 1
Y = 0.43X^ - 5.0X2 + 30.5
Using this formula, the correlation between the actual 
and predicted values for platelet adhesiveness is significant 
at the Yfo level (r = +0,75).
DISCUSSION.
The significant plasma UEFA increase induced by cigarette- 
smoking confirmed the findings of previous workers (Xershbaum 
at , 1961 ; Soloff and Schwartz, I964). Although Kershbaum 
et al. (1962) reported that patients with healed myocardial 
infarction showed, a markedly exaggerated NKFA response to 
cigarette-smoking, neither in the present series (page 21l) 
nor in that of Soloff and üchwartz (1964) were there significant 
differences in this respect between arterial disease patients 
and controls. It was of interest that sham-smoking also was 
followed by a plasma NEPA increase in five of the twelve tests. 
The fact that the rise followed a steady basal period suggested .
I
that it was an effect of sham-smoking rather than of repeated 
venepuncture, and might possibly be due to the embarrassment 
of puffing an unlit cigarette, Irving and Yamamoto (1963), 
in their investigation of the . effects of cigarette-smoking 
on cardiac output, recognised that sham-smoking may produce 
physiological effects.,
The increase in plasma NBFA was found to be accompanied 
by an increase in unsaturated fatty acids at the expense of 
the saturated fatty acids, Rothlin at (1962) observed 
a similar change in NEPA pattern when an acute increase in 
plasma NEPA was induced by norepinephrine infusion. Conversely, 
a rise in saturated and fall in unsaturated fatty acids occurred 
on lowering of the plasma NEPA level either by inhibition of 
adipose tissue lipolysis (Nakamura et al#, 1967), or by 
increased NEPA utilisation during muscular exercise (Wood 
et al., 1969). Increased adipose tissue lipolysis appears, 
therefore, to be associated with an increased proportion of 
unsaturated fatty acids in the EEPA fraction, while the reverse 
change in NEPA pattern is found during inhibition of lipolysis. 
These changes in EEPA pattern are presumably a consequence of 
the greater unsaturated to saturated fatty acid ratio found 
in depot fat than in the plasma KEPA fraction (insull and 
Bartsch, I967). It was somewhat surprising that the change 
in NEPA pattern after sham-smoking was more striking than 
that following smoking, and that the changes in individual 
NEPA did not correlate well with the change in total plasma 
NEPA level.
The lack of effect of short-term cigarette-smoking on 
fasting serum cholesterol and triglyceride levels confirmed 
the findings of earlier workers (Page et al., 1999; Kershbaum
et al., 1961). Because of this lack of effect it was suggested 
by Mustard and Murphy (1963) that the higher serum cholesterol 
levels in habitual cigarette-smokers than in nonsmokers might 
be due to dietary differences in the two groups, or that 
hyperoholesterolaemia and cigarette-smoking might be independent 
consequences of some common cause. It is possible, however, 
that habitual cigarette-smoking may itself be the cause of 
elevation of the plasma cholesterol concentration. Shafrir 
et al. (1959) showed that sustained or repeated elevation 
of plasma NEPA levels in dogs by subcutaneous injection of 
epinephrine in oil was followed after several days by a sub­
stantial rise in plasma cholesterol. Kaplan et al. (195?) 
and Bury (1957) also found an elevation in serum lipids in 
dogs and rabbits after administration of epinephrine in oil.
It has been postulated that the increased circulating NEPA 
stimulate the production of cholesterol and other lipoprotein 
lipids by the liver (Shafrir et al., 1959; Shafrir and Steinberg, 
i960). This suggests a mechanism by which NEPA elevation 
by repeated cigarette-smoking, as well as by psychic stress, 
might result in elevated blood cholesterol levels.
Some earlier workers reported that cigarette-smoking 
caused increased blood glucose levels (Lundberg and Thyselius- 
Lundberg, 1951), but Rehder and Roth (1959) suggested that the
rise shown was due to stress rather than an effect of smoking. 
Since in our subjects blood glucose concentrations increased 
following smoking but not sham-smoking, the increase can be 
attributed to smoking per se.
The increased platelet count following cigarette-smoking 
is presumably due to nicotine-induced catecholamine release, 
since Beckman jet ' (1925) have shown that injections of 
catecholamines are followed by significant increase in 
circulating platelets.
Platelet adhesiveness has been reported to be increased 
in patients with ischaemic heart disease (McDonald and Edgill, 
1957), and. also in disseminated sclerosis (Caspaiy et al., 
1965; Payling Wright et al., I965). Since fatty-acid 
abnormalities have been described in both these conditions 
(Colehour and Leonard, 1964; Thompson, I966), a relationship 
between platelet-adhesiveness and serum fatty acids has been 
suggested. The proposal was supported by the ju vitro studies 
of Kerr ^  (1965), who showed that saturated fatty acids
induced greater platelet aggregation than unsaturated fatty 
acids, some of which seemed to have an inhibitory effect.
The results of the present study showed that when the blood 
glucose remained constant there was a good correlation between 
the changes in platelet adhesiveness and the changes in NEFA 
(Fig. 57)« When the blood glucose also altered (in the
smoking test) the relationship between the changes in platelet 
adhesiveness and NEPA was less close (Pig. 38). In this 
situation, the rise in blood glucose seemed to have a 
suppressive effect on platelet adhesiveness, since there 
was a negative correlation between the changes in blood 
glucose and platelet adhesiveness (Pig. 39)*
Bridges _et al. (I965) showed that platelet adhesiveness 
increased after an oral glucose load, but he was unable to 
show a correlation between the rise in blood glucose and the 
rise in platelet adhesiveness. This situation, however, was 
quite different.to the present one in which endogenous glucose 
was being mobilised. Bridges £t al. (I965) also showed that 
the addition of glucose m  vitro resulted in an increase 
in platelet adhesiveness, but this was contrary to the work 
of Hellem (1960) who was unable to demonstrate any effect 
within the physiological ??ange for glucose.
A significant increase in platelet adhesiveness following 
cigarette-smoking in the non-fasting state has been reported 
by Ashby et al. (1965). Although in the present series the 
platelet adhesiveness showed a considerable increase after 
smoking in seven subjects, it decreased in the five other 
subjects, in whom there was a marked rise in blood glucose.
This inhibitory effect of the blood glucose was most evident 
in two patients who felt nauseated at the end of the smoking
period, and who showed the largest increase in blood glucose
in association with a delayed NEPA rise. Since Ashby ejb al.
(1965) measured only platelet adhesiveness it is not possible
to explain the discrepancy between his results and those
presented here. It may be, however, that in the non-fasting
state the blood glucose response to smoking is less striking.
The somewhat surprising finding of a significant increase
in platelet adhesiveness after sham-smoking is clearly associated 
,
with the unopposed effect of the rise in NEPA which has already 
been discussed.
SWIARY AND CQNCL1JSIQNS
1. The smoking of two cigarettes was followed by significant 
increases in plasma total NEPA, blood glucose, and total 
platelet count. There was a small, but statistically insig­
nificant, increase in platelet adhesiveness.
2. Sham-smoking produced no significant changes in plasma 
total NEPA, blood glucose, or total platelet count in the
group as a whole, although in five of twelve cases an appreciable 
.increase in plasma NEPA occurred. There was a significant 
increase in platelet adhesiveness following sham-smoking.
3. Changes in plasma total NEPA were found to show a 
significant positive correlation with changes in platelet 
adhesiveness, whereas changes in blood glucose correlated 
negatively with changes in platelet adhesiveness. In both 
smoking and sham-smoking tests, therefore, increases in 
plasma total NEPA- were associated with increased platelet 
adhesiveness, but where an increase in blood glucose occurred 
platelet adhesiveness was inhibited. •
4# The increases in plasma total NEPA were associated with
an increase in the proportion of unsaturated fatty acids at 
the expense of the saturated fatty acids. The changes in 
platelet adhesiveness correlated more closely with changes 
in plasma total NEPA than with changes in the individual 
NEPA.
5. Serum cholesterol and triglyceride concentrations did
not. alter significantly during either smoking or sham-smoking 
tests. *
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Chapter VII THERAPEUTIC STARVATION
OBESITY AND ATHEROSCLEROSIS
For many years it has been believed that obesity pre­
disposes to ischaemic heart disease. Much of the earlier evidence 
of this association was obtained from life insurance statistics 
which showed increased mortality rates from heart disease in 
overweight Subjects (Armstrong £t §1. 1951; Katz et a l» , 1958), 
Most surveys of ischaemic heart disease demonstrated that in 
relation to height patients were heavier than controls (Gertler 
and White, 1954; Thomas et aO.,, 1958; Ache son, 1961; Brown,
1962), although others showed no difference (Epstein et al,,
Keys, 1956), One large prospective study in Framingham, 
Massachusetts, showed that gross obesity predisposed strongly 
to ischaemic heart disease (Dawber £t al., I962), whereas 
in another prospective study (Paul al., 1963) there was 
no clearcut relationship of overweight to the development 
of ischaemic heart disease. Siqce all prospective studies 
have shown an association between elevated cholesterol values 
and ischaemic heart disease, it.is possible that obesity 
might predispose to ischaemic heart disease by its effect on 
the plasma lipid levels, ^
OBESITY M D  PLASM LIPIDS
Many investigations of the effect of obesity on plasma 
lipids have been carried out, and conflicting reports have 
appeared. In general, plasma lipid levels have been found to 
be higher in the obese than in persons of average weight, although 
many obese subjects may have normal or even low plasma lipid 
concentrations.
A positive correlation between serum cholesterol concen­
tration and body weight has been reported by some investigators 
(Gofman and Jones, 1952; Lewis et al., 1957), whereas others 
have found no such relationship (Taylor e t al., 1962; Keys 
et al,, 1963), and have been unable to demonstrate any effect 
of recent weight gain on. serum cholesterol (Feldman et al,,
1963; Hallberg and Svanborg, 1967). However, Montoye et 
■(1966) have shown in a large population study that there is, 
in fact, a low but statistically significant correlation between 
serum cholesterol concentrations and various measures of body 
fatness (relative weight and skinfold thicknesses). No effect 
has been found of body weight on plasma phospholipid levels. 
(Rifkind and Begg, I966; Sailer I966; Hallberg and
Svanborg, 1967).
Plasma triglyceride levels, also, have been shown to 
be higher on average in the obese than in subjects of normal 
weight (Waxier and Craig, I964; Hollister et al.,. 1967)
although it has been pointed out that many obese subjects 
have normal or low triglyceride levels (Bifkind and Begg, 1966),
A positive correlation between plasma triglyceride and overweight, 
measured by a variety of methods, has been demonstrated by 
many workers (Schrade et I96O5 Benedek, 1965; Evans and 
Ostrander, 196?),.Albrink et al, (1962) has reported that 
elevated triglyceride levels are more closely associated with 
weight gain than with obesity per se, and Feldman ^  ad.
(1963) and Hallberg and Svanborg (1967) have found higher 
triglyceride levels in women with a history of recent weight 
gain.
The plasma NEFA values of obese subjects have been shown 
repeatedly to be higher after an overnight fast than those of 
subjects of normal, weight (Dole, 1956; Corvilain ^  al„ 1961; 
Glennon et al,, 1965). Further fasting has been found to 
reduce the differences in NEFA level between obese and non- 
obese subjects (Gordon, I960; Opie and Walfish, 1963; Beck
et al,, 1964)- *
THERAPEUTIC STAWATION IN OBESITY
Obesity has long been recognised as an undesirable state, 
both for aesthetic reasons and on account of its complications.
In addition to the reduced life expectancy and increased rislc
of ischaemic heart disease already mentioned, obesity is 
associated with respiratory, locomotor, and metabolic disorders. 
Clinicians are constantly faced with the problem of reducing 
a patient*s weight in an effort to alleviate these complications, 
but the success rate in such endeavours has been very low.
In the last'few years total starvation has been used 
as a means of initiating weight reduction (Bloom, 1959) and 
also as a long-term measure, either by means of intermittent 
fasts (Duncan ^  al., 1962; Stewart et , 1966), or by 
prolonged starvation (Prenick. et al,. 1964; Thomson et al,,
1966, Such therapeutic starvation has been shown to be 
acceptable to most patients, and to be an effective method 
of reducing weight rapidly.
Rapid weight reduction produces many changes in metabolism, 
affecting particularly salt and water balance and the metabolism 
of carbohydrate and fat. It is important to ensure that such 
sudden changes are entirely safe. It has been suggested, for 
example, that plasma lipid changes resulting from rapid weight 
reduction may aggravate atheromatous arterial disease or 
induce thrombosis (Beckett and Le\d.s, I96O). An investigation 
has been carried out, therefore, of the plasma lipid and other 
metabolic changes induced by short-term therapeutic starvation, 
together with a study of blood platelet function.
METHODS
(a) Patients
The patients had all presented at medical clinics for 
advice on ?/eight reduction or with symptoms which were 
attributable mainly to obesity. Sixteen patients, 15 women 
and 5 men, completed the 10-day starvation period, and 2 
of these patients. (E. Gib and M.L.) underwent a second period 
of starvation after an interval of several months. These 18 
episodes of starvation are described in this study, and the 
initial status of the patients is summarised in Table XXXIII.
A further 2 female patients, both with features of a depressive 
illness, commenced starvation, but declined to continue after 
2 or 5 days. They are therefore not considered further in 
this study.
(b) Procedure
The patients were treated singly or in pairs in a general 
medical ward. They were ambulant in the ward for most of the 
day. During an initial control period of 5 to 7 days, they 
continued on a diet similar to the one they had had prior to 
admission, in 10 instances this had been an unrestricted diet, 
and in 8 instances a 6oo Calorie diet* They then fasted for 
10 days. Unlimited quantities of acaloric fluids, such as
TABLE XXXIII. Initial Status of Patients
Patient Age Sex Height 
(cm. )
Weight 
(kg- )
Relative
Weight Presenting Symptoms and Signs
16 F 162.6 77.5 141 Obesity
Ï0F0 19 F 162.6 72.7 132 Obesity
E.Gih(l) 21 F 168.9 85.5 143 Obesity- Mild 
depression.
E.Gib(2) 21 F 168.9 79.4 136 Obesity. Mid 
depression.
B.H. 26 M 165.1 100.7 175 Obesity. Paraplegia
M.L.(l) 28 F 158.8 88.4 168 Obesity.
M.L.(2) 28 F 158.8 76.8 146 Obesity.
M.W. 30 F 168.9 113.5 194 Obesity.
E.Gr. 37 F 157.5. 96.9 187 Obesity.
H.B. 58 F 160.0 84.5 158 Obesity.
M.G. 45 F 160.0 91.5 170 Obesity.
W.H. 46 M 176.5 11108 172 Obesity,
M.M. 55 F 161.3 99.5 183 Obesity.
C.H. 54 F 147.5 102.2 221 Varicose veins.
1.8. 57 F 160.0 92.4 172 Obesity,
L.H. 58 F 154.9 76 .4 151 Dyspno ea, Mi tral 
stenosis.
J.R. 58 F 152.4 88.2 180 0 s t e 0 arthritis 
of knees.
P.M. 64 M 163.8 106.9 188 Obesity.
-K-
Actual weight as percentage of standard weight (Kerasley al., 1962)
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water, black coffee, or unsweetened lemon tea, were allowed 
during this period. No vitamin supplements or drugs were 
administered. Following completion of the 10-day starvation 
period, all patients commenced a 600 Calorie diet, and after 
a period varying between 1 and 4 days they were allowed home. 
They returned after 1 to. 4 weeks, in most cases after 2 weeks, 
for follow-up examination.
The following determinations were made in each case;
While in hospital, the patients were weighed daily, 
on rising, in bed attire. At the follow-up examination, they 
were weighed in indoor clothes. In order to malce this weight 
comparable with the others, deductions were made of 2,7 kg. for 
females and 4*6 kg, for males, as recommended by Nemsley et 
(1962).
Skinfold thicloiess
The skinfold thicloiesses were measured by means of 
Harpenden calipers at the lower angles of the scapulae, and 
at the midpoints of the triceps and ulnae. At each site, the 
mean thickness of the two sides was used. Skinfolds were 
measured during the control period and at the end of the 10- 
day fast. In 5 subjects they were also measured during the
refeeding phase, and in 12 subjects at the follow-up. examination. 
Fluid balance
Fluid intake and urine output were measured for each 24- 
hour period from 8.00 a.m. throughout the whole stay in hospital.
Ketonuria ....
Ketonuria was assessed each day using Acetest tablets 
(Ames);
Timing of blood samples
Blood samples for lipid, glucose, and haematological 
estimations were withdrawn after an overnight fast on 3 
occasions during the control period, and on day 2 (that is, 
after 60 hours* fasting) day 4 or 5, day 6 or 7, and day 9 
of the fast. Further samples were obtained after refeeding 
for 24 to 48 hours prior to discharge from hospital, and again 
at the follow-up visit. The folloMng measurements were carried 
out on each blood sample:- serum cholesterol and triglyceride, 
and total and individual plasma NEFA, as described in Chapter 
II; haematocrit (page 132); blood sugar (page 216); and platelet 
count and platelet adhesiveness (page 216).
RESULTS
I. General Effects of Total Starvation
The fast was tolerated well by all patients, although mild 
fatigue and lethargy were fairly constant symptoms. One patient 
had mild diarrhoea lasting for less than 24 hours during the 
starvation period, but this did not necessitate termination 
of the fast. No other side-effects were encountered in this 
series.
Although the patients were purposely not questioned 
systematically about the presence or absence of hunger, this 
was not complained of after the first 1 to 2 days. Most 
patients, however, were not anorexic, and several stated that 
they would have enjoyed a meal if this had been provided.
II. Changes in Weight
A rapid and marked weight loss occurred during starvation,
and a prompt, but smaller, weight increase was seen on
♦
resumption of food intake (Fig, 40).
During the basal period, the 10 patients on an unrestricted 
diet showed a small mean weight loss of 0.25 ±  0.10 kg. per 
24 hours. This occurred in the first 24 to 48 hours after 
admission, and the weight remained Steady thereafter. The
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Pig. 40* Individual weight changes during 
starvation and rofeedin^j.
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basal weight loss was significantly greater in the 8 subjects 
on a 600 Calorie diet (0.74 1  0.51 kg. per 24 hours), and 
continued throughout the basal period.
Weight loss during starvation was greatest in the 
first 24 hours, and decreased progressively thereafter (Pig.
41). The total weight lost during the 10-day fast ranged 
from 3.9 to 9.4 kg. (mean 6.8 kg ), and the largest weight 
losses occurred in the most obese subjects. Resumption of 
calorie•intake was associated with a prompt weight increase 
which continued for several days (Pigs. 40 and 41)#
Pollow-up examination in 14 of the patients showed that, 
at approximately 2 weeks from the end of the fast, they weighed 
on average 7.1 1 2.4 kg. less than their initial weight 
recorded on admission to hospital, and 1.5 ± 2.1 kg. more than 
at the end of the fast.
III. Skinfold Measurements
i
Weight loss during starvation was accompanied by significant 
decreases in thickness of the subscapular and triceps skinfolds, 
but not of the ulnar skinfold (Table XXXIV). On refeeding, 
the subscapular skinfold promptly showed a small but significant 
increase of I.4 mm. (p< 0.05) from the level observed at the 
end of the fast, while the triceps and ulnar skinfolds were
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Pig. 41. Mean weigiat ohaiiges and fluid balance 
during starvation and refeeding.
TABLE XXXIV. Changes in Slcinfold Measurements during
Starvation and Eefeeding (mean + S.B.)
Skinfold Thicloiess mm.
Skinfold Before Past End of Past Pollow-up^ '
29.94 5.2Subscapular 31.1 + 6.7 27.1 + 6.9
Triceps 28.0 + 6.1 26.3 + 6.4 25.7 + 6.0 ■
Ulnar 12.5 i 4.6 12.1 + 4.3 12.2 + 4.6
Significant differences froir^  prefasting level
1 ***
^P<0.01, P<0.01, P< 0.001
(l) 12 subjects only
unchanged. Pollow-up examination in 12 patients showed that 
the triceps skinfold thickness had continued to decrease 
(Table XXXIV). At this time the subscapular skinfold, though 
significantly less than in the prestarvation period, was 
greater than at the end of the fast. Althou^ the'changes 
in the individual- skinfold thicknesses did not show a close 
relationship to the amount of weight lost, a significant 
positive correlation was observed between the decrease in the 
mean of the subscapular and triceps skinfold thicknesses and 
the amount of weight lost during the whole period of obser­
vation (r - +0.65, P<0.02).
In the prestarvation period, the only skinfold measure­
ment which correlated significantly vath the degree of obesity 
as measured by relative weight was the subscapular skinfold 
(r = +0.61, P%0.01). Uo differences were observed in ulnar 
skinfold thicknesses between subjects with childhood-onset 
and adult-onset obesity.
i
IV« ' Fluid Balance
The main changes noted in fluid balance were a diuresis 
in the first few days of starvation, and fluid retention 
associated with resumption of food intake (Fig. 41). Complete 
fluid balance figures for the whole period (basal, fasting,
and refeeding) were obtained for 10 patients, and the results 
are summarised in Table XXXV. Althou^ the fluid intake , 
in individuals fluctuated considerably from day to day, especially 
during the fasting period, there was no consistent trend from 
one period to the next (Fig- 41).
Follovfing admission to hospital, there was a diuresis 
lasting for 24 to 36 hours; for example, in 7 of our 13 patients 
the urine output exceeded the fluid intake in the first complete 
24-hour period after admission. After the diuretic phase the 
urine output was relatively constant for the rest of the basal 
period. For this reason the values for the first complete 
24-hour period were discarded when the mean basal values were 
calculated for comparison with the fasting and refeeding 
periods.
In the first 24 hours of starvation, the urine output 
again increased and the patients were in negative water balance 
for the first 48 hours of the fast (Fig, 41). Over the rest 
of the first week the apparent fluid retention (fluid intake 
minus urine output) gradually returned to basal levels.
During the first 24 hours of refeeding there was a reduction 
in urine output, with fluid retention significantly greater 
than that during the basal period. Several patients were 
observed for 2 to 3 days of refeeding, during which the 
oliguria and fluid retention persisted.
■j.üi3jj£i VULA.V. rxuia mxance in Ten patients me an .and range j
Fluid intake 
ml,/24 hrs.
Urine output 
ml./24 hours
Net Fluid 
Balance
DAYS BEFORE FAST
5 1668 
(990 - 2660) (540 - 4560)
2 1724
(990 - 5480) (600 - 5800)
 ^+407
1 1889 
(1180 - 4070)
1412 
(600 - 3090)
DAYS OF FAST '
*
-2901
(720 - 2190)
, i m  ,
(500 - 4050)
2 1570 
(600 - 5720)
1627
(600 - 5950)
-57
3 1859
(650 - 5845)
1628 
(800 - 3050)
+211
4 ‘
(550 - 2450)
1576 
(800 - 3250)
■ +150
5 1505 
(360 - 2440)
.1165 
(600 - 2000)
+249
6
(750 - 4045)
1558 
(600 - 3400)
+575
7 1910 
(950 - 5410)
1287 
(450 - 5500)
+625
8 1758 
(660 - 5290)
/ iMâ- \ 
(700 - 2090)
+412
- 9 15I8 
(450 - 2940)
, M 2 1  ■ 
(500 - 3400)
+115
10 I694 
(950 - 2560)
1168 
(450 - 5500)
+527
DAYS OF REFEEDING
1 I852 
(1100 - 5450)
828
(400 - 2050)
+954
2 I885 
(1170 - 2940)
1246 
(525 - 5900)
+639
Significant difference from mean basal level P.^0*05> P< 0*01
T. Xetosis
After one day's fasting, 5 patients had significant 
ketonuria and another 4 had a trace. By next day the 
majority of patients had moderate ketonuria, 4 had only a 
trace, and 2 had negative Acetests.- By the fifth day all 
but one patient were showing heavy ketonuria, and continued 
to show it until starvation ended. Patient J. S. had negative 
urine tests for ketones until the sixth day, when she developed 
a moderate degree of ketonuria which persisted till the end 
of the 10-day fast. Patients began to show a decline in 
ketonuria after 24 hours' refeeding, but were not tested in 
detail thereafter.
V I Haematocrit
The haematocrit of all subjects in the pre-starvation 
period was within normal limits at 43*6 + 3*9^ (Table XXXVl).
During starvation the haematocrit increased significantly,
»
reaching a maximum between the 4ih and 7th days, and subse- 
q^uently tending to fall (Pig. 42). It returned rapidly 
to prestarvation levels, on refeeding. At follow-up a small 
but significant reduction of 1.6yô below the prestarvation 
level was noted.
TABLE XXXVI. Changes in Haematocrit, Blood Sugar, and
Platelets during Starvation (mean + S.B.)
Time
of
estimation
Haematocrit
io
. Blood 
sugar 
mg’./lOO ml.
Platelet 
count 
per cu.mm.
Platelet
adhesiveness
%
Mean basal 
level
■ 45.6 
± 5.9
75.5 
. + 11.0
188,090
+45,210
39.2
±9.5
After 2 
days' fast
44.8^ 
+ 4.0
. -X-X-ît 
56.0
± 8.9
197,560*
+50,210
57.0
±14.2
After 4 or 5 
days' fast
46.1**
+5.1
• -X**
50.8
±11.3
200,190
+45,080
40.0 
±16.6
After 6 or 7 
days' fast
***
45.5
+4.0
X X *
54.0 
± 7.0
208,590
+47,110
40.3
±15.4
After '9 
days' fast
44.9
+5.5
X X X
59.8 
Hh 9.8
191,990
+59,860
39.1
±13.3
Refeeding 45.4
+4*6
77.8 
+12.4
182,920
+45,760
34.4
±11.5
Pollow-up
-X"
42.1
+4.7
74.9
+14.5
211,190
+57,440
41.3 
±14.6
Significant difference from mean basal level.
* / ***
P<0.05, ^P<0.02, P<0.01, P < 0.001
•h
SERUM 
CHOLESTEROL
SERUM 
TRIGLYCERIDE
NEFA 
Inqlc ex
NEFA 
ouble  e; 
/jEq./l.
BLOOD
SUGAR
platelet
COUNT
x lO */c u .m m .
PLATELET
ADHESIVENESS
•/o
4Û “
44
42
4 0
275
250
200
lOO
9 0
8 0
70
1400
OO
7 0 0
5 0 0
1000
8 0 0
6 0 0
4 0 0
80
70
60
SO
210
200
190
180
44
4 0
36
32
time in day* 
FASTING
MEAN
BASAL
' RE-
f eeoingI follow-up
Pig# 42* Haem atological and biochem ical resultso
fSorura t r ig ly c e r id e  re s u lts  fo r  l6  p a tie n ts  o n ly ). 
(HSFA-double e x tra c tio n  - i n  8 p a tie n ts  o n ly ).
VII. Blood Sugar
The blood sugar level fell considerably during starvation, 
reaching its lowest level after 4 or 5 days (Table XXXVI,
Pig. 42)* It then showed a tendency to rise, but nevertheless 
remained significantly below the basal level throughout the 
whole fasting period. On refeeding it rose rapidly to 
prestarvation levels, and remained at these levels at follow- 
up.
In the prestarvation period, the fasting blood sugar 
vras not related to the age of the subjects, nor to their 
degree of obesity as measured by relative weight. There was, 
however, a significant positive correlation between the mean 
fasting blood sugar and the triglyceride level (r = +0.55> 
P<0.05).
VIII. Serum Cholesterol
Starvation was associated with a significant increase 
in serum cholesterol (Table XXXVII, Pig. 42), maximal between 
the 4th and 7th days, and returning towards the basal level 
after 9 days. On refeeding there was a rapid and highly 
significant decrease to 36 mg. per 100 ml. below the basal 
level. By 2 to 4 weeks after the fast, however, the cholesterol 
had returned to prefasting levels.
TABLE XXXVII. Plasma Lipid Changes during Starvation
(mean + S.I). )
Time
of
estimation
Serum 
Cholesterol 
mg./lOO ml.
Serum(  ^
triglyceride 
mg./lOO ml.
Plasma REPA 
(single ext.) 
microe%./l.
Plasma K P A  
(double ext.) 
microeq./l.( 2 )
Mean basal ■ 245-8 84-5 545 503
level ± 59.1 ± 19.7 + 125 ± 143
250.9
* * i t *
After 2 88.9 865 894-
days* fast ± 41.7 ± 18-3 ± 4I8 ± 279
i t * * **
After 4 or 2 7 2 . 5 108.7 885 856
5 days' fast +  5 0 . 2 i 18.3 ± 349 ± 2 3 2  •
I * * * * * * * *
After 6 or 275. y 104.9 1118 930
7 days* fast ± 65.8 ± 21.3 ± 435 +  226
248.0
i t * * * **
After 9 88.0 965 823
days * fast ±  45.8 ± 40.5 ± 361 ±  187
* * *
76.3
* *
Refeeding 209.5 799 ~ 712
± 57.0 ±  13.9 ±  303 + 246
Follow-up 243.2 
± 45.2
88.2 
± 3I-O
538 
+ 181
453 
± 176
(1) 16 normoglyoeridaemic subjects only.
(2) 8 subjects Only.
Significant difference from mean basal level 
. P<0.05, "P<0.02, • P^O.Ol, P< 0.001.
^ 4 ^
The prefasting serum cholesterol levels were within 
normal limits for the patients’ ages with three exceptions - 
W. H. (48 years) 546 mg. per 100 ml., J. R. (58 years) 519 mg. 
per 100 ml., J. S. (16 years) 267 mg. per 100 ml. There was 
no correlation between the serum cholesterol concentration 
and the degree•of obesity,
IX. Serum Triglyceride
The effect of starvation on the serum triglyceride was 
found to depend on the initial serum triglyceride concentration; 
in those subjects with initially normal levels small, transient 
increases occurred, whereas in hypertriglyceridaemic subjects 
marked decreases were recorded. The initial serum triglyceride 
levels were not related to the degree of obesity, as meaaured 
by relative weight or skinfold thicknesses. There was no 
correlation between serum triglyceride and serum cholesterol 
levels, although one subject (W.H.) had elevated serum concen­
trations of both triglyceride and cholesterol.
The prestarvation triglyceride levels were within the 
range 58 to 118 mg. per 100 ml. in 16 subjects. In these 
normoglyceridaemic subjects, starvation resulted in a rise 
in triglyceride which was maximal after 4 to 5 days, but 
remained significantly above the initial level throughout 
the fast (Table XXXVII, Pig. 42). On refeeding there was
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a slight fall in triglyceride to levels not significantly 
lower than prefasting levels. By the time of follow-up 
examination, it had returned to prefasting levels.
The remaining 2 patients, H. B. and W. ÏÏ., had grossly 
elevated initial serum triglyceride levels (328 and 507 mg. 
per 100 ml. respectively). Both subjects showed rapid and 
progressive falls in triglyceride throughout the fasting 
period, but different responses to resumption of food intake 
(pig. 43)" In H. B., the serum triglyceride continued to 
fall during refeeding and at follow-up examination 2 weeks 
later. Two days' refeeding in W. H., however, resulted in 
doubling of the serum triglyceride, and by 2 weeks later it 
had returned almost to prestarvation levels.
X. Total Plasma Non-Esterified Patty Acids (HEPA)
During starvation the "NEPA" level (single extraction 
technique) rose in all but one patient (j.S.), and after 6 
to 7 days was more than double the basal value (Table XXXVII, 
Pig. 42). The mean "MPA" level then declined, and on refeeding 
a further decrease was observed. After 24 hours' refeeding 
the plasma "REPA" had fallen in 5 and risen slightly in 3 
instances from'the level recorded at the end of the fast.
After 48 to 96 hours* refeeding it had fallen in 7 out of 8 
instances. By the time of follow-up examination the "MPA"
SERUM
TRIGLYCERIDE
mgi/lOOml.
400
300
200
too
time in 4#ym
FASTING FOLLOWUP
I R E -' 
[FEEDINGBASAL
FiC* 43» Plasma triglyceride changes during
. starvation in two byportriglyceridaemic 
subjects.
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had returned to prestarvation levels. The changes in plasma 
'NEFA as measured by the more specific double extraction 
technique showed a similar pattern, although the peak values 
recorded during starvation were lower (Table XXXVII, Fig. 42). 
During the basal period I6.O + 2.$^ of the apparent "HBFA" 
value was due■to-substances other than long-chain, non-esterified 
fatty acids. This is in agreement with the figure of 10 to 
2Cÿü quoted by Dole and Meinertz (I96O). After 6 to 7 days* 
starvation this percentage had risen to 28,0 + 10.5/^ , due 
to the inclusion of ke.tone bodies.
In the'prestarvation period half of the 18 patients 
had mean **NEFA’* levels between 530 and 500 microeq. per litre.
The two highest values were 810 and 820 microeq, per litre.
The highest "NEFA" levels during the fast were found in these 
subjects with the highest prestarvation levels; a positive 
correlation was demonstrated between the mean prestarvation 
"NEFA" value and the maximum level recorded during starvation 
(r = +0.60, P<0.01). There was also a negative correlation 
between the mean plasma "NEFA" and the mean blood glucose 
level for each individual in the basal period (r = -0.52,
P<0.05). No significant differences were found in "NEFA" 
level between subjects on a 600 Calorie diet and those on an 
unrestricted diet, nor between those with childhood-onset
245
and adult-onset obesity. No relationship was demonstrated 
( between "NEFA" level and age, or degree of obesity.
XI. Individual Non-Esterified Fatty Acids
The elevation of plasma NEFA levels induced by starvation 
was associated with a change in the proportions of the individual 
fatty acids (Table XXXVIII). During starvation there was a 
significant increase in the proportion of oleic acid, with a 
corresponding decrease in palmitic and myristic acids. The 
fall in stearic acid did not reach conventional levels of 
significance. These changes were maximal after 2 to 5 days, 
and thereafter the pattern showed a tendency to return to 
the normal prefasting state. Refeeding, however, resulted 
in a further small increase in oleic and decrease in palmitic 
acid. At follow-up examination the pattern had reverted to 
that seen in the basal period.
XII. Platelet Count and Platelet Adhesiveness
i
As in the case of the haematocrit, the platelet count 
increased slightly during starvation, and returned to basal 
values on refeeding (Table XXXVI, Fig. 42). The platelet 
adhesiveness, however, showed marked variability from day to day 
and no significant trends were observed during starvation 
or subsequently (Table XXXVI, Fig. 42),
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DISCUSSION
Total starvation was tolerated well by the subjects, 
vfho made little complaint of hunger after the first one to 
tv/o days' starvation. The amount of weight lost during the 
ten-day period of starvation could be regarded as worthwhile 
from a therapeutic point of view. Despite the early weight 
gain on refeeding, the nett weight loss of 7.1 + 2.4 hg. 
recorded at follow-up examination two to four weeks later 
was sufficient to convince the patients that an appreciable 
amount of weight could be lost rapidly and permanently. The 
serial measurements of skinfold thickness suggested that 
the central (trunk) depots of adipose tissue were reduced 
more than the peripheral (limb) depots.
The plasma lipid results showed that the most strilcing 
and consistent changes during total starvation were in the 
NEFA fraction (Table XXXVIl), although smaller changes occurred 
in the other plasma lipids also. The effect of starvation 
on the‘plasma lipids will be discussed in some detail. Since 
these plasma lipid changes are accompanied by, and in some 
cases secondary to, the starvation-induced alterations in 
fluid balance and in the glucose and other blood constituents, 
the mechanisms of these alterations will also be considered.
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Total Plasma KEFA
A considerable number of investigations have been 
reported to show that plasma NEFA levels of obese subjects 
after an overnight fast are on average higher than those of 
normal weight (Opie and Walfish, 1$6$; G-lennon e^ ad., 19^5) 
although the reason for this difference is not known, llany 
of the grossly obese subjects in the present series, howeveiç*, 
had plasma NEFA concentrations within normal limits (page 
2^4). It has been suggested that inhibition of the action 
of insulin by increased plasma NEFA concentrations in some 
obese subjects leads to tissue resistance to insulin, with 
compensatory hypersecretion of insulin, and eventually to 
the glucose intolerance commonly present in longstanding 
obesity, and in some cases to frank diabetes (Randle et al., 
1963)' In the subjects presented here a significant negative 
correlation was demonstrated between fasting blood glucose 
and plasma KSFA levels in the prestarvation period. The 
apparently paradoxical finding of lower fasting blood glucose 
levels in those subjects with higher fasting NEPA levels is 
compatible with Jenkin*s (1967) hypothesis that, when plasma 
NEFA concentrations are persistently elevated, a stage of 
increased insulin secretion occurs during which raised plasma 
NEFA levels and normal or low blood glucose levels are found.
Later pancreatic insufficiency may supervene and fasting 
blood glucose levels tend to rise*
The estimation of "NEFA** by the single extraction 
technique of Dole and Meinertz (I960) includes substances 
such as lactic acid and ketones. During starvation, these 
were found in our.patients to account for approximately 28 
per cent (in one case as much as 4^  per cent) of the total 
"NEFA" figure (page 244). A value due almost entirely to 
true long-chain non-esterified fatty acids is obtained by 
the double extraction method recommended when exceptional 
amounts of ketones or short chain acids are believed to be 
present. The latter technique was followed in eight of the 
eighteen studies reported here. However, the changes in 
plasma NEFA during starvation were of such magnitude, and 
differed so little in pattern after both single and double 
extraction methods, that useful information was obtained even 
by the single extraction technique.
Elevations of plasma "NEFA*,* levels during starvation 
have been reported by a number of investigators, almost all 
using techniques of NEFA estimation that included varying 
amounts of ketones (Laurell, 1956; van Riet , I964),
The two-fold rise in plasma "NEFA** in the present study (Table 
XXXVIl): is similar to that observed by Hager and lampietro 
(1966) in normal individuals subjected to starvation and cold
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exposure, and by Opie and V/alfish (19&5), and Saraaan _et al.,
(1965) in obese subjects. It is considerably smaller than the 
changes found in normal subjects by Albrink and Neuwirth (I96O) 
and Bloom ^  al. (1966a). Gordon (i960) and Schwarz at al.
(1966) carried out comparisons of the effect of fasting on 
NEFA levels in obese and non-obese subjects, and found a much 
higher and more rapid rise in the normal subjects than in the 
obese. The plasma NEFA concentration is the result of dynamic 
and rapidly-changing processes in lipid mobilisation, utilisation, 
and deposition. A very rapid NEFA turnover rate has been 
demonstrated, about half of the NEFA reaching the plasma being 
cleared into other tissues within one to three minutes (Fredrickson 
and Gordon, 1958a)* No impairment of NEFA utilisation has been 
found in obesity (Opie and V/alfish, I965). There is, however, 
considerable evidence that in some obese subjects the release
of NEFA from fat stores is impaired. A decreased rate of
NEFA release vitro from the adipose tissue of obese subjects.
was found by Laszlo _et . (I961), who were unable to demonstrate
»
any significant qualitative differences on analysis of adipose 
tissue samples from obese and non-obese subjects. The forearm 
metabolic studies of Rabinowita and Zierler (1962) showed that 
in the basal state NEFA release in the obese was about half 
that of the non-obese. Diminished or delayed plasma NEFA 
responses were demonstrated, in the obese to lipid-mobilising
stimuli such, as catecholamines (Berkowitz, 19&4; Heald et al,, 
1965} ÿ exercise (Opie and V/alfish, 1965) a,nd sociopsychological 
stress (Klein et , 1965).
In the grossly obese subjects in the present series, with 
one exception (J. S.), total starvation produced a marked and 
sustained increase in plasma NEFA concentrations. The results 
reviewed above appear to indicate that NEFA mobilisation in 
response to a variety of stimuli, including starvation, is 
rather less in the obese than in lean subjects, despite the 
tendency of the obese to higher NEFA levels after an overnight 
fast.
Individual Hon-Esterified Fatty Acids
The raised plasma NEFA levels during starvation were 
associated with an increased proportion of the unsaturated 
oleic acid, and a decreased proportion ofpalmitic and, to 
a lesser extent, other saturated fatty acids (Table XXXVIIl).
A similar change in NEFA pattern has been observed when an 
acute increase in plasma NEFA is induced by norepinephrine 
infusion (Rothlin £t , I962) or, as shown in Chapter VI, by 
cigarette-smoking’. Conversely, a rise in saturated and fall 
in unsaturated fatty acids occurs during lowering of the 
plasma NEFA-level either by inhibition of adipose tissue 
lipolysis (Nalcamura et , I967) or by increased NEFA
utilisation (Wood £t , I965)-
The plasma NEFA pattern is thought to he determined 
mainly by the rate of release of fatty acids from adipose tissue, 
but is also influenced by their rate of clearance from plasma.
As sho^ vn in Table XXXIX, the fatty acid pattern of adipose 
tissue differs.from that of plasma NEFA. In the present study 
the plasma NEFA pattern shows an approach during starvation 
towards the fat depot pattern (Table XXXIX), in contrast to 
the findings of Imaichi _et (1965), This suggests that the 
individual fatty acids are not released from adipose tissue 
in a selective manner, and is consistent with the observation 
of Hirsbh (1965) that marked shrinkage of depot fat in obese 
subjects by total starvation or prolonged calorie restriction 
is not associated with changes in the fatty acid composition 
of adipose tissue.
Serum Cholesterol
Although a low grade positive correlation between serum 
cholesterol concentration and overweight has been demonstrated 
in studies of large populations (Montoye et , I966), the serum 
cholesterol has frequently been found to be within normal limits 
even in the grossly obese. This was the case in the present 
series, only three of whom had raised serum cholesterol levels 
(page 242),
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During starvation a small but significant increase in 
serum cholesterol occurred in the first four to seven days, 
and thereafter it tended to return to basal levels. Similar 
changes were described by other investigators under somewhat 
different circumstances. Kart in ^  (1944) showed
progressive increases in cholesterol and phospholipid levels 
in normal subjects during starvation combined with water 
deprivation, Rubin and Aladjem (1954) noted increased 
concentrations of the cholesterol-rich (Sf 0-12) lipoprotein 
fraction in healthy subjects who.fasted for four to five days, 
Mager and lampietro (1966) found that in healthy males subjected 
to cold and starvation the serum cholesterol rose in the early 
stages of the fast, but returned to fasting levels by the 
fourteenth day. Bloom al, (1966a) showed greater increases 
in serum cholesterol during four-day fasts in normal females 
than in normal males.
Reports on serum cholesterol changes during total star­
vation in obese subjects are contradictory, Ende (1962) 
found that the serum cholesterol increased during 72-hour 
fasts in his obese subjects as well as in the non-obese, and 
Cochran ofc (I964) described a variable slight rise followed
by fall in sezum cholesterol in twelve obese patients starved 
for periods of five to twenty-five days. Varying responses
or no change were reported hy Drenick ob (19^4) their
male obese subjects, and by van Riet et al. (I964) in their 
hypercholesterolaemic female subjects. The transient increases 
in serum cholesterol during starvation in this study were 
similar to the changes in haematocrit (Fig. 42) and may simply 
reflect alterations in plasma volume. This effect of total 
starvation on serum cholesterol concentration is in contrast 
to that produced by calorie restriction, where little or no 
change occurs in serum cholesterol level unless the total fat 
intake is restricted (Galbraith et , I966) or the type 
of dietary fat is altered (Jolliffe et , 1962).
The sharp decline in serum cholesterol on refeeding 
was out of proportion to the fluid retention which occurred 
in this period, as reflected by the fall in haematocrit. Ende 
(1962) also noted a drop in serum cholesterol in the first 
48 hours of refeeding in six of twenty-nine subjects, and 
commented that it could be only partially accounted for by 
an increase in plasma volume. A similar decrease in cholesterol 
to levels significantly lower than that in the prestarvation 
period was seen in Mager and lampietro*s (I966) data, although 
they made no comment on it. Although the cause of this fall 
in serum cholesterol cannot be stated from the present study, 
it might be contributed to by the unmasking of an actual decrease 
in serum cholesterol content, obscured during the starvation
period by haenioooncentration. The synthesis of cholesterol 
and fatty acids has been shown to be markedly reduced during 
starvation in animals, and on refeeding there is a time-lag 
before resumption of synthesis of cholesterol, but not of 
fatty acids (Jansen et al., 1966).
The long-term effect of weight reduction on the serum 
cholesterol level appears to be small. In this respect the 
results at two to four weeks are in agreement with those of 
other investigators (Caldwell £t , 196$; Drenidk et al., 1964). 
Walker et (1955) have suggested that those subjects with
initially high serum cholesterol levels tend to show a permanent 
decrease in cholesterol, whereas those whose cholesterol levels 
are normal or low show no change. Ho such effect was discernible 
in the present series.
Serum' Triglyceride
The obese subjects in this series could be separated into 
two distinct categories on the basis of their serum triglyceride 
concentrations;- two subjects had grossly elevated triglyceride 
levels, while in the remainder the serum triglyceride was within 
normal limits (page 242). Serum triglyceride levels have been 
shown to be, on average, higher in the obese than in subjects 
of normal weight (v/axler and Craig, 1954; Hollister et. ad., I967) 
despite the fact that many obese subjects have low or normal
triglyceride.values (Rifkind and Begg, I966).
The lov/grade positive correlation between basal glucose 
and triglyceride levels in the present study is of some interest. 
This relationship still holds if only those with normal tri­
glyceride levels are considered, and is of the same order as that 
noted by Albrink and Meigs (1964) in a large series of healthy 
males. Similarly, Waxier and Craig (1964) demonstrated in their 
series of chronically obese, but otherwise healthy, females that 
subjects with a prediabetic glucose tolerance curve have elevated 
serum triglyceride levels as compared with those with a normal 
glucose tolerance curve. It has been suggested (Farquhar £t , 
1966) that this association between blood levels of glucose and 
triglyceride results from stimulation of hepatic synthesis 
of triglyceride by repetitive postprandial elevations of both 
plasma glucose (a potential substrate for triglyceride synthesis) 
and insulin (a hormone which enhances the synthetic process).
Partly from conjecture and partly as a result of animal 
experiments (Bloor, 1 9 1 4 )1 earlier workers believed that 
starvation induced marked increases in all blood lipids, but 
particularly in neutral fat.. This ‘‘starvation hyperlipaemia" 
was thought to be due to mobilisation of neutral fat from adipose 
tissue to meet metaboliq requirements (Kartin et al., 1944)•. 
Subsequent investigations in obese and non-obese humans have 
produced conflicting results, some workers reporting significant
25b
increases (Bloom et al., 1956a; Mager and lampietro, 1956), 
and others variable responses or no change in plasma total 
lipids (Brenick £t , 1954; van Reit et al., 1954) • This 
confusion may be due in part to the nonspecificity of the lipid 
methods employed in most of these investigations. The present 
study shows that there are, in fact, two types of triglyceride 
response to starvation;- a small, transient triglyceride increase 
in those with initially normal levels (Fig. 42); and a marked,, 
progressive decrease in hypertriglyceridaemic subjects (Fig.
45). In the former case, the transient increase in triglyceride, 
like that in cholesterol, may be the result of haemoconeentrâtion, 
Withdrawal of carbohydrate is the most likely explanation of the 
dramatic fall in triglyceride in the two hypertriglyceridaemic 
patients, since hypertriglyceridaemia has been shown to be most 
commonly due to excessive carbohydrate intake (Ahrens ^  ,
1951). One of these patients showed a considerable rise in 
serum triglyceride levels during the refeeding and follow-up 
period, despite a diet which contained only 54 g. per day of 
carbohydrate. The fact that his weight did not rise suggests 
that he was observing.his diet.
Fluid Balance
The diuresis which occurred early in the starvation 
period, particularly in the first 48 hours, accounted for the
z y i
more rapid loss of weight in this phase. This has been noted 
in all detailed studies of total starvation. Total deprivation 
of food is not essential to produce the diuresis. Gamble et 
al. (1925) showed that a reduction in carbohydrate intake alone 
may be responsible, and Bloom and Azar (1955) found that the 
substitution for an ordinary mixed diet of an isocaloric diet 
containing only protein and fat produced changes in water and 
electrolyte excretion similar to those of total starvation.
The diuresis has been shown to cease abruptly on infusion of 
glucose, or on ingestion of carbohydrate, when fasting is under­
way (Bloom, 1952). The patients in the present study all retained 
fluid when dietary intake was recommenced. Even a 5OO Calorie 
diet has been reported to produce such a retention of salt and 
water (Smith and Brenick, 1956), and it is probably the re- 
introduction of dietary carbohydrate which is responsible. The 
mechanism by which carbohydrate controls water balance is not 
fully understood, but Wright at al., (1965) have suggested that 
renal concentrating ability is impaired in the presence of low 
blood sugar levels.
Haematocrit
As might be anticipated from the acute changes in fluid 
balance the haematocrit was found to increase during starvation.
A decrease in plasma volume during the first two weeks of fasting
has been demonstrated by Rapoport et al. (1965a) and Bloom
et al. (19660). A decrease in red cell volume, of lesser degree 
than that of plasma volume, has also been sho\?n to occur during 
starvation (Rapoport et al., 1965a), and this may be due to 
lack of erythropoietin, as suggested by Ito and Reissman
(1966) on the basis of their rat experiments.
Blood Sugar
The blood sugar concentration fell considerably during 
star\ration (Table XXXVI), In spite of the low blood sugar , 
levels recorded, the lowest being 56 mg. per 100 ml., no hypoglycaemic 
symptoms were apparent. Similar findings in obese subjects 
have been reported by Brenick et (I964), and by Rapoport
et al. (1965b), but van Riet et (1964) found only insig­
nificant decreases in blood sugar during a ten-day fast. The 
necessity of maintaining adequateblood sugar concentrations • 
during fasting is evident from the fact that, although most 
tissues readily utilise fatty acids as a source of energy, 
for certain tissues, such as nerve cells and erythrocytes, glucose 
is an essential nutrient (Reitsma, I967). The raised plasma 
concentrations of NEFA and ketones inhibit utilisation of glucose 
by muscle during starvation, and gluconeogenesis is eniianced 
(Randle et al •, I965), The increased production during 
starvation of hormones with a hyperglycaeraic action, such as
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glucagon (Unger at , 19&5) and growth hormone (Roth at al., 
1965) may also be an important factor in maintaining the blood 
glucose levels.
Ketones
It is generally accepted that absolute or relative carbo­
hydrate deprivation leads to accumulation of ketone bodies 
in the blood. The mechanism of ketogenesis is believed to be 
the stimulation of hepatic production of acetoaoetic acid and 
p-hydroxybutyric acid as a result of the increased plasma NEFA 
concentrations (Steinberg, I965)' Although obese subjects 
have been reported to be resistant to the development of ketosis 
(Kekwiok ejt al., 1959)? ketonuria or hyperketonaemia has been 
a universal finding in studies of therapeutic starvation in 
obesity (Cochran et al., 1964, Silverstone et al., 1966; Stewart 
et al.3 1966). The patients in the present study usually had 
ketonuria within two or three days of beginning the fast, and 
during the latter half of the ten-day period showed heavy 
ketonuria. The one exception was a girl (J. S.) aged 16 years, 
who lost only 5*9 kg. in the ten days, had no rise in plasma 
NEFA, and showed only slight ketonuria, beginning after six days.
Zbü
Platelet Adhesiveness
In this study starvation was not associated with any 
significant changes in platelet adhesiveness (Table XXXVl). This 
is consistent with the fact that there have been no reports of 
thrombotic episodes in patients subjected to therapeutic star­
vation. .
Various investigators have produced evidence that platelet 
function is influenced by fatty acids. Long-chain, saturated 
fatty acids have produced thrombosis following intravenous 
injection in animals (Connor et al., 1965; Soloff and Wiedeman, 
1965), and, by in vitro techniques, have been shown to accelerate- 
thrombus formation (Connor and Poole, I96I), and to cause platelet 
aggregation (Kerr et , I965). In the subjects described in 
Chapter VI, alteration of plasma NSPA and blood sugar by cigarette- 
smoking or stress was associated with alterations in platelet 
adhesiveness. The changes in platelet adhesiveness correlated 
positively with the changes in plasma NEFA,- and negatively with 
the blood sugar changes. If these alterations in plasma NEFA 
and blood sugar were directly responsible for the alteration 
■in platelet adhesiveness, a considerable increase in platelet 
adhesiveness would be anticipated during starvation, in view 
of the large increase in plasma NEFA and fall in blood sugar in 
this situation. -Since this increase in platelet adhesiveness
did not occur, it appears that changes in blood sugar and 
plasma NEFA from day to .day are not the main factors influencing 
changes-in platelet adhesiveness.
Inter-relationship between Metabolic Changes
Most of the changes described during this study of short­
term starvation are believed to result from withdrawal of carbo­
hydrate rather than from deficiency of total calories, and 
are readily reversed by refeeding with carbohydrates alone or 
with a mixed diet. This is true in the case of the early 
diuresis, which leads to reduction of the plasma volume and the 
consequent increased haematocrit. The reduction in plasma 
volume is partially the cause also of the small increases in, 
cholesterol and triglyceride which occurred in most of our 
subjects. An additional or alternative explanation of these 
serum lipid changes is an increase in hepatic lipoprotein synthesis 
induced by the increased plasma NEFA levels. Increased delivery 
of NEFA to the liver has been shown in animal studies to result 
in increased production and secretion of lipoprotein (Nestel 
and Steinberg, 1963), but may not have this effect during 
starvation, when reduction in hepatic synthesis of cholesterol 
and triglyceride has been described (Jansen , I966).
Carbohydrate deficiency is also the factor in starvation
leading to the rise in blood NEFA level and the associated 
ketosis. The sharp fall in triglyceride in the two hyperlipaemic 
subjects in this study is another effect attributable to carbo­
hydrate withdrawal. That metabolic changes similar to those 
of total starvation can be produced by carbohydrate mthdrawal 
alone has been confirmed by Bloom and Azar (1963). They fed 
to normal subjects a 2,000 calorie diet consisting of 75 per cent 
fat and 25 per cent protein, and demonstrated a pattern of weight 
loss, with increased urinary sodium excretion, and raised blood 
levels of ketones, NEFA, cholesterol and total lipids, similar 
to that seen in total starvation.
The evidence that NEFA mobilisation in the obese during 
starvation is less than that in subjects of normal weight 
has been discussed earlier (page 249), With one exception, 
however, the patients in the present series seemed to mobilise 
fat adequately, and achieved a satisfactory weight reduction.
The subject J. S. appeared to have diminished catabolism of 
adipose tissue; during the ten-day fast there was no rise 
in plasma "NEFA" concentration, ketonuria was slight and delayed, 
and the weight loss was only half that achieved by the other 
subjects. No evidence could be obtained that she was not, in 
fact, adhering to the zero-calorie regime. It may be that in 
her case there was accentuation of the adaptive enzymatic changes
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during starvation which lead to suppression of fatty acid release, 
as Kaunitz (1966) has suggested may occur in some obese subjects.
STJI.MlRY i\m COKCLÜSIQNS
(1) Plasma lipid and other metabolic changes were studied 
during 18 ten-day periods of starvation in obese subjects. '
Weight was lost most rapidly early in the starvation period, 
and the total weight loss during starvation averaged 6.8 kg.
Weight loss was accompanied by reduction in the subscapular 
and triceps skinfold thicknesses. Resumption of food intake 
resulted in temporary weight gain.
(2) The onset of starvation was associated with a diuresis 
which accounted for part of the weight loss, and the resumption 
of food intake with water retention. There was a small but 
significant increase in haematocrit during starvation.
(5) The most striking change in plasma lipids was in the ïïSFA 
fraction which rose to more than'double the basal values after 
six to seven days. NEFA levels fell gradually on refeeding, 
and by the time of follow-up examination two to four weeks 
later had returned to prestarvation levels. The changes in 
plasma NEFA as measured by the more specific double extraction
technique were similar in pattern but peaic values were lower.
There was an increase in unsaturated at the expense of saturated 
fatty acids during starvation, maximal after two to five days.
(4) Ketonuria was marked throughout the starvation period 
in all but one subject, who also failed to show an increase 
in NEFA levels, and whose weight loss was much less than that 
shown by the rest of the group.
(5) Starvation resulted in a small but significant increase 
in serum cholesterol, maximal after four to seven days. On 
refeeding, there was a rapid fall to levels significantly lower 
that the prestarvation values. After a further two to four 
weeks the cholesterol had returned to prestarvation values*
(6) Prestarvation triglyceride levels were within normal 
limits in sixteen instances, and grossly elevated in two subjects. 
In normoglyceridaemic subjects, starvation resulted in a small 
but significant triglyceride increase, maximal after four to
five days. By the time of the follow-up examination in these 
subjects, triglyceride concentrations had returned to prefasting 
levels. In the two hypertrig;lyceridaemic subjects starvation 
resulted in marked reductions in triglyceride. On refeeding, 
the triglyceride rose in one subject, but continued to fall 
in the other subject.
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(7) The blood sugar decreased during starvation, reaching 
its lowest level at four to five days, and remained below 
the prestarvation concentration throughout the starvation 
period. On refeeding, it returned to prestarvation levels.
(8) The platelet count increased significantly during 
starvation, but platelet adhesiveness showed no consistent 
change.
Chapter VIII. GENERAL DISCUSSION AND
CONCLUSIONS
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Chapter VIII. GENERAL DISCUSSION AND CONCLUSIONS
The findings of the present study have been discussed 
in detail in the appropriate sections, and an evaluation 
of the study as a whole will therefore be made in this 
Chapter.
The main objective at the outset of this study was to 
investigate the possible role of gastro-intestinal factors in 
the alimentary hyperlipaemia described in many oases of ischaemic 
heart disease. It was necessary, therefore, in the first instance 
to establish the frequency and severity of fat tolerance abnor­
malities in subjects with and without clinical evidence of 
atherosclerosis. The need for this was apparent for several 
reasons;- the wide variation in plasma lipid concentrations 
from country to countly (Boyd and Oliver, 1958), and the lack 
of information on lipid levels in this area of south-west 
Scotland; the likelihood in an area such as this with a very 
high incidence of ischaemic heart disease (Bronte-Stewart,
1965) that a number of the controls had clinically undetectable 
atherosclerotic disease, so that a simple comparison of gastric 
function in controls and patients might be uninformative; and 
the use in many previous studies of inaccurate techniques for 
lipid estimation (page 118), or unsatisfactory control series 
(page 146)• Standard fat tolerance tests were therefore carried
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out on control subjects and atherosclerotic patients (Chapter 
i t), prior to the gastric function studies (chapter V), which 
were then considered in relation to the relevant fat tolerance . 
tests. Since the fasting plasma lipid concentrations were found 
to have a marked influence on fat tolerance (Table XII), a 
detailed analysis was made of factors affecting the fasting 
plasma lipids (Chapter III), including habitual cigarette- 
smoking. The reason for the close association of cigarette- 
smoking vd-th atherosclerosis is unknown (page 210), and a 
further phase of this study was an investigation of the acute 
effects of cigarette-smoking on plasma lipids and the thrombotic 
tendency of the blood (Chapter Vl). This was followed by an 
examination of these parameters in another situation producing 
acute plasma lipid changes in subjects predisposed to athero­
sclerosis - namely acute starvation in obesity (Chapter VIl).
Despite the numerous population studies of plasma cholesterol, 
and occasionally of other plasma lipids, there have been only 
a few publications on plasma cholesterol levels in healthy 
subjects in Great Britain (Oliver and Boyd, 1953? Acheson and 
Jessop, 1961). The plasma cholesterol levels reported in 
Chapter III revealed a large measure of agreement with figures 
published ih the United States of America, but differed somewhat 
from the findings in older males in Scandinavian series (pages 
89 and 9 2), The present study also amplified the rather scanty
information available on triglyceride and NEFA levels in healthy 
subjects. The finding of a marked overlap in plasma cholesterol, 
phospholipid, and triglyceride concentrations between arterial 
disease patients and controls (page 87) emphasises that 
elevation of the plasma lipids is only one factor in a disease 
of multifactorial.origin. In contrast to the other plasma 
lipids, plasma NEFA concentrations did not differ in controls 
and arterial disease patients (Table VIl). The finding of 
similar plasma lipid elevations in ischaemic heart disease and 
peripheral arterial disease patients (Tables III, V, VI, and 
VIl) indicates that the different clinical types of atherosclerotic 
disease have a common aetiology, althou^ the factors which 
determine the localisation of the disease are, as yet, incompletely 
understood.
The present study (Chapter IV) showed that impaired fat 
tolerance was not a characteristic of arterial disease patients 
in general, but occurred in those who developed the disease at 
an early age (page 139)* This was true of patients with 
peripheral arterial disease as well as of ischaemic heart 
disease patients (page I40), and suggests that the atherosclerotic 
process is accelerated in the presence of abnormalities 
in triglyceride metabolism. It was emphasised that abnormal 
fat tolerance tests occurred in those with already elevated
e~\jy
fasting triglyceride levels (Table Xll). This relationship 
between fasting and postprandial plasma triglyceride concen­
trations had previously been obscured by the use of crude 
techniques for plasma lipid estimation such as optical density 
measurements. The absence or infrequency of differences in 
fasting optical, density between patients and controls, and 
subsequent large differences in optical density produced by 
fat loading suggested that the defect was in the handling of 
exogenous fat. The present results, however, indicate that 
the disorder is in endogenous lipid metabolism. Since the 
8-hour postprandial triglyceride level gave only marginally 
better .separation of arterial disease patients from controls, 
and as fat tolerance tests are time-consuming for both patients 
and staff, it, would appear that they are of little value in the 
detection of lipid abnormalities in atherosclerosis. Ihirthermore, 
the plasma cholesterol value was found at all ages to distinguish 
arterial disease patients from controls better than either 
fasting or postprandial triglyceride concentrations (page I46J•
A prospective population study would be required to determine 
beyond doubt whether antecedent elevation of cholesterol or 
triglyceride is more closely related to the development of 
atherosclerotic disease. From the present study, however, it 
appears that elevation of the plasma cholesterol is the most 
common plasma lipid abnormality in atherosclerosis, but when
elevation of the plasma triglyceride occurs it may he an 
important factor in accelerating the disease*
In the past twenty years there have been repeated 
suggestions that the fat tolerance abnormality is due, not to 
abnormalities in fat transport or clearing, but to an abnormal 
mode of fat absorption associated with impaired gastrointestinal 
function (page 159)# The results of the investigations reported 
in Chapter V, as well as those reviewed in the above paragraph 
indicate this is not the case. Basal gastric secretion, gastric 
emptying rates, and gastric lipolysis were found to be similar 
in arterial disease patients and controls (page 207), even when 
significant differences were found in alimentary lipaemia (page 
176). The rate of gastric emptying was found to influence 
the shape of.the fat tolerance curve (page 198), but not the 
intensity of the lipaemia, already shown to be dependent on 
the fasting triglyceride level (Table XIl). At the outset 
of this study the techniques available for determination of 
gastric emptying could not measure simultaneously gastric 
emptying and alimentary lipaemia (Method I, p.l62), and 
estimated the time required for completion of gastric emptying 
rather than the rate of gastric emptying (Method II, p.lôs).
A more recently developed technique (Griffith _et , I966) 
may provide a satisfactory method for the simultaneous 
determination of alimentary lipaemia and gastric emptying rate.
c. f J.
Gastric lipolysis appeared to occur in a random fashion 
(page 204), and the evidence was against a significant function 
of gastric lipase.
The recently-publicised association of cigarette-smoking 
with atherosclerosis (page 210) emerged at several, points in 
this study. A- considerably higher incidence of habitual cigarette- 
smoking was noted in the arterial disease patients, particularly 
those with peripheral arterial disease, than in the controls 
(Table II). Some evidence was found of higher cholesterol 
levels (page 65) and slower gastric emptying (page 187) 
cigarette-smokers than in non-smokers. The possibility that 
the association of cigarette-smoking with atherosclerosis is 
due to the production of an increased thrombotic tendency 
was explored in Chapter VI. Evidence was found of a homeostatic 
mechanism, whereby a rise in EEFA was associated with increased 
platelet adhesiveness (whether by direct action or as an index 
of catecholamine release), whereas the rise in blood glucose 
which frequently accompanied cigarette^smolcing inhibited platelet 
adhesiveness (page 227). Further investigation of these phenomena 
is indicated to determine whether the increased platelet adhesive­
ness is due to a rise in KEFA per se, or to the catecholamines 
released during smoking, and whether or not these changes found 
in fasting subjects also occur in the nonfasting state. In 
the platelet studies during starvation (Chapter VII), a situation
in which a marked rise in NEFA was accompanied by a. fall in 
blood glucose, the platelet adhesiveness did not show the 
anticipated increase (page 265)* Interpretation of these 
findings is difficult, however, since large day-to-day fluctuations 
occur in platelet adhesiveness due to factors at present unknown 
(page 260). .... .
The studies of lipid mobilisation during starvation in 
obese subjects (Chapter VIl) emphasises that fat mobilisation 
occurs readily under these conditions even in subjects with 
refractory obesity, and. that satisfactory short-term weight 
reduction can be achieved. The possibility of a defect in 
fat mobilisation in some obese subjects, supported by the 
findings in one of the patients in this study (page 262), is 
worthy of further investigation. The role of KEPA as the 
transport form of fat mobilised to meet energy requirements 
has been underlined in this study. The older erroneous reports 
of mobilisation of triglyceride and cholesterol from fat depots 
during starvation were probably due to failure to appreciate 
the dehydration effect of total starvation (page 258). The 
present study also clarifies the changes which occur in plasma 
triglyceride during starvation, two distinct effects being 
observed depending on the initial triglyceride level (page 242).
In summary, therefore, this study showed no evidence
Z’i^
that alimentary hyperlipaemia was associated with impaired 
gastric function. It emphasised the frequency in atherosclerotic 
disease of elevated plasma cholesterol levels, the lesser 
frequency of triglyceride disorders, and the interrelationship 
of plasma cholesterol, phospholipid, and triglyceride concen­
trations resulting from their common plasma transport meolianism. 
No differences were found between atherosclerotic patients and 
controls in plasma HEFA concentrations either in the basal 
state or following various stimuli, and plasma ffiFA levels 
fluctuated independently of the other plasma lipids.
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S0Î.3 FACTORS APF2CTISG THE PMSKA. LIPIDS
SUMÎJARY
SüI'MARY
Some factors affecting the plasma lipid concentrations 
were studied in healthy subjects, in patients with atherosclerotic 
arterial disease, and in two groups of subjects predisposed to 
atherosclerosis: namely, habitual oigarette-smokers, and obese 
persons.
1. FASTING PLASMA LIPIDS
In healthy subjects, plasma cholesterol, phospholipid, 
and triglyceride concentrations were markedly influenced by 
age and sex.. There was a considerable overlap in lipid values 
between healthy controls and patients with atherosclerotic 
arterial disease.
At all ages arterial disease patients had significantly 
higher mean plasma cholesterol levels than controls.
Elevated fasting plasma triglyceride concentrations 
occurred only in young arterial disease patients. There were 
no significant differences in triglyceride between patients 
and controls in older subjects.
Similar plasma lipid abnormalities were seen in the three 
clinical types of arterial disease studied - myocardial infarction, 
angina pectoris, and peripheral arterial disease.
Plasma non-esterified fatty acid levels did not differ 
in patients and controls. The only factor shown to influence 
plasma non-esterified fatty acids was habitual cigarette-' 
smoking. Significantly lower non-esterified fatty acid levels 
were found in habitual cigarette-saiokers after overnight 
abstention from smoking.
2, FAT TOIERANGB TESTS
Fat tolerance tests, using a 75 g* fat mixed meal, were 
carried out in patients and controls.
The fat tolerance curves of male arterial disease patients 
aged 40 to 44 years were significantly higher than those of 
healthy men of the same age. Fat tolerance tests in older 
male and female patients did not differ from those of controls 
of corresponding age. Patients with myocardial infarction, 
angina pectoris, and peripheral arterial disease showed similar 
abnormalities in alimentary lipaeraia.
High fat tolerance curves occurred in those subjects 
whose fasting triglyceride concentrations were already 
elevated.
In arterial disease patients of all ages elevation of 
the plasma cholesterol concentration was more common than 
elevation of the fasting or 8-hour triglyceride value.
3* GASTRIC FUNCTION IN RELATION TO FAT TOLERANCE AND 
ATHEROSCLEROSIS
Studies of gastric secretion, rates of gastric emptying, 
and gastric lipolysis were carried out in patients and controls
Basal gastric secretion was similar in volume and 
composition in healthy controls and arterial disease patients.
Gastric emptying rates were similar in controls and 
arterial disease patients.
The peak in postprandial lipaemia occurred earlier in 
subjects with a rapid gastric emptying rate, determined both 
by an intubation technique and by a radiological method.
Gastric lipolysis occurred to a variable degree in all 
subjects, but did not differ in controls and arterial disease 
patients. The extent of gastric lipolysis showed no relation 
to the degree of postprandial lipaemia.
4. SHORT-TERiM EFFECT OF CIGidüîlTTE-SMOKING ON PLASMA LIPIDS, 
BLOOD GLUCOSE, AND PLATELET ADHESIVENESS
Plasma lipids, blood glucose, and platelet adhesiveness 
were measured in six arterial disease patients and six controls 
before and after smoking and sham-smoking. The changes were 
similar in patients and controls.
Cigarette-smoking elevated plasma non-esterified fatty 
acid levels and resulted in an increase in the proportion of 
unsaturated fatty acids at the expense of saturated fatty acids. 
Smoking was also followed by a rise in blood glucose and 
transient increase in the total platelet count. The variable 
effect of smoking on platelet adhesiveness seemed to be due to 
opposing actions of changes in non-esterified fatty acid and 
glucose levels. A rise in plasma non-esterified fatty acid 
was associated with increased platelet adhesiveness, whereas 
a rise in glucose inhibited platelet adhesiveness,
5. EFFECT OF THERAPEUTIC STARVATION ON PIASIvA LIPIDS
The changes in plasma lipids and other metabolic changes 
were observed during ten-day periods of total starvation in 
sixteen obese subjects.
Starvation produced a marked rise in plasma non-esterified 
fatty acid, and-a fall in blood sugar. Small increases in 
cholesterol and triglyceride occurred in most subjects, but the 
two patients with hypertriglyceridaemia showed a dramatic fall 
in triglyceride throughout the fast. The majority of these 
changes were maximal after four to seven days, but tended to 
return towards prestarvation levels as fasting continued.
CONCLUSIONS
This study emphasised the frequency of elevated plasma 
cholesterol values in atherosclerosis, the lesser frequency 
of triglyceride abnormalities, and the inter-relationship of 
cholesterol, phospholipid, and triglyceride concentrations 
resulting from their common plasma transport mechanism. Plasma 
non-esterified fatty acid levels did not differ in atherosclerotic 
and healthy subjects, either in the basal state or in response 
to various stimuli, and showed no correlation with the other 
plasma lipid values.
